SYNTHESIS OF C-GLYCOSYL AMINO ACIDS AS

STABLE BUILDING BLOCKS FOR MODIFIED

GLYCOPEPTIDE SYNTHESIS by Aldhoun, MOHAMMAD MOUSA ALI
  
I 
 
   
 Università degli Studi di Ferrara
 
 
DOTTORATO DI RICERCA IN  
" SCIENZE CHIMICHE " 
 
CICLO 
(XXI) 
 
 
 
COORDINATORE: 
Prof. GASTONE GILLI 
 
 
 
 
 
SYNTHESIS OF C-GLYCOSYL AMINO ACIDS AS 
STABLE BUILDING BLOCKS FOR MODIFIED 
GLYCOPEPTIDE SYNTHESIS 
 
… 
Settore Scientifico Disciplinare  
Settore: Chimica organica 
 
 
 
 
 
 
 Dottorando  Tutore 
Dott. MOHAMMAD MOUSA ALDHOUN                           Prof. ALESSANDRO DONDONI 
 
 
_______________________________ _____________________________ 
 (firma) (firma) 
 
 
 
 
 
Anni Accademici 2006-07, 2007-08, 2008-09 
 
 
 
 
  
II 
 
 
 
 
 
 
DEDICATION 
 
 
TO 
 
WHOM I LOVE 
 
MY 
 
MOTHER, FATHER 
 
 
BROTHERS, SISTERS 
 
 
Nephews ANS Nieces 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
III 
 
 
 
 
 
 
Acknowledgments  
 
 
 
I am grateful to many people for helping me accomplish this research. Sincere thanks 
to my advisor Prof. Dr. Alessandro Dondoni for his help, guidance, patience, and 
understanding. Much appreciation should be given to Dr. Alessandro Massi and Prof. 
Alberto Marra for their continued support throughout this research. 
 
Special thanks for my parents, brothers, sisters and all of my family for their 
encouragements, help and prayers. 
 
I   also owe a debt of gratitude to the Italian Ministry of Foreign Affairs and the 
Italian embassy in Amman, for their generous financial contribution to cover my 
study expenses and make it possible for this academic work to be achieved.  
 
I would like to thank my colleagues and friends for their encouragement, especially 
Alessandra Vecchi, Lisa Moni, Michele Fiore, Maoro Lo Conte,  Omer, and  Thenesh 
Kumar. I also would like to show gratitude to Roland Ferrucci for his English 
revising and editing of my initial manuscripts and Paolo Formagio for his help in 
spectroscopic measurements 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
IV 
 
 
 
List of Contents 
 
 
• Abbreviations                                                                                             V 
• Abstract (English)                                                                                      VII 
• Abstract (Italian)                                                                                                                            VIII 
          
1. C-glycosyl amino acids as stable building blocks for modified 
 glycopeptide synthesis                                                                            1 
                     
1.1. Definition, distribution and functions of glycoproteins                          4          
1.2.Biological roles of sugar chains in natural glycoproteins                         8        
1.3. Synthesis of natural glycopeptides: use of glycosyl amino acids            9  
1.4. Glycosidic linkages in nature: N-and O-glycosyl amino acids              13  
1.5. Natural and unnatural glycopeptide synthesis                                        17 
2. Syntheses of C-glycosyl amino acids: the state of the art                        22 
  
3. Research project: aim and methods                                                       35 
    
4. Results and discussion                                                                43 
      
5. References                                                                                   44  
6.      Attached papers                                                                                            
 
 
 
 
 
 
 
  
V 
 
 
 
ABBREVIATIONS 
 
Amino Acids: 
Ala alanine 
Arg arginine 
Asn asparagine 
Asp aspartic acid 
Cys cysteine 
Gly glycine 
His histidine 
Hyl hydroxylysine 
Hyp hydroxyproline 
Ile isoleucine 
Leu leucine 
Lys lysine 
Phe phenylalanine 
Pro proline 
Ser serine 
Thr threonine 
Trp tryptophan 
Tyr tyrosine 
Val valine 
Xxx general amino acid 
Monosaccharides: 
Gal galactose 
GalNAc 2-N-acetyl-2-deoxy-galactopyranose 
Glc glucose 
GlcNAc 2-N-acetyl-2-deoxy-glucopyranose 
Man mannose 
Xyl xylose 
Other abbreviations: 
Ac acetyl 
B base 
Bn benzyl 
Boc tert-butoxycarbonyl 
t-Bu tert-butyl 
  
VI 
 
C carbon 
DBAD di-tert-butyl azodicarboxylate 
DBU 1,8-diazabicyclo[5.4.0]undec-7-ene 
 
Bu                       butyl 
DCC dicyclohexylcarbodiimide 
DCM                   dichloromethane 
DIBALH diisobutylaluminium hydride 
DMAP 4-(dimethylamino)pyridine 
DME 1,2-dimethoxyethane 
DMF dimethylformamide 
DMP dimethoxypropane 
DMSO dimethylsulfoxide 
DNA deoxyribonucleic acid 
Dol dolichol 
DPPA diphenylphosphoryl azide 
Et ethyl 
Fmoc fluorenylmethoxycarbonyl 
HIV human immunodeficiency virus 
HMPA hexamethylphosphoramide 
LDA lithium diisopropylamide 
Me methyl 
MeOTf methyl triflate 
MPM p-methoxybenzyl 
Nu nucleophile 
OT oligosaccharyl transferase 
PCC pyridinium chlorochromate 
pfp pentafluorophenyl 
Ph phenyl 
Py pyridine 
r.t. room temperature 
SPPS solid-phase peptide synthesis 
TBAF tetrabutylammonium fluoride 
TBDMS tert-butyldimetylsilyl 
TFA trifluoroacetic acid 
THF tetrahydrofuran 
TsCN p-toluenesulfonyl cyanide 
MW                     Microwave  
MCPA                meta-Chloroperbenzoic acid 
MeCN                acetonitrile 
 
  
VII 
 
 
SYNTHESIS OF C-GLYCOSYL AMINO ACIDS AS STABLE BUILDING 
BLOCKS FOR MODIFIED GLYCOPEPTIDE SYNTHESIS 
By 
MOHAMMAD MOUSA ALDHOUN 
 
ABSTRACT 
 
In this thesis, we have studied and synthesized new class of C-glycosly amino acids whose structure features a 
hetrocycle ring holding the carbohydrate and the amino acid fragments. Pyridine and tetrazole rings were used as 
hetrocycle linkers in this project. This class of C-glycosyl amino acids is of interest as new chealtors and as building 
building blocks for cotranslational glycopeptides synthesis. In the first part, C-Glycosylmethyl pyridylalanines were 
synthesized via thermally induced Hantzsch-type cyclocondensation using an aldehyde-ketoester-enamino ester system. 
To one of these reagents was attached a C-glycosyl residue, while to another was bound an amino acid fragment. In a 
one-pot optimized methodology, the dihydropyridine was not isolated while its purification was carried out by removal 
of unreacted material and side products using polymer-supported scavengers. Then the dihydropyridine (mixture of 
diastereoisomers) was oxidized by a polymer-bound oxidant to give the target pyridine bearing the two bioactive 
residues. In this way, a range of eight compounds (58-68% yield) was prepared in which the elements of diversity were 
(i) the gluco and galacto configurations of the pyranose ring, (ii) the α- and β-configurations at the anomeric center, and 
(iii) the positions of the carbohydrate and amino acid sectors in the pyridine ring. The orthogonal functional group 
protection in these amino acids allowed their easy incorporation into oligopeptides via sequential amino and carboxylic 
group coupling. 
In the second part, tetrazole moiety was constructed via Huisgen 1,3-dipolar cycloaddition between nitriles and organic 
azides. Two sets of compounds have been prepared, one being constituted of C-galactosyl and C-ribosyl O-tetrazolyl 
serines, while the other contains S-tetrazolyl cysteine derivatives. In both cases, the synthetic scheme involved a two-
step route: the first one being the thermal cycloaddition of a sugar azide with p-toluensulfonyl cyanide (TsCN) to give a 
1-substituted 5-sulfonyl tetrazole and the second the replacement of the tosyl group with a serine or cysteine residue. 
For the high efficiency and operational simplicity, the azide-TsCN cycloaddition appears to be a true click process. 
Finally, one of the amino acids prepared was incorporated into a tripeptide 
 
Key words: C-glycosyl amino acid, C-Glycosylmethyl pyridylalanines, dihydropyridine, glycopeptide synthesis, 
polymer-supported scavengers, Hantzsch multiconmponent reaction, orthogonal functional group, Click chemistry, 
Huisgen 1,3-dipolar cycloaddition, 1-substituted 5-sulfonyl tetrazole, C-ribosyl O-tetrazolyl serines, C-galactosyl O-
tetrazolyl serines,  
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Sintesi di C-glicosil amminoacidi quali intermedi reattivi per la sintesi di C-
glicopeptidi modificati 
 
Riassunto: 
In questo lavoro abbiamo studiato e sintetizzato una nuova classe di C-glicosil amminoacidi la cui struttura presenta un 
anello eterociclico funzionalizzato con un residuo di amminoacido e di carboidrato. In questo progetto sono stati 
utilizzati come spaziatori delle due unità biologicamente attive (amminoacido e carboidrato) strutture piridiniche e 
tetrazoliche. L’interesse verso questa nuova classe di C-glicosil amminoacidi risiede nelle loro potenzialità come 
chelanti e nel loro utilizzo come intermedi reattivi per la sintesi co-traslazionale di glicopeptidi modificati. 
Nella prima parte del progetto, sono state sintetizzate C-glicosilmetil piridil alanine mediante ciclocondensazione 
termica di Hantzsch a tre componenti di aldeidi, enamino-esteri e β-cheto-esteri. Uno di questi reagenti è stato 
opportunamente derivatizzato con un residuo C-glicosidico, mentre un altro componente è stato funzionalizzato con 
un’unità amminoacidica. Nella metodologia one-pot ottimizzata, il derivato diidropiridinico intermedio è stato 
purificato dai componenti non reagiti utilizzando reattivi supportati su polimero. 
Successivamente l’intermedio diidropiridinico presente come miscela di diastereoisomeri è stato ossidato mediante 
l’uso di un ossidante supportato su polimero fornendo la corrispondente piridina funzionalizzata con le due unità 
biologicamente attive. Mediante questa strategia sono stati sintetizzati otto composti (resa: 56-68%) che presentavano i 
seguenti elementi di diversità: i) la configurazione gluco o galatto dell’anello piranosidico, ii) la configurazione α o β 
in posizione anomerica, e iii) la posizione relativa delle unità di zucchero ed amminoacido sull’anello piridinico. La 
presenza di gruppi protettivi ortogonali sulle molecole target ha poi permesso il loro facile inserimento in sequenze 
oligopeptidiche attraverso accoppiamento sequenziale del gruppo amminico e carbossilico. 
Nella seconda parte del progetto, è stata costruita la struttura tetrazolica mediante cicloaddizione 1,3-dipolare di 
Huisgen di nitrili ed azidi organiche. In questo modo è stato possibile sintetizzare due categorie di molecole target, 
ovvero C-galattosil o C-ribosil-O-tetrazolil serine e i corrispondenti S-tetrazolil derivati cisteinici. 
In entrambe i casi lo schema sintetico si è completato attraverso due stadi di reazione,:il primo ha previsto la 
cicloaddizione termica del para-toluensulfonil cianuro (TsCN) con un’azide funzionalizzata con un residuo di 
carboidrato per dare 5-sulfonil tetrazoli-1-sostituiti; il secondo stadio ha comportato la sostituzione del gruppo tosile 
con un residuo di serina o cisteina. Data l’alta efficienza e la semplicità della procedura, si ritiene che la cicloaddizione 
di azidi e TsCN possa essere considerata una reazione click. Infine, uno degli amminoacidi preparati è stato incorporato 
in un tripeptide. 
 
Parole chiave: C-glicosil amminoacidi, C-glicosilmetil piridil alanine, diidropiridine, sintesi di glicopeptidi, sequestranti 
supportati su polimero, reazione multicomponente di Hantzsch, gruppo funzionale ortogonale, click chemistry, 
cicloaddizione 1,3-dipolare di Huisgen, 5-sulfonil tetrazoli-1-sostituiti, C-ribosil-O-tetrazolil serine, C-galattosil-O-
tertazolil serine. 
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1. C-GLYCOSYL AMINO ACIDS AS STABLE BUILDING BLOCKS FOR 
MODIFIED GLYCOPEPTIDE SYNTHESIS 
 
Glycosyl amino acids are molecules that combine the structural features of simple amino 
acids (amino and carboxylic acid functions) with those of simple carbohydrate (cyclic 
polyols). The resulting hybrids are highly substituted polyfunctionalized building blocks 
which can be used for the synthesis of compound libraries by means of combinatorial 
synthesis with high potential of diversity, to generate potential glycomimetics and 
peptidomimetics, and due to a high degree of functionalization can be used as multivalent 
scaffolds or platforms for projecting pharmacophore groups. The importance of 
glycopeptides as anticancer vaccines, 1 antiviral vaccines against HIV and influenza, 1 
antibiotics, 2 and their use as mimetics of natural carbohydrates3 reflect the importance of 
glycosyl amino acids as building blocks for them. 
 
 Glycosyl amino acids of type A and B are components of naturally occurring O- and N- 
linked glycoproteins. They are building blocks for co-translation of glycopeptide 
synthesis. Many natural glycopeptide and glycoproteins are considered as therapeutic 
agents, and indeed some are currently in clinical use.4 However, the lability of the 
glycosidic bond towards chemical and enzymatic degradation in vivo results in low 
bioavailability of carbohydrate derivatives and prevents their oral application.5 Chemists 
have observed that substitution of the glycosidic C-O or C-N bonds found in O-linked 
and N-linked glycoproteins, respectively, with a C-C bond confers resistance to 
enzymatic hydrolysis.6 In addition, C-glycosides demonstrate solution conformations and 
biological activities similar to their native counterparts.7 Accordingly, much effort has 
been devoted to the synthesis of C-glycosyl amino acids of general structure C.8 
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Figure1: Natural (A and B) and unnatural C glycosyl amino acids. 
 
Hence, glycopeptide mimics are promising leads for novel pharmaceuticals. Different 
designs and manipulations on the glycosyl amino acid structure have been applied, and as 
a result broad spectrums of C-glycosyl amino acids have been synthesized.8 New families 
of general formula (D) have appeared and have attracted considerable attention for 
several reasons. 
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Figure 2: General formula of new families of glycosyl amino acids D 
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The structures of this family are not very different than natural structures of C-mannosyl 
tryptophan E, which has been identified in several biologically important proteins, 9 and 
O-glycosyl tyrosine H, frequently encountered in glycopeptide antibiotics2 and as 
humoral factors in the pheromone gland of the Silkmoth.10 
 
Simple structure comparison of synthetic molecules11 F and G (derived from formula D 
when n = 0, X=C, m = 0, ring= isoxazol, triazole) with the chemical structure of naturally 
occurring C-mannosyl tryptophan may show the differences (i.e. different heteroaromatic 
ring and regio modification) 
N
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Figure 3: structures comparison of natural C-mannosyl tryptophan E and synthetic 
glycosyl amino acids F and G.  
 
Another example, the modified structure L, can be derived from the general formula D. 
This structure has two modifications that differ from natural O-glycosyl tyrosine H (i.e. 
C-C bond and heteroaromatic ring instead of C-O bond and phenyl ring, respectively) 
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Figure 4: structures comparison of natural O-glycosyl tyrosine H and glycosyl amino 
acid L 
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Such modifications can afford important traits such as chemical stability, enzymatic 
stability, and chelatability (tridentate ligand) which could be used as ligands for 
radioactive compounds.12 Moreover the heterocyclic ring of glycopeptide could be 
involved in molecular recognition processes. Finally, these molecules are building blocks 
for the cotranslational modification of glycopeptides and glycoprotein and can be utilized 
as effective molecular tools to probe and understand mechanisms of key cellular 
processes of natural proteins. 
 
1.1. Definition, distribution, and functions of natural glycoproteins 
      
   For a long time, carbohydrates and proteins were considered as separate classes of 
natural products; however, it is now well established that nearly 50% of proteins are 
glycosylated, 13 in which the proteins are covalently linked to carbohydrate (glycan). 
Carbohydrates have the ability to convey large amounts of information due to high 
permutation potential (i.e. possible linkage between two pyranoses are 1-2, 1-3, 1-4, 1-
5,1-6, substituted, sulphated, phosphated, α, β…ect). Proteins are biopolymers of amino 
acids or polypeptides. Unlike carbohydrates that are linear and branched in nature, 
proteins commonly are linear in nature. The alliance between carbohydrates and proteins 
has produced a family of compounds that are found in almost all living organisms from 
unicellular yeast to humans. They occur in cells, in both soluble and membrane-bound 
forms, as well as in the intercellular matrix and extracellular fluids, where they include 
numerous biologically active macromolecules.14The ubiquity of this family in nature 
reflects their broad functions as markers in cell-cell communication events that determine 
microbial virulence, 15 inflammation, 16  and host immune responses.17 Moreover, correct 
glycosylation of proteins is critical for expression and folding,18 increases thermal and 
proteolytic stability,19 stabilizes proteins, affects physical properties such as solubility 
and viscosity, helps for correct orientation in the membrane, and improves recognition to 
other biochemical molecules or cells (figure 5). Many proteins released by cells to the 
blood and other fluids are glycoproteins. One set of glycoproteins also carry the blood 
group determinants.14 Glycoproteins are involved in many physiological and pathological 
processes. Many hormones and an increasing number of enzymes have been shown to 
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contain covalently bound sugars.
20
The collagens, the structural proteins essentials in the 
formation of connective tissues, and interferon, the antiviral agent produced by mammals, 
are glycoproteins. Moreover, glycoproteins serve as antigenic determinants, virus 
receptors, and markers of cellular identity.21, 17a  
 
Figure 5: Cell-surface Carbohydrates involved in Molecular Recognition 
 
Glycoproteins are macromolecules containing protein cores to which oligosaccharide 
chains are linked by glycosidic bonds. Glycopeptides are partial structures of the 
connecting regions of glycoproteins and, therefore, always contain glycosidic bonds 
between the carbohydrate and peptide components. Another group of compounds in 
which carbohydrates are covalently bound to proteins, but differ from the typical 
glycoproteins, are proteoglycans of connective tissue. They may be considered a special 
class because they contain long unbranched polysaccharide chains, with molecular 
weights of 20,000 or more, and are composed largely of repeating disaccharide units. To 
the contrary, the carbohydrate moieties of typical glycoproteins vary in size and the 
chains can be a single monosaccharide or a complex, possibly branched, oligosaccharide 
containing up to about 30 monosaccharide units per peptide (or protein) component. The 
nature, and indeed existence, of the carbohydrate moieties can vary during the life cycle 
of a cell, as a sophisticated battery of glycosyl transfer enzymes operate on it. As such, 
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the carbohydrate component may account for as little as 1% or up to 80-85% of the total 
weight of the glycoproteins but, in general, its dimensions are significant when compared 
with the size of the proteins to which it is bound (see Figure 6)  
 
 
 
 
 
Figure 6: Space-filling model of a portion of the glycoprotein CD2
22
 illustrating the 
relative dimensions of the carbohydrate (black) and protein (gray) moieties. 
 
 
Although numbers of monosaccharides are known in nature, only ten have been detected 
in glycoproteins, consisting of 2-acetamido monosaccharides (2-acetamido-2-deoxy-D-
galacto- and -D-glucopyranose), neutral monosaccharides (D-galactose, D-glucose, D-
mannose, L-fucose, L-arabinose, L-rhamnose or D-xylose), and the sialic acid with its N-
acetylated, N-glycolated, and in some cases O-acetylated derivatives (Figure 7). 
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Figure7: Monosaccharides constituting the oligosaccharide units occurring in 
glycoproteins 
 
Glycosylation in the cells is a post translation process, it is not under direct genetic 
control but is determined by enzymes, and many different enzyme reactions are involved 
in the processing pathways. Each individual enzyme reaction may not go to completion, 
giving rise to heterogeneous range of glycoforms17a that possess the same peptide 
backbone but differ in the nature and site of glycosylation. This occur in all natural 
glycoproteins, For example, chicken ovalbumin contains a single glycosylated amino-
acid residue (Asn-293), but more than a dozen different oligosaccharides have been 
identified at that site, even in a preparation isolated from a single egg of a purebred hen.23 
The external and internal environment of the individual cell in which the protein is 
glycosylated may be influenced by physiological changes such as pregnancy and also by 
some diseases which may affect one or more of the enzymes in the cell give rise different 
glycosylations.17b In the conclusion glycoprotein can be defined as a set of glycoforms, 
these mixtures of glycoforms could provide a spectrum of activities that can be biased in 
one direction or another as means of fine-tuning.24 
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1.2. Biological roles of sugar chains in natural glycoproteins 
 
Glycoproteins occur naturally in a number of glycoforms, 17a i. e. glycosylated fragments 
that differ for the type of oligosaccharide and the site of attachment to the protein 
backbone.  Each component of the mixture has different properties24, 25 that could present 
regulatory difficulties26 and problems in determining exact function through structure 
activity relationships, but also could provide a broad spectrum of activities that would 
work as means of fine-tuning24. As previously described, the carbohydrate moiety of 
glycoproteins can exert a wide range of biological functions, such as in fertilization, 
embryogenesis, neuronal development, hormonal activities, proliferation of cells and 
their organization into specific tissues, immune surveillance, and inflammatory 
reactions27 they can also modulate protein folding, intra- and intercellular trafficking, and 
receptor binding and signaling.17 Remarkable changes in cell surface carbohydrates occur 
with tumor progression, which appears to be intimately associated with the dreaded state 
of metastasis.28 Furthermore, carbohydrates of host cells are often employed by 
pathogens for cell entry or immunological evasion.29  
Though clear dramatic effects display on the physical, chemical, and biological properties 
of the naturally occurring glycoproteins and their mimics, as a result of the presence of 
carbohydrate units no single common theory has emerged yet for the role of carbohydrate 
units in glycoproteins, even where the function of the complete molecule is well 
understood.  
A feasible approach to understand the biological roles of sugar chains consists in the 
removal or modification of carbohydrate moieties with different techniques30. The 
consequences of altering these types of glycosylation range from being essentially 
undetectable to the complete loss of particular functions.  
The biological roles of the sugar chains of major classes of glycoproteins in eukaryotic 
cells have been reviewed in a recent work by Varky17a. This includes: 
i) a structural role. Some oligosaccharides offer an aid in the maintenance of protein 
solubility and conformation: in fact many proteins that are incorrectly glycosylated fail to 
fold properly and can not exit the endoplasmic reticulum and they are consequently 
degraded. 
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ii) an interaction role. For example carbohydrates of membrane glycoproteins constitute 
recognition signals in the regulation of the cell growth and cell differentiation.31 In 
according with these results, it has been found that the glycoprotein profiles in the cell 
membranes of normally growing cells and of tumor cells are very different28.  
iii) a protection role. The oligosaccharide portion of the glycoproteins often offers 
protection against the attack of proteolytic enzymes.32  
iv) a modulation role. There are several cases in which glycosylation can modulate the 
interactions of glycoproteins with others molecules. For example the binding process of 
some cell surface receptors for growth factors is affected only when the attachment of the 
carbohydrate side chains to the protein is blocked. Thus, glycosylation and 
deglycosylation are able to mediate a “switching" effect. 
 
  
1.3. Synthesis of natural glycopeptides: use of glycosyl amino acids 
 
Owing to the decisive functions exhibited by carbohydrates of glycoproteins in the 
regulation of cell metabolism, host-pathogen interactions, tumor cell metastasis, and cell 
development (see § 1.2.), and in order to fully define the roles carbohydrates play in these 
processes, the availability of these glycoconjugate structures is receiving increased 
interest. The isolation of these complex molecules is often made difficult by low 
concentrations in raw materials. Moreover, nature tends to produce heterogeneous 
glycoproteins (glycoforms) which vary in many aspects, including the extent of 
glycosylation. Separating individual compounds from such families of closely related 
molecules is not trivial. Moreover, the gene-technological production of these 
glycoconjugates is still limited because, in contrast to other proteins, glycosylated 
proteins are posttranslational products resulting from the activity of glycosyl hydrolases 
and transferases.33 Therefore, organic synthesis provides a valuable alternative for the 
preparation of model glycopeptides as partial sequences of glycoproteins bearing one or 
many saccharide side chains.  Synthetic glycopeptides do not have the disadvantages of 
microheterogeneity and are available, with variations in both the peptide and 
carbohydrate part, in higher quantities and superior purities than for the natural 
glycoconjugates. For these reasons, synthetic glycopeptides are becoming the model 
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compounds of choice for biomedical and structural investigations where glycoproteins 
are involved.  
 
Nature synthesizes proteins by stepwise assembly of amino acid building blocks, a menu 
comprising 19 L-α-amino acids of general structure 1 and L-Proline 2 can be involved in 
such assembly (scheme 1a). For chemical synthesis of particular dipeptide, protection the 
amino group of one amino acid and the carboxyl group of the other amino acid 
selectively is required (scheme 1b). The most commonly used amino protecting groups 
are t-butoxycarbonyl (BOC) and fluorenylmethoxycarbonyl (Fmoc), while t-butyl ester, 
benzyl ester, methyl ester and allyl ester can be used to protect the carboxyl group.34 
 
H2N
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1 2
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OH H2N OP2 P1HN
H
N
OP2
R2
O R1
O
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ACTIVATOR
R2
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P1=Fmoc or Boc P2= Bn , t-But
A
B
 
 
Scheme 1: a) general structures of L-α-amino acids, b) Chemical synthesis of particular 
dipeptide  
 
The peptide backbone can be built up either in solution or solid phase. In solution phase, 
the troublesome isolation of the products makes the approach cumbersome. Unlike this 
approach, the solid phase is used widely for synthesis of more complex peptides. Small 
solid beads, insoluble yet porous, are treated with functional units (linkers) in which 
peptide chains can be built. The peptide will remain covalently attached to the bead until 
cleaved from it by reagents such as TFA or HF. The peptide is thus immobilized in the 
solid-phase and can be retained during a filtration process, whereas liquid-phase reagents 
and by-products of the synthesis are flushed away. Solid-phase peptide synthesis is 
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usually performed from C-terminus to N-terminus; the C-terminus of N-protected amino 
acid is introduced to the linker in the presence of coupling reagents, and this would be the 
nucleus for peptide chain. The N-protecting group of the peptide nucleus is cleaved, and 
the deprotected amino functionality is coupled to the C-terminus of another N-protected 
amino acid. The cycle of coupling–deprotection is repeated to build up the peptide chain. 
Finally, the protecting groups are removed and the peptide chain is released from the 
solid resin. A crucial step in the chemical synthesis of glycopeptides is the incorporation 
of the saccharide into the peptide. To accomplish this, two approaches may be used: a 
convergent method or a stepwise method (scheme 2). 
 
i) In the convergent method (post-translational), direct glycosylation of 
properly protected oligopeptides is employed either chemically or 
enzymatically. The success of O-glycosylation by this method is limited 
because of the low solubility of peptides under the conditions commonly 
employed for glycosylation and the low reactivity of the side chains of 
hydroxyls of Serine and Threonine.35 The advantage of the direct 
glycosylation method is that the route is more convergent, permitting fast 
access to glycopeptides with different glycan structures but this method 
suffers from low yields due to steric factors, difficulty of glycosylation, and 
there is the potential for an intramolecular cyclization reaction36 (scheme 3). 
 
 
Scheme 2: glycopeptide synthesis by stepwise and convergent methods 
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Scheme 3: intramolecular cyclization side reaction in glycopeptide synthesis 
 
 
The chemical mediated coupling has only been described by a few authors37-40 reporting 
moderate success in the preparation of glycopeptides. However, this methodology does 
not constitute a feasible route to complex glycopeptides containing longer (more than 3-5 
amino acids) peptides with multiple attachment sites.  Regarding enzymatic 
glycopeptides synthesis, it is important to stress that the use of enzymes is restricted to 
the formation of glycosidic linkages between sugar units and to the segmented coupling 
of peptides or small glycopeptide fragments.41 little is known about the enzymes which 
catalyze the formation of the key glycosidic linkages between the carbohydrates and the 
peptide. An exception to this is oligosaccharyl transferase (OT) which has been isolated 
and studiated.22 But the low availability of the enzymes at present, restricts the 
widespread use this type of glycosylation 
 
 
 
ii) stepwise approach(co- translational) 
This methodology employs glycosylated amino acids, molecules composed of the 
carbohydrate moiety bound to a first amino acid through a glycosidic linkage, as building 
blocks for the stepwise assembly of glycopeptides, preferably on solid-phase (Figure 8). 
Versatility is one of the main advantages of this procedure which allows the synthesis of 
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glycopeptides with variations at the peptide part and structures containing more than one 
carbohydrate residue as well. It is also an advantage that the difficulties of generating the 
crucial bond (stereoselective connection) between the oligosaccharide and the amino acid 
are solved before the glycosyl amino acid is incorporated into the peptide. 
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Figure 8: Use of glycosyl amino acids as building blocks for stepwise glycopeptide 
synthesis 
 
 
1.4. Glycosidic linkages in nature: N- and O-glycosyl amino acids 
 
Owing to the efficiency demonstrated by suitably protected glycosylated amino acid 
building blocks in the preparation of synthetic glycopeptides (see § 1.3.), investigations 
on the forms of protein glycosylation are receiving increasing interest. Figure 9 shows all 
the known types of glycosidic linkage between the carbohydrate and the peptide 
occurring in natural glycoproteins; such a draw is a dynamic picture due to the continuing 
discovery of new forms of glycosylation.42  
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Figure 9: Forms of protein glycosylation 
 
Bonding of sugars to protein involves only ten monosaccharide (see § 1.1.). Of the 20 
coded amino acids, seven contain either no side chain (Gly), or purely hydrocarbon side 
chains (Ala, Val, Leu, Ile, Phe, Pro) and no evidence has so far been found for C-
glycosylation of the side chains of these residues. The remaining 13 coded amino acids 
contain various functional groups in their side chains but only asparagine (Asn), serine 
(Ser), and threonine (Thr) are known to form linkages with carbohydrates. Only in few 
cases, tryptophan (Trp), histidine (His), cysteine (Cys) and two non coded amino acids, 
4-hydroxyproline (Hyp) and 5-hydroxylysine (Hyl) have also been identified at the 
linkage site in glycoproteins. Therefore there are only three important types of connection 
between the carbohydrate and peptide portions in natural glycoproteins. Most common 
are N-glycoproteins 3, in which the side chain amide function of an asparagine unit is 
joined to the monosaccharide residue (GlcNac, GalNAc, Glc) through a β-N-glycosydic 
linkage (Figure 10). 
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Figure 10: Main types of glycodidic linkages in natural glycopeptides 
 
N-linked glycoproteins14 are synthesized and modified within two membrane-bound 
organelles in the cell: the rough endoplasmic reticulum and the Golgi apparatus. The 
protein component of the glycoprotein is assembled on the surface of the rough 
endoplasmic reticulum by the sequential addition of amino acids, creating a linear 
polymer of amino acids called a polypeptide. Twenty different amino acids can be used 
for the synthesis of polypeptides. The specific order of amino acids in polypeptide is 
critical to function and is referred to as the amino acid sequence. The carbohydrate of the 
N-linked glycoprotein is always attached to the  amide   nitrogen of an aspargin side 
chain, and  is always found in amino acid sequences where the asparagine is followed by 
some other amino acid and then a serine or threonine residue (-Asn-Xaa-Ser/Thr). 
Carbohydrate is not attached to the polypeptide one sugar at a time. Rather, a large 
preformed carbohydrate containing fourteen or more sugar residues(dolichol-linked 
Glc3Man9GlcNAc2 oligosaccharide) is transferred en bloc to an Asn-X-Ser/Thr sequon 
on newly synthesized polypeptides through the action of a multi-subunit oligosaccharide 
transferase complex( figure 11) 
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Figure 11: Nature's approach to N-glycosylation 
 
Subsequent trimming and processing of the transferred oligosaccharide results in a 
Man3GlcNAc2 core structure, which is transported to the middle complex of the Golgi 
apparatus where maturation of the oligosaccharide gives rise to an extreme structural 
diversity.22 Another type of glycosidic linkage that occurs in natural glycoproteins 
involves the side chain hydroxyl function of serine and threonine through an α- and β-O-
glycosidic linkage (Figure 10). O-linked glycoproteins are usually synthesized in the 
Golgi apparatus, where the GalNAc moiety of UDP-GalNAc is transferred to the 
hydroxyl side chain of serine or threonine and catalyzed by polypeptide GalNAc 
transferase43 Unlike N-linked glycoproteins, O-linked glycoproteins are synthesized by 
the addition of a single sugar residue at a time.  
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1.5. Natural and unnatural glycopeptide synthesis  
 
The most reliable and efficient methodology for natural glycopeptide synthesis is the use 
of glycosylated amino acid building blocks in step-wise assembly of glycopeptides , 
either in solution or preferably on solid phase (see § 1.3). The natural glycosyl amino 
acids are molecules composed of a carbohydrate moiety bound to an amino acid through 
different glycosidic linkages: all these types of connection have been reviewed in § 1.4. 
Synthetic routes to suitably protected amino acid building blocks constitute a key to 
success for the synthesis of natural glycopeptides. The construction of glycosyl amino 
acids of exactly specified structure requires the combined application of synthetic 
methods and protecting group strategies of both carbohydrate and peptide chemistry. 
Dealing with natural glycopeptides and their building blocks are more complicated due to 
the high potential for anomerization, racemization and β-elimination when treated either 
with strong acidic44 or basic medium45 (scheme 4). 
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Scheme 4:  sensitivity of the glycosidic linkage in acidic and basic conditions 
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In order to avoid hard reaction condition that could lead to racemization and β-
elimination, protecting groups for glycosyl amino acids used in glycopeptide synthesis 
have to be judiciously chosen.46 Two main common orthogonal strategies can be 
considered for this goal. The first is the classical strategy, which uses BOC to protect the 
amino group34. In this strategy, the benzyl ether protects the hydroxyls of the sugar and 
the carboxyl can be free acid or methyl ester47. The three protecting groups are 
orthogonal with each other, which mean that any of the protecting groups could be 
removed without affecting the others (scheme 5). The reaction conditions required to 
cleave them causes neither racemization nor β-elimination. 
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Scheme 5: The orthogonality of BOC strategy  
 
The BOC group is stable under basic medium, catalytic hydrogenation and Nucleophilic 
reagents but can be removed by treating with acid such as TFA (scheme 6). The 
hydroxyls of the sugar are protected as benzyl ether, which is stable under both acidic and 
basic medium that are required to cleave the BOC and methyl ester, respectively. Benzyl 
ether can be cleaved by catalytic hydrogenation over Pd but benzyl ether is rarely used as 
protecting group when the peptide contains cysteine residues. The problem arises from 
the poising of the Pd catalyst by the sulfur atom of the cysteine. Most chemists use 
benzyl protecting groups for assembly of oligosaccharide moieties and replace it with 
another group that is suitable for glycopeptide synthesis. While the BOC group is 
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removed by moderately strong acid such as TFA, the cleavage from the solid-phase 
requires strong acids such as HF. As a result, the glycosidic bonds don’t survive this 
treatment. In conclusion, the BOC is convenient for solution not for solid phase natural 
glycopeptide synthesis. 
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Scheme 6: a) BOC cleavage in acidic medium b) Fmoc cleavage in basic medium 
 
The second strategy is sufficiently mild for solid phase synthesis of glycopeptides using 
glycosylated amino acids as building blocks, 48 it employs Fmoc to protect the amino 
group. The Fmoc group is stable in acidic medium, but hydrolyzed in basic conditions 
such as 20% piperidine, morphaline. (Scheme6). The hydroxyls of the sugar are usually 
protected with acetyl groups that stabilize the glycosidic bonds toward the acidic 
treatment used for side chain deprotection and cleavage from the solid phase49, 44c. The 
carbohydrate acetyl protective groups can be removed before or after cleavage from the 
solid phase by treating with dilute sodium methoxide in methanol, while the carboxyl 
group can be free acid, activated ester such as pentafluorophenyl ester, t-butyl ester, or 
any other orthogonal ester with Fmoc. 
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 The development of new solid-phase supports, protecting groups and coupling reagents 
has solved the problem of natural glycopeptide synthesis 35, 48c. However, the lability of 
the glycosidic bond towards chemical and enzymatic degradation in vivo is an important 
limitation in using N- and O-glycopeptides as potential drugs.  The substitution of the 
glycosidic C-O or C-N bonds found in O-linked and N-linked glycoproteins, respectively, 
with a C-C bond confers resistance to enzymatic hydrolysis6. In addition, C-glycosides 
demonstrate solution conformations and biological activities similar to their native 
counterparts7. For example, the water soluble galactosphingolipid 8 was shown to bind 
specifically to HIV-1 gp 120 and therefore represented potential inhibitoin of the first 
step in the infection process causing the AIDS. This compound is the carbon-linked 
analogue of the natural product 7, compound 8, synthesized by using C-glycosyl amino 
acid 650 
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Scheme 7 
 
Various C-glycosyl amino acids have appeared8 as a result, of mimicry of the natural 
products, such as C-glycosyl serine, C-glycosyl asparagine, C-glycosyl tyrosine, C-
glycosyl tryptophan and broad spectrum of more modified structure such as compound 9 
which can be used as chealtors for technetium-99m (Tc). The product 10 can be used in 
radio diagnosis and radiotherapy.12 
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Figure 12 
 
Due to many applications of carbon-glycopeptides used in cancer, HIV, immunotherapy, 
and infectious and pathogenic researches, interest in the stereoselective synthesis of 
different C-glycosyl amino acids as precursors for them is becoming an important issue 
in organic chemistry. 
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2. SYNTHESES OF C-GLYCOSYL AMINO ACIDS: THE STATE OF 
THE ART 
 
Methods for the synthesis of C-glycosyl amino acids until 2000 have been reviewed.8 
Methods that have been reported between 2000 and 2008 are reviewed and described 
below. 
 
1. Cross metathesis 
Olefin cross metathesis between different olefinic α-amino acids and unsaturated C-
glycosides has been extensively used for the synthesis of C-glycosyl amino acids. In 
2001, Dondoni et al51 carried out cross metathesis catalyzed by second generation Grubbs 
catalyst 13 of  perbenzylated C-alkenyl glycosides 11 with a vinyl oxazolidine 12, 
derived from Garner’s aldehyde to afford 14 in ~50% yield. The alkene 14 was 
transformed into the corresponding peracetylated oxazolidine derivative 15 by 
hydrogenation over Pd (OH)2 and acetylation. Finally, oxidative cleavage of oxazolidine 
ring by Jones reagent (CrO3 aq. H2SO4) affords glycosyl amino acid 16 with 2 to 4 
carbons linking the sugar anomeric position to the glycinyl moiety (Scheme 8). This 
methodology has also been extended to prepare a potential glycopeptide nephritogenoside 
mimetic. 
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Scheme 8 
• In 2002, McGarvey et al.52 described a successful cross metathesis-based 
approach between C-alkenyl glycosylamines (17and 22) and L-allyl glycine 18 
using Grubbs' Catalyst 19 (10-20 mole %) to produce alkene 20 and 23 in very 
good yields. Hydrogenation of 20 and 23 with catalytic Pd (OH)2  afforded  
glycosyl amino acid 21 and 24 featuring 3 or 4 carbon tethers (Scheme 9).   
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Scheme 9 
McGarwey has succeeded also in post-translational metathesis by subjecting peptides 
carrying olefinic functionality 25 with C-glycosides 26, 27, and 28 in the presence of 20 
mol % of catalyst 19 (Scheme 10).  
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Scheme10: Post-translational metathesis 
 
• In 2003 Nolen et al53 chronicled olefin cross metathesis between C-allyl glycoside 
32 and L-vinyl glycine 33 for C-glycosyl amino acid synthesis 35 in very good 
yields (60-86%) (Scheme: 11). This reaction was much less efficient with vinyl 
glycosides as the yields of the cross coupling product were only 11%.  
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Scheme 11 
• Neolen et al.54 in 2005 utilized a cross metathesis / cyclization strategy to produce 
C-glucosyl serine and alanine 39 with high stereoselectivity.  Alkenyl sugars in 
their ring opening form were used to vary the reactivity for cross-metathesis 
olefination. For example, the cross metathesis on glucoheptenitol 36 with ally or 
vinyl glycine 37 produced acyclic gluco-amino acid alkene 38, which upon 
electrophilic cyclization afforded the desired C-glycosyl serine (one carbon) or C-
glycosyl alanine (two carbons) (Scheme 12).  However, this methodology didn’t 
succeed in the case of C-mannose derivatives. 
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Scheme 12 
 
2. Chiral auxiliary based approach toward the synthesis of C-glycosyl amino 
acids (1,3-dipolar cycloaddition reaction) 
In 2001 Westermann and coworkers55 used a chiral auxiliary based approach with 
cycloaddition reaction to synthesize C-glycosyl amino acid 45.  They used the 1,3-dipolar 
cycloaddition of ally glycoside 40 and nitrone (-) 41 (glycine equivalent) to give 
isoxazolidine 42. The reductive cleavage of the N-O bond in 42 by Sm(II) produced the 
corresponding 1,3- amino alcohol 43 in high yield . Then, the N, N-acetal group of 43 
was quantitatively hydrolyzed by 0.6M aqueous HCl and small amounts of acetic acid, 
and the amidic bond was cleaved with an equimolar amount of lithium hydroxide to give 
44.  Both hydrolytic steps were nearly quantitative (Scheme 13). 
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Scheme 13 
 
The broad applicability of this methodology to different glycosides (gluco, galacto, 
manno, GlcNAc derivatives, vinyl derivative pseudo-glucal α & β), the ability to 
synthesize both diastereomers in high regioselectivity and stereoselectivity with high 
percentage yields by using the appropriate nitrone (- or +), the orthogonal protecting 
group strategy, and the ease of the preparation of building blocks (glycosides and 
nitrone), considered to be advantages of this methodology.  
 
3. Ramberg-Bäcklund rearrangement  
In 2002 Taylor’s et al.56 established a Ramberg-Bäcklund approach to synthesize C-
glycosyl amino acid 51. The method involves alkylation of thiol 46, a cysteine 
equivalent, with glycosylmethyl iodide 45 to give sulfide 47. The resulting sulfide was 
oxidized to sulfone 48, which was then subjected to Chan’s halogenative Ramberg-
Bäcklund conditions to give alkene 49 in ~37% yield. The resulting alkene 49 was 
reduced with diimide generated in situ from tosyl hydrazine and the amino acid moiety 
was unmasked from the N-Boc oxazolidine ring using the Jones reagent to afford the 
glycosyl amino acid as a single diastereomer. This was isolated and characterized as 
methyl ester 51 (Scheme14). 
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Scheme 14 
4. Acetylide coupling 
In the same year, Dondoni et al57 used coupling of the lithium derivative of ethynyl 
galactoside 52 with Garner aldehyde 53 to give the alcohol 54 in good yield. This was 
transformed into the intermediate 55 via reduction of the triple bond with tosylhydrazine 
and deoxygenation by using the Barton-McCombie method. Finally, the oxidative 
cleavage of the oxazolidine ring of 55 afforded the target amino acid 56 (Scheme: 15).   
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Scheme 15 
 
5. Homologation of dialdoses 
In 2003, Grison and coworkers58 prepared glycosyl amino acids 61 and 61’ in pure form 
in three steps starting from dialdose 57.  The reaction of these sugar aldehydes with 
potassium dibromoacetonitrile carbanion provided the corresponding β-bromo-α- 
ketonitriles 59/59’ as a mixture of diastereomers that were easily transformed into α-
bromo esters 59/59’ by treatment with methanol or isopropanol. Substitution of bromine 
by the azide group gave the azides 60/60’. The authors utilized the difference in rate of 
hydrogenation of epimers 60/60’ to obtain epimer 61’ (D configuration) as a pure isomer, 
after 4 hr of hydrogenation, while the unreacted epimer 60 was totally recovered. This 
methodology can be considered the most rapid access to the key α-glycosyl amino acid 
moiety of polyoxins in high yield.  
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Scheme 16 
 
6. Ring opening of chiral activated Aziridine 
In the same year, Thiem,s group59 synthesized glycosyl amino acid 69 by using the Lewis 
acid catalyzed ring opening of activated aziridine 67 by alcohol  66 as a key step 
(Scheme:17). Alcohol 66 was synthesized by reacting peracetylated galactopyranose 62 
with propargyl trimethylsilane 63 in the presence of Lewis acid. The α-allene 64 formed 
in this way was cleaved by treatment with ozone to give the labile aldehyde 65, which 
was reduced without isolation to alcohol 66.  
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7. The tandem Tebbe/Claisen rearrangement 
In 2004, Fairbanks and coworkers60 applied the tandem Tebbe/Claisen approach to 
synthesize C-glycosyl amino acid 74. This approach initially involves esterification of the 
hydroxy-free glycal 70 with N-Boc glutamic acid monoester 71 to give ester 72. Tebbe 
methylenation of this ester gave 73 which underwent [3,3] sigmatropic Claisen 
rearrangement yielding the C-glycosyl amino acid 74 with entirely stereoselective fashion 
(Scheme:18).  
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           Scheme 18 
It is worth mentioning that this approach was limited to the use of protected glutamic acid 
and did not succeed with other α-amino acids such as aspartic acid.  Also the use f 4, 6-
O- benzylidene protected glucal was a prerequisite for a successful reaction. 
 
8. Proline–catalyzed direct electrophilic α-amination  
In 2008, Dondoni et al.61 synthesized C-glycosyl amino acid 79 via a proline-catalyzed 
electrophilic α-amination approach. Glycosylmethyl aldehyde 75 was reacted with the 
electrophilic nitrogen source dibenzyl azodicarboxylate (DBAD) in the presence of 30% 
of L-proline to afford α-hydrazino aldehyde 76 as single diastereomer. Crude 76 was 
reduced by sodium borohydride and ethanol to give alcohol 77 in very good yield and 
high diastereomeric purity. Subsequently, hydrogenation of alcohol 77 over Raney Nickel 
selectively removed the Cbz protective group and cleaved the N-N bond to give free 
amine which was treated with Boc2O to afford the N-Boc- protected amino alcohol 78. 
The alcohol 78 was oxidized and esterified to give the target product in high yield 
(Scheme: 19). 
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Scheme 19 
This methodology has the ability to afford the two diasteroisomers in pure form by using 
the appropriate proline (L or D). 
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3- RESEARCH PROJECT: AIM AND METHODS 
Broad spectrums of C-glycosyl amino acids as potential building blocks for C-
glycopeptide synthesis have been synthesized.8 Recently, considerable attention has been 
given to a class of artificial C-glycosyl amino acids whose structure features a hetrocycle 
ring holding carbohydrate and amino acid fragments (figure 2), isoxazole, and triazole 
moieties, were synthesized via Huisgen cycloaddition reaction,11 whereas tetrazole, and 
pyridine moieties were planned to be synthesized in this project.  
O
OPG1
(PG1O)3
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n
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N
NN
N N
NN
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Figure 2 
These compounds are of interest as new chelating agents for the binding of radioactive 
metal ions (Tc, Re). Their complexes can be used in radiodiagnosis, radiotherapy, 12 and 
radiolabeling62. Radiolabeled glycopeptides can be used for angiogenesis imaging. For 
example, 99mTc-glycopetide was used to assess efficiency of anti-angiogenic cancer 
therapy.62 Moreover, because the carbohydrate unit is bound to the polyamide backbone 
through an artificial tether resistant to chemical and enzymatic degradation, synthetic 
glycopeptides can be used as probes in biological studies for a deeper understanding of the effect 
of glycosylation on protein structure and function in molecular detail.13 These products can be 
used in drug-discovery for carbohydrate-based metabolic disorders. We envisaged the 
heterocycle ring in the constructed glycopeptides to serve as a rigid and robust linker as 
well as an active site for molecular recognition processes through H-bonding and dipolar 
interactions. In addition, the efficient construction of the heterocycle-tethered glycosyl 
amino acid architecture would allow the preparation of a collection of strictly related 
compounds in which structural and stereochemical diversity can be explored by varying 
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the nature of the sugar residue as well as its position in the heterocyclic rings. Indeed, the 
search for structural changes and new biological properties of peptides induced by 
introduction of non-natural heterocycle amino acid fragments has been actively pursued 
since several years.63 
 
Thus, the first part of the project was the construction of carbohydrate-pyridine -amino 
acid hybrids. Specifically: the two regioisomers; 2-(C-Glycosylmethyl)-4-
alaninylpyridines 80 and 4-(C-Glycosylmethyl)-2-alaninylpyridines 81 (figure 13). 
N
t -BuO2C
CO2Me
NHBoc
CO2t-Bu
Me
O * OBn
80
N
t -BuO2C CO2t-Bu
Me
MeO2C NHBoc
O
*
OBn
81  
Figure 13 
The pyridine ring plays a key role in several biological processes. Most notably is its role 
in oxidation/reduction processes64. The pyridine ring can be constructed via a Hantzsch 
multicomponent reaction,65 which involves coupling of an aldehyde-ketoester-enamino 
ester system in a one-step reaction to generate dihydropyridine, which can be easily 
oxidized to the pyridine ring.  We planned to use the same system in which one of these 
reagents was planned to carry C-glycosyl residue, while to another was bound an amino 
acid fragment. With carbohydrate linked to the ketoester and the amino acid as a part of 
aldehyde, we set the two components of the first regioisomer 80. Alteration the positions 
of the carbohydrate and the amino acid was used to set the two components of the second 
regioisomer 81, in which the carbohydrate was a part of aldehyde and the amino acid was 
linked to the ketoester. Since our purpose was to use these building blocks for 
glycopeptide synthesis, the first issue was to design reagents with functional protective 
groups that are stable under the reaction conditions and orthogonal in the product. To 
achieve this purpose, N-Boc and methyl ester were chosen to protect the glycine moiety, 
benzyl ethers were used to protect the hydroxyls of the carbohydrate, and t-butyl ester 
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was chosen as electron withdrawing group in both ketoester and enamino ester. Thus, the 
three reagents for the preparation of the first regioisomer 80 were planned to be aldehyde 
82, ketoester 83, and enamino ester 84 (scheme21).  
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Scheme 21: Retrosynthetic pathways 
 
The three reagents for preparation of the second regioisomer 81 were planed to be 
aldehyde 86, ketoester 87, and enamino ester 84 (scheme 22). 
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Scheme 22: Retrosynthetic pathways 
 
Cyclocondensation of the three reagents (either (82, 83, and 84) or (86,87, and 84))  was 
done in t-BuOH at 70 °C to give, after 24 h, the dihydropyridine (either 85 or 88) as a 
mixture of diastereoisomers. This mixture was transformed into the target (80 or 81) by 
oxidation with pyridinium chlorochromate (PCC). Substantial improvement to method 
efficiency was achieved by executing the cyclocondensation under MW irradiation and 
then performing product purification and oxidation using polymer supported sequestrants. 
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MW irradiation at 120 °C reduced the cyclocondensation time from 24 to 1.5 h. Then, the 
reaction mixture was treated with a mixed-resin bed constituted of three polymer-bound 
reagents which were chosen as specific scavengers of unreacted material and side 
products. Specifically: (i) the supported sulfonic acid A-15 removed the residual 
enamine, (ii) the strong base Ambersep sequestered the ketoester, and (iii) the 
aminomethylated polystyrene (AM-resin) subtracted the aldehyde. This supported amine 
also removed the Knoevenagel adduct that was formed as initial condensation product 
between the aldehyde and the ketoester. After filtration of the resins, the diastereomeric 
dihydropyridines were oxidized to pyridine with PCC supported on silica gel. 
 
The glycine moiety in the first regioisomer 80 was in the form of aldehyde 82, which was 
prepared from the readily available aspartate mono ester 89 in two steps by reduction – 
oxidation sequence.66 However, this method afforded the aldehyde in low yield because 
of the lactonization of the alcohol intermediate 89.67 Hence, the preparation was more 
conveniently carried out in gram quantities, starting from the aspartate diester 91 
according to the procedure of Martin and co-workers.68 (scheme23) 
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Scheme 23: Retrosynthetic pathways 
 
The glycine moiety in the second regioisomer 81 was the ketoester 87 which was first 
synthesized by reaction of aldehyde 82 with t-butyl diazoacetate 93 in the presence of 
boron triflorid69 (scheme 24). The yield was low. Hence, an alternative synthesis of 87 
was performed starting from the N-Boc aspartic acid monoester 89 by a procedure similar 
to that described by Frank and co-workers.66 This method involves the transformation of 
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89 into the Meldrum’s acid derivative 95 and then treatment of this crude material with 
refluxing t-BuOH. This method affords 87 in good yield with identical optical value of 
product obtained by the other route from 82 (scheme 24).  
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Scheme 24 
The C-glycosyl group in the second regioisomer 85 was in the form of aldehyde 86, 
which was prepared from double bond oxidative cleavage of the corresponding C-ally 
glycoside 96 70 (scheme 25).  
O
*
OBnCHO
O
*
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86 96
 
Scheme 25 
The C-glycosyl moiety in the first regioisomer 80 was in the form of ketoester 83, which 
was prepared from reaction of aldehyde 86 with t-butyl diazoacetate 93 in the presence of 
boron triflorid.71 However, this method afforded 83 in low yield, and therefore another 
procedure was followed. This involved the nearly quantitative oxidation of 86 to the 
carboxylic acid 97 and treatment of the latter with Meldrum’s acid 94 in the presence of 
isopropenyl chloroformate. Then, the crude product 98 was cleaved by treatment with t-
BuOH and MW irradiation at 120° C.  
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Scheme 26 
In the second part of the project, we planned to construct carbohydrate-tetrazole-amino 
acid hybrids. Specifically: C-glycosyl O-tetrazolyl serines 99 and C-glycosyl S-tetrazolyl 
cysteines 100. These glycosyl amino acids were planned to be suitable building blocks 
for glycopeptide synthesis. Hence, N-Boc, methyl ester, and benzyl ether were used as 
suitable orthogonal protecting groups in case of C-glycosyl O-tetrazolyl serines 99, while 
N-Fmoc and O-acetyl were used as suitable orthogonal protecting groups in case of C-
glycosyl S-tetrazolyl cysteines 100 (figure 14). 
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Figure 14 
Tetrazole moiety is quite stable under a variety of reaction conditions and can serve as a 
metabolically stable surrogate for a carboxylic or amide group.72 The simplest tetrazole 
synthesis is provided by the Huisgen-type azide-nitrile 1,3-dipolar cycloaddition.73 The 
scope and efficiency of this reaction, however, are limited due to the need of using 
nitriles activated by strong electron-withdrawing groups and harsh reaction conditions. 
While the former point still remains a major drawback for this transformation, safety 
concerns have been recently addressed by Vilarrasa and Bosch, who reported on the first 
tentative metal-catalyzed “click” protocol for the organoazide-nitrile coupling.74 These 
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authors found that simple 1,5-disubstitued tetrazole derivatives can be prepared in 
excellent yields in dichloromethane at ambient temperature in the presence of 1-10 mol% 
of soluble Cu2(OTf)2.C6H6 catalyst, while 1,4-disubstituted tetrazoles are obtained as 
major regioisomers under heterogeneous conditions with 50-100 mol% of the same 
catalyst. Foregoing work in Sharpless75 and our own laboratories76 solved the problem of 
azide-nitrile ligation of more complex substrates. A two-step reaction sequence has been 
developed involving the cycloaddition of azides with an activated nitrile such p-
toluenesulfonyl cyanide and then substitution of the tosyl group in the tetrazole thus 
formed by a suitable nucleophile. On applying this strategy to the synthesis of C-glycosyl 
tetrazole amino acids, we reacted the benzylated and acetylated glycosylmethyl azide 
101,102 with p-toluenesulfonyl cyanide 103 in the absence of solvent to give the 1,5-
disubstituted tetrazole 104,105, which were used as starting material to produce target 
glycosyl amino (Scheme 27).  
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Scheme 27 
1,5-disubstituted tetrazole 104 was subjected to the alcohol 106, a masked serine form, 
under basic conditions to give the product 107 from which the amino ester 99 was 
unmasked by N-Boc oxazolidine ring cleavage and esterification (scheme 28). 
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Scheme 28 
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C-glycosyl tetrazolyl cysteines 100 were obtained from the direct replacement of the 
tosyl group by the sulfur nucleophile of protected cysteine 108 in mild basic condition 
(scheme 29). 
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Scheme 29 
To the best of our knowledge, no one has used amino acid moieties as nucleophiles to 
replace the tosyl group of the 1-substituted, 5-sulfonyl tetrazole. Most reactions were 
done using simple nucleophiles such as methoxide ion, pyrrolidine, and thiophenol.75 
Moreover, the noticeable development was the new method that we followed to 
synthesize glycosylmethyl azides 101 and 102. In this method, we used C-glycosylmethyl 
amine 109 to prepare C-glycosylmethyl azides 101 and 102. Azide 101 was obtained 
directly from amine 109 in one step by using imidazole-1-sulfonyl azide hydrochloride as 
diazotransfer reagent, 77 while azide 102 was obtained using two steps starting from 
amine 109, involving debenzylation then azidation and acetylation. Glycosylmethyl 
amines 109 of both forms α and β were synthesized  by reducing the corresponding 
glycosyl cyanide 110 and these cyanides easily to synthesize in the two anomers α and β 
by cyanation of glycosyl acetate with trimethylsilyl cyanide (scheme 30). 78 
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Scheme 30 
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4- RESULTS AND DISCUSSION 
 
In this work, we have studied and synthesized new class of C-glycosly amino acids 
whose structure features a hetrocycle ring holding the carbohydrate and the amino acid 
fragments. As described in chapter three, the two regioisomers; 2-(C-Glycosylmethyl)-4-
(alaninyl)-pyridines 80 and 4-(C-Glycosylmethyl)-2-(alaninyl)-pyridines 81 were 
synthesized using Hantzsch multicomponent reaction. Cyclocondensation of the three 
reagents ((82, 83, and 84) or (86, 87, and 84)) under MW irradiation, produced 
dihydropyridines (85 or 88).The dihydropyridine was not isolated while its purification 
was carried out by removal of unreacted material and side products using polymer-
supported scavengers. Then the dihydropyridine (mixture of diastereoisomers) was 
oxidized by a polymer-bound oxidant to give the target pyridine bearing the two 
bioactive residues. In this way, a range of eight compounds (58-68% yield) was prepared 
in which the elements of diversity were (i) the gluco and galacto configurations of the 
pyranose ring, (ii) the α- and β-configurations at the anomeric center, and (iii) the 
positions of the carbohydrate and amino acid sectors in the pyridine ring. The orthogonal 
functional group protection in these amino acids allowed their easy incorporation into 
oligopeptides via sequential amino and carboxylic group coupling. 
In the second part, tetrazole moiety was constructed via Huisgen 1,3-dipolar 
cycloaddition between nitriles and organic azides. Two sets of compounds have been 
prepared, one being constituted of C-galactosyl and C-ribosyl O-tetrazolyl serines while 
the other contains S-tetrazolyl cysteine derivatives. In both cases, the synthetic scheme 
involved a two-step route, the first one being the thermal cycloaddition of a sugar azide 
with p-toluensulfonyl cyanide (TsCN) to give a 1-substituted 5-sulfonyl tetrazole and the 
second the replacement of the tosyl group with a serine or cysteine residue. For the high 
efficiency and operational simplicity, the azide-TsCN cycloaddition appears to be a true 
click process. Finally, one of the amino acids prepared was incorporated into a tripeptide. 
 
More details on results and discussion could be found in the attached papers. 
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C-Glycosylmethyl pyridylalanines reported in this paper constitute a novel family of glycosyl amino
acids that contain a pyridine ring linking the carbohydrate and amino acid residues. These amino acids
may serve to prepare nonnatural glycopeptides displaying firmly bound carbohydrate fragments through
a rigid and highly stable tether. A viable route to these new hybrid molecules has been opened via thermally
induced Hantzsch-type cyclocondensation using an aldehyde-ketoester-enamino ester system. To one
of these reagents was attached a C-glycosyl residue, while to another was bound an amino acid fragment.
In a one-pot optimized methodology, the dihydropyridine was not isolated while its purification was
carried out by removal of unreacted material and side products using polymer-supported scavengers.
Then the dihydropyridine (mixture of diastereoisomers) was oxidized by a polymer-bound oxidant to
give the target pyridine bearing the two bioactive residues. In this way a range of eight compounds
(58-68% yield) was prepared in which the elements of diversity were (i) the gluco and galacto
configurations of the pyranose ring, (ii) the R- and â-configurations at the anomeric center, and (iii) the
positions of the carbohydrate and amino acid sectors in the pyridine ring. The orthogonal functional
group protection in these amino acids allowed their easy incorporation into oligopeptides via sequential
amino and carboxylic group coupling.
Introduction
Because of their potential use as probes in glycobiology and
leads in carbohydrate-based drug discovery, synthetic glyco-
peptides in which the native O- or N-glycosidic linkages have
been replaced by C- or S-linkages have garnered in recent years
an increasing attention by researchers in industry and academia.1
This modification is considered to provide substantial resistance
to chemical and enzymatic deglycosylation while retaining the
original biological properties of the peptide. Hence, several
methods for the synthesis of C-glycosyl2,3 and S-glycosylli amino
acids have been reported in view of their use in co-translational
modification of natural glycopeptides. Moreover, in order to
introduce in peptides a more substantial modification which may
† This work is part of the lecture presented by A.D. in the Symposium on
Asymmetric Synthesis of Amino Acids at the 233rd ACS National Meeting,
Chicago, March 25-29, 2007.
‡ The paper is dedicated to the memory of the late Professor Yoshihiko Ito,
Kyoto University, a good friend to A.D. and a respected colleague.
(1) Reviews and selected articles: (a) Arya, P.; Dion, S.; Shimizu, G.
K. H. Bioorg. Med. Chem. Lett. 1997, 7, 1537-1542. (b) Taylor, C. M.
Tetrahedron 1998, 54, 11317-11362. (c) Marcaurelle, L. A.; Bertozzi, C.
R. Chem. Eur. J. 1999, 5, 1384-1390. (d) Palomo, C.; Oiarbide, M.; Landa,
A.; Gonza´lez-Rego, M. C.; Garcı´a, J. M.; Gonza´lez, A.; Odriozola, J. M.;
Martı´n-Pastor, M.; Linden, A. J. Am. Chem. Soc. 2002, 124, 8637-8643.
(e) Zhu, X.; Pachamuthu, K.; Schmidt, R. R. J. Org. Chem. 2003, 68, 5641-
5651. (f) Zhu, X.; Schmidt, R. R. Chem. Eur. J. 2004, 10, 875-887. (g)
Dondoni, A.; Massi, A.; Sabbatini, S. Chem. Eur. J. 2005, 11, 7110-7125.
(h) Gustafsson, T.; Hendenstro¨m, M.; Kihlberg, J. J. Org. Chem. 2006, 71,
1911-1919. (i) Pachamuthu, K.; Schmidt, R. R. Chem. ReV. 2006, 106,
160-187.
(2) Dondoni, A.; Marra, A. Chem. ReV. 2000, 100, 4395-4421. See also
ref 1g for an updated list of references.
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induce changes in physicochemical and biological properties,
C-glycosyl amino acids with rigid linkers such the acetylene
group4 and phenyl ring5 have been prepared. In this context,
we have recently reported6 on the first synthesis of C-glycosyl
amino acids with isoxazole and triazole bridges via alkyne-
nitrile oxide and azide-alkyne cycloaddition (Huisgen-type
reactions),7 respectively. The latter reaction was carried out both
thermally and under Cu(I) catalysis according to the recent
discovery of Sharpless and Meldal and their co-workers.8 A
similar work was reported almost at the same time by another
group.9 We report here the synthesis of a novel family of
heterocycle-linked C-glycosyl amino acids in which the flat and
rigid pyridine ring holds the two chiral bioactive entities (Figure
1). The presence of nitrogen heterocycles bearing carbohydrate
residues in C-glycopeptides may be quite beneficial since these
heteroaromatic bridges can participate in hydrogen-bonding and
dipole interactions, which can favor the binding to biomolecular
targets and improve solubility as well as membrane transport
properties.10 Only one natural C-glycosyl amino acid, identified
as an R-C-mannopyranosyltryptophan,11 has been found so far
in biologically important glycoproteins. Therefore, quite inter-
estingly, this compound features the rigid heteroaromatic indole
ring holding the sugar and amino acid moieties. Very recently,
the â-isomer and analogues of this natural product have been
synthesized by the Nishikawa and Isobe group.12
Results and Discussion
Multicomponent one-pot reactions13 have emerged in recent
years as a useful tool to maximize synthetic efficiency,14 an
aspect of increasing relevance in modern chemistry toward the
ideal synthesis.15 Hence, we decided to approach the construc-
tion of carbohydrate-heterocycle-amino acid hybrids depicted
in Figure 1 by the three-component version of the pyridine
Hantzsch synthesis16 comprising the aldehyde-ketoester-
enamino ester system (Scheme 1). To one of these reagents is
bound the C-glycosyl residue and to another the amino acid.
With the carbohydrate linked to the ketoester and the amino
acid as a part of the aldehyde, the dihydropyridine formed from
the cyclocondensation and the pyridine I obtained afterward will
bear the amino acid at C-4 and the carbohydrate at C-2 of the
ring. The regioisomer II will be instead obtained using a
C-glycosyl aldehyde and a ketoester with incorporated the
glycinyl group. We planned to use in both routes the same
enamino ester with a methyl group adjacent to the amino group
in order to keep as low as possible the steric encumbrance in
this reagent. Evidently, this methodology will lead to a densely
substituted pyridine ring. However, we considered the presence
of the two ester groups as an advantage because these func-
(3) For a special family of C-glycosyl amino acids comprised of
iminosugar moieties, see: (a) Fuchss, T.; Schmidt, R. R. Synthesis 2000,
259-264. (b) Dondoni, A.; Giovannini, P. P.; Perrone, D. J. Org. Chem.
2005, 70, 5508-5518.
(4) Lowary, T.; Meldal, M.; Helmboldt, A.; Vasella, A.; Bock, K. J.
Org. Chem. 1998, 63, 9657-9668.
(5) Xu, X.; Fakha, G.; Sinou, D. Tetrahedron 2002, 58, 7539-7544.
(6) Dondoni, A.; Giovannini, P. P.; Massi, A. Org. Lett. 2004, 6, 2929-
2932.
(7) (a) Huisgen, R. Angew. Chem., Int. Ed. 1963, 2, 565-598. (b)
Huisgen, R. Angew. Chem., Int. Ed. 1963, 2, 633-645.
(8) (a) Rostovtsev, V. V.; Green, L. G.; Fokin, V. V.; Sharpless, K. B.
Angew. Chem., Int. Ed. 2002, 41, 2596-2599. (b) Tornoe, C. W.;
Christensen, C.; Meldal, M. J. Org. Chem. 2002, 67, 3057-3062.
(9) Kuijpers, B. H. M.; Groothuys, S.; Keereweer, A. R.; Quaedflieg, P.
J. L. M.; Blaauw, R. H.; van Delft, F. L.; Rutjes, F. P. J. T. Org. Lett.
2004, 6, 3123-3126.
(10) (a) Horne, W. S.; Yadav, M. K.; Stout, C. D.; Ghadiri, M. R. J.
Am. Chem. Soc. 2004, 126, 15366-15367. (b) Bezouska, K. ReV. Mol.
Biotech. 2002, 90, 269-290.
(11) (a) Beer, T.; Vliegenthart, J. F. G.; Lo¨ffler, A.; Hofsteenge, J.
Biochemistry 1995, 34, 11785-11789. (b) Lo¨ffler, A.; Doucey, M.-A.;
Jansson, A. M.; Mu¨ller, D. R.; Beer, T.; Hess, D.; Meldal, M.; Richther,
W. J.; Vliegenthart, J. F. G.; Hofsteenge, J. Biochemistry 1996, 35, 12005-
12014. (c) Doucey, M.-A.; Hess, D.; Blommers, M. J. J.; Hofsteenge, J.
Glycobiology 1999, 9, 435-441.
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M. Org. Biomol. Chem. 2006, 4, 1268-1277.
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VCH: Weinheim, Germany, 2005.
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O. G.; Dediu, N.; Oeser, T.; Mu¨ller, T. J. J. J. Org. Chem. 2006, 71, 3494-
3500. (b) Dondoni, A.; Massi, A. Acc. Chem. Res. 2006, 39, 451-463.
(15) (a) von Wangelin, A. J.; Neuman, H.; Go¨rdes, D.; Klaus, S.;
Stru¨bing, D.; Beller, M. Chem. Eur. J. 2003, 9, 4286-4294. (b) Andraos,
J. Org. Process Res. DeV. 2005, 9, 149-163. (c) Wender, P. A.; Handy, S.
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FIGURE 1. Basic structure of designed pyridine-tethered C-glycosyl
amino acids.
SCHEME 1. Synthesis Plan via Hantzsch Reaction for
Pyridine-Tethered C-Glycosyl Amino Acid Regioisomers
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tionalities can be varied in library preparations or serve as
reactive points for the introduction of the glycosyl amino acid
in molecular frameworks other than peptides. We were spurred
to adopt the Hantzsch multicomponent reaction in this project
as a logical evolution of our recent research on the synthesis of
dihydropyridine C-glycoconjugates and piridylalanines.14b,17 The
information collected in the earlier work constituted a precious
guide in the choice of suitable reagents and conditions to
perform the construction of the pyridine ring bearing both sugar
and amino acid residues.
A. Design and Synthesis of Reagents for the Three-
Component Hantzsch Reaction (3CHR). The first issue to
be addressed in this project was to design reagents with
functional protective groups which are stable under the reaction
conditions and orthogonal in the product. The latter condition
was crucial for the elaboration of the product via selective
reactions at each functional group at will. In particular, the
protection of the NH2 of the glycinyl group should preserve
the configurational integrity of the R-stereocenter and permit
the introduction of the product into peptides via sequential
carboxylic and amino group coupling reactions. Toward this
goal, the N-Boc and methyl ester protection of the glycinyl
moiety was previously demonstrated to be a quite convenient
combination.17c,e Moreover, the tert-butyl group in the ketoester
and enamino ester appeared to be a convenient choice as well
because it differentiated the carboxylic groups of the ring from
that of the amino acid and avoided the lactam formation via
intramolecular reaction with the free amino acid group.17c
Finally, the O-benzyl protective group in the carbohydrate
moiety was demonstrated in several instances to be orthogonal
with the N-Boc methylglycinate1g,2,6 and proved to be readily
removed in the presence of the pyridine ring by Pd-catalyzed
hydrogenolysis.17e
Following the above reasoning, we first examined the
synthesis of aldehyde and ketoester starting reagents bearing
the N-Boc methyl glycinate group. Because of the easy
elimination of this group from the dihydropyridine ring in the
oxidation step to pyridine,17c we decided to prepare reagents
holding the glycinate residue through a methylene spacer. Hence,
the N-Boc-O-methyl aspartate semialdehyde 2 was prepared in
two steps by a reduction-oxidation sequence from the readily
available aspartate monoester 118 (Scheme 2). However, this
method afforded the aldehyde in low yield because of the
lactonization of the alcohol intermediate.19 Hence, the prepara-
tion of 2 was more conveniently carried out in gram quantities,
starting from the aspartate diester 320 according to the procedure
of Martin and co-workers.21 However, it is worth noting that
the optical rotation value of 2 ([R]D ) 34.5) obtained by both
routes was more than double that previously registered by these
authors (lit.21b [R]D ) 16.4).22
With the aldehyde 2 available in gram scale, the synthesis of
the â-ketoester 5 was first carried by reaction of 2 with tert-
butyl diazoacetate and BF3ÆEt2O (Scheme 3) according to the
procedure already employed in our laboratory.17c,e In contrast
to previous results, the yield of isolated 5 was only 38%. Hence,
an alternative synthesis of 5 was performed starting from the
N-Boc aspartic acid monoester 118 by a procedure similar to
that described by Frank and co-workers.23 This method involves
the transformation of 1 into the Meldrum’s acid derivative 6
and then treatment of this crude material with refluxing t-BuOH.
The overall yield of 5 was 60%, and its optical rotation value
([R]D ) 25.4) was identical to that of the product obtained by
the other route from 2.
For reasons given below in section B, aldehydes and
ketoesters with a directly linked C-glycosyl group appeared to
be unsuitable reagents in the planned 3CHR. On the other hand,
C-glycosylmethyl derivatives turned out to be the reagents of
choice. Fortunately enough, the C-glucosyl (Glc) acetaldehydes
R-7a24 and â-7a24,25 as well as the C-galactosyl (Gal) derivatives
(17) (a) Dondoni, A.; Massi, A.; Minghini, E. Synlett 2002, 89-92. (b)
Dondoni, A.; Massi, A.; Minghini, E. HelV. Chim. Acta 2002, 85, 3331-
3348. (c) Dondoni, A.; Massi, A.; Minghini, E.; Sabbatini, S.; Bertolasi,
V. J. Org. Chem. 2003, 68, 6172-6183. (d) Dondoni, A.; Massi, A. Mol.
DiVers. 2003, 6, 261-270. (e) Dondoni, A.; Massi, A.; Minghini, E.;
Bertolasi, V. Tetrahedron 2004, 60, 2311-2326.
(18) Ghosh, A. K.; Devasamudram, T.; Hong, L.; DeZutter, C.; Xu, X.;
Weerasena, V.; Koelsch, G.; Bilcer, G.; Tang, J. Bioorg. Med. Chem. Lett.
2005, 15, 15-20.
(19) Baldwin, J. E.; Flinn, A. Tetrahedron Lett. 1987, 28, 3605-3608.
(20) Englund, E. A.; Gopi, H. N.; Appella, D. H. Org. Lett. 2004, 6,
213-216.
(21) (a) Padro´n, J. M.; Kokotos, G.; Martı´n, T.; Markidis, T.; Gibbons,
W. A.; Martı´n, V. S. Tetrahedron: Asymmetry 1998, 9, 3381-3394. (b)
Herna´ndez, J. N.; Ramı´rez, M. A.; Martı´n, V. S. J. Org. Chem. 2003, 68,
743-746.
(22) In a control experiment, the aldehyde 2 was reduced to alcohol
(NaBH4, MeOH, 0 °C) which spontaneously cyclized (CH2Cl2, rt) to give
in quantitative overall yield the known (S)-tert-butyl 2-oxotetrahydrofuran-
3-ylcarbamate whose optical rotation value [R]D ) -29.2 was identical to
that reported in the literature ([R]D ) -29.5).19
(23) Bartolozzi, A.; Li, B.; Franck, R. W. Bioorg. Med. Chem. 2003,
11, 3021-3027.
(24) (a) Sparks, M. A.; Panek, J. S. Tetrahedron Lett. 1989, 30, 407-
410. (b) Nolen, E. G.; Watts, M. M.; Fowler, D. J. Org. Lett. 2002, 4,
3963-3965.
(25) Postema, M. H. D.; Piper, J. L.; Liu, L.; Shen, J.; Faust, M.;
Andreana, P. J. Org. Chem. 2003, 68, 4748-4754.
SCHEME 2. Synthesis of N-Boc-O-methyl Aspartate
Semialdehyde 2
SCHEME 3. Synthesis â-Keto Ester 5
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R-7b26 and â-7b26 (Figure 2) were readily available by double-
bondoxidativecleavageofthecorrespondingC-allylglycosides.24b,26,27
Then, the four sugar aldehydes 7 were used for the preparation
of the ketoesters 8 (Figure 2). As an example, the synthesis of
one of these compounds is illustrated in Scheme 4. In one
approach, the aldehyde R-7a was transformed into the ketoester
R-8a by reaction with tert-butyl diazoacetate as described for
other sugar ketoesters.28 However, this method afforded R-8a
in low yield (35%), and therefore, another procedure was
followed. This involved the nearly quantitative oxidation of R-7a
to the carboxylic acid R-9a and treatment of the latter with
Meldrum’s acid in the presence of isopropenyl chloroformate.
Then the crude product R-10a was cleaved by treatment with
t-BuOH and MW irradiation at 120 °C. The crude ester R-8a
obtained in this way was purified and isolated in fairly good
overall yield (66%). All of the sugar ketoesters shown in Figure
2 were prepared in good yields by this two-step route.
B. Synthesis of 4-(C-Glycosylmethyl)-2-alaninylpyridines
15. In recent disclosures from this laboratory, we reported that
C-glycosyl formaldehydes readily available via thiazole-medi-
ated chemistry29 take part in 3CHR to give the corresponding
C-glycosyl dihydropyridines.17a,b Hence we considered a model
reaction constituted of the C-galactosyl formaldehyde â-11b,29
the â-ketoester 5, and tert-butyl aminocrotonate 12 (Scheme
5). Under the usual standard conditions used in our previous
work of Hantzsch reactions (t-BuOH, 70 °C, 24 h) and even
under MW irradiation at 120 °C for 4 h, only traces of the
desired dihydropyridines â-13b were detected by MALDI-TOF
analysis of the crude reaction mixture. Instead, various side
products were isolated including the glycal arising from
debenzylation of the aldehyde â-11b and carboxylic acids
derived from the hydrolysis of the ester groups of 5 and 12.
Therefore, we considered the use of the C-galactosyl acetalde-
hyde â-7b with the hope that the presence of a methylene spacer
between the formyl group and the carbohydrate residue would
reduce the steric congestion of the system and the cyclocon-
densation could take place. The change turned out to be quite
(26) Wang, Z.; Shao, H.; Lacroix, E.; Wu, S.-H.; Jennings, H. J.; Zou,
W. J. Org. Chem. 2003, 68, 8097-8105.
(27) Patnam, R.; Jua´rez-Ruiz, J. M.; Roy, R. Org. Lett. 2006, 8, 2691-
2694.
(28) (a) Dondoni, A.; Massi, A.; Sabbatini, S. Tetrahedron Lett. 2001,
42, 4495-4497. (b) Dondoni, A.; Massi, A.; Sabbatini, S.; Bertolasi, V. J.
Org. Chem. 2002, 67, 6979-6994.
(29) (a) Dondoni, A.; Marra, A. Chem. ReV. 2004, 104, 2557-2599. (b)
Dondoni, A. Pure Appl. Chem. 2000, 72, 1577-1588. (c) Dondoni, A.;
Scherrmann, M.-C. J. Org. Chem. 1994, 59, 6404-6412.
FIGURE 2. C-Glucosyl (Glc) and C-galactosyl (Gal) acetaldehydes
7 and ketoesters 8.
SCHEME 4. Synthesis of Sugar â-Keto Esters r-8a
SCHEME 5. Optimization of Reaction Conditions for the
Synthesis of 4-(C-Galactosylmethyl)-2-(alaninyl)pyridine
â-15b
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beneficial because this new substrate combination upon heating
at 70 °C in t-BuOH for 24 h afforded the Hantzsch dihydro-
pyridine â-14b in fair yield (45%) as a mixture of diastereoi-
somers in 1:1 ratio. The lack of asymmetric induction by the
chiral sugar fragment is very likely due to its distance from the
newly formed stereocenter and the harsh reaction conditions
employed. The mixture of diastereoisomers was oxidized with
PCC to give the pyridine â-15b as a single product (40% overall
yield), thus confirming, as already observed in our earlier
work,17e the conservation of the configurational integrity of the
amino acid stereocenter during the Hantzsch cyclocondensation.
In order to achieving higher efficiency and establish the
conditions for an automatable process, the above reaction
sequence was performed in one-pot using polymer-bound
reagents. Hence, the cyclocondensation of the aldehyde â-7b,
ketoester 5, and aminocrotonate 12 in a 1:1:1 ratio was carried
out by MW irradiation at 120 °C, which reduced the reaction
time from 24 to 1.5 h. Then, the reaction mixture was treated
with a mixed-resin bed constituted of three polymer-bound
reagents, each one acting as specific scavenger of unreacted
material and side products. Specifically, the supported sulfonic
acid A-15 removed the residual enamine 12, the strong
hydroxylic base Ambersep sequestered the ketoester 5, and the
aminomethylated polystyrene (AM-resin) subtracted the alde-
hyde â-7b. This supported amine removed also the Knoevenagel
adduct formed as initial condensation product between the
aldehyde and the ketoester.17e After filtration of the resins, the
diastereomeric dihydropyridines were oxidized to pyridine with
PCC supported on silica gel. Also this operation was quite
convenient because the noxious chromium salts anchored to the
resin were easily removed by filtration. A final column
chromatography of the crude product afforded pure C-galacto-
sylmethyl-pyridylalanine methyl ester â-15b in 62% yield. This
compound was identical in all respect (NMR, [R]D) to that
obtained via the two-step procedure illustrated above and
involving the isolation of the dihydropyridine â-14b. Accord-
TABLE 1. Glycosylmethylalaninylpyridines Prepareda
a All Hantzsch cyclocondensations were run with 0.50 mmol of each component (see the Experimental Section). b Time of microwave irradiation was
1.5 h. c Isolated yield by chromatography. d Time of microwave irradiation was 2.5 h.
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ingly, treatment of crude â-14b with the set of resins employed
in the direct route afforded again authentic â-15b. This
observation opens the route to an automatable and operatively
simple synthesis with total preservation of stereocenter integrity
and functional group protection.
Three more sugar amino acids with the same substitution
pattern in the pyridine ring as in â-15b, i.e. the sugar sector
linked to C-4 and the amino acid fragment linked to C-2, were
prepared using the C-glycosyl acetaldehydes â-7a, R-7a, and
R-7b with carbohydrate configuration corresponding to â-Glc,
R-Glc, and R-Gal respectively (Table 1). The reactions were
carried out by MW irradiation and processed by the use of
polymer-bound reagents as described above. The three further
amino esters â-15a, R-15a, R-15b thus prepared were isolated
in comparable yields (55-61%) and stereochemically pure form
as judged by NMR analysis.
C. Synthesis of 2-(C-Glycosylmethyl)-4-alaninylpyridines
16. The approach to this class of compounds started by
examining a three-component model reaction (Scheme 6)
constituted of the methyl C-galactosylacetoacetate â-8b, the
N-Boc-O-methyl aspartate semialdehyde 2, and the already
exploited valuable aminocrotonate 12.30 In this case, the two-
step procedure involving the isolation of the dihydropyridine
was not explored. Instead, the same reaction conditions and
workup operations of the one-pot process illustrated in Scheme
5 were used. In this way, the sugar-pyridine-amino acid â-16b
was isolated in more than 90% purity. This product was mainly
contaminated by the residual sugar ketoester â-8b because the
basic resin Ambersep turned out to be a scarcely efficient
scavenger toward this bulky compound. However, filtration of
the crude mixture through a short column of silica (cyclohex-
ane-AcOEt) afforded the analytically pure amino ester â-16b
in 68% isolated yield. This product resulted to be stereochemi-
cally pure as judged by NMR analysis. By changing the
configuration of the carbohydrate moiety in the ketoester, the
stereoisomers â-16a, R-16a, and R-16b (Table 1) were prepared
in comparable fair yields (52-68%).
D. Synthesis of Pyridine-Tethered Glycopeptides. In order
to demonstrate the potential of the C-glycosylmethyl amino
esters 15 and 16 as orthogonally protected building blocks for
the co-translational modification of glycopeptides, the product
â-15b was selected as a prototype in this crucial validating test
(Scheme 7). Toward this goal, we first carried out the selective
hydrolysis of the ester functionality of the glycinyl group. The
use of very mild conditions (LiOH in THF at 0 °C) afforded
the N-Boc alanine 17 in excellent yield (95%). Then, the
condensation of this product with H-Phe-OEt under activation
of the condensation agent (benzotriazol-1-yloxy)tripyrrolidino-
phosphonium hexafluorophosphate (PyBOP) and the presence
of the Hu¨nig base diisopropylethylamine (DIPEA), afforded the
dipeptide 18 in fair yield. The N-Boc group in this compound
(30) A parallel experiment involving the microwave-assisted 3CHR of
2, 12, and tert-butyl 3-oxo-3-(2′,3′,4′,6′-tetra-O-benzyl-â-D-galactopyrano-
syl)propanoate, i.e. the lower homologous of â-8b, resulted in no isolation
of the corresponding dihydropyridines due to the steric congestion of the
system, as previously observed in the preparation of regioisomers â-13b
(Scheme 5).
SCHEME 6. Synthesis of
2-(C-Galactosylmethyl)-4-(alaninyl)pyridine â-16b
SCHEME 7. Synthesis of Tripetide 19
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was removed under slightly acid conditions (diluted TFA), thus
liberating the NH2 group that was used in the condensation with
Boc-Ala-OH under the same coupling conditions illustrated
above. The tripeptide 19 featuring a pendant galactosylmethyl
residue linked through a rigid pyridine ring to the peptide
backbone was isolated in 65% yield.
Conclusions
After about one and half century after its discovery,31 the
Hantzsch pyridine synthesis continues to manifest its prolific
nature and potential as a tool in synthetic organic methodology.
In the present work, we have further validated these exceptional
prerogatives by assembly in one-pot procedure, without added
catalysts and under the simple cooperation of a clean physical
energy, such as MW irradiation, three densely functionalized
substrates, such as a carbohydrate, a pyridine, and an amino
acid. This simple yet efficient chemistry was performed with
the assistance of an orchestrated sequence of polymer supported
reagents. In this way, only one chromatographic purification
of the final product was required. The configurational integrity
of the chiral reagents was preserved throughout the whole
synthetic procedure. In this way a collection of eight news
optically pure C-glycosylmethyl pyridine amino acids (C-
glycosyl pyridylalanines) was prepared. It is noteworthy that
all products have the sugar residue linked to the pyridine ring
through an all carbon tether, thus providing high stability toward
glycosidases. Moreover, the orthogonal protection of the various
functional groups allows the use of these amino acids in
glycopeptide co-translational modification. The way has been
now paved for the preparation of a larger library of these amino
acids by the change of the carbohydrate and amino acid residues
in the reagents employed in the Hantzsch cyclocondensation.
This work has been carried out with a view to biological and
pharmaceutical applications. In this context, focus on the
heterocycle-based ligation strategy of carbohydrate fragments
to a peptide backbone via Cu(I)-catalyzed azide-alkyne cy-
cloaddition has been recently brought by Danishefsky and co-
workers in their continuous efforts to develop carbohydrate-
based anticancer vaccines.32
Experimental Section
Aspartates 118 and 320 and aldehydes 2,21b 4,21a R-7a,24 â-7a,24,25
R-8a,26 and â-8a26 are known compounds. Spectroscopic data of
intermediate acids â-9a and â-9b were identical to those re-
ported.33,25 PCC immobilized on silica gel was prepared according
to the procedure described by Eynde and co-workers.34
(2S)-Methyl 2-(tert-Butoxycarbonylamino)-4-oxobutanoate (2).
Route A. To a cooled (-15 °C), stirred solution of Boc-L-Asp-
OMe 118 (1.00 g, 4.05 mmol) in anhydrous THF (2 mL) were added
4-methylmorpholine (0.45 mL, 4.05 mmol) and isobutyl chloro-
formate (0.53 mL, 4.05 mmol). The suspension was stirred at
-15 °C for an additional 10 min, and then salts were filtered off
and washed thoroughly with cold THF (2  15 mL). The combined
filtrates were cooled to -10 °C, and then a solution of NaBH4 (230
mg, 6.08 mmol) in H2O (1.5 mL) was added in one portion. The
solution was stirred for an additional 10 min and then diluted with
AcOEt (75 mL) and H2O (50 mL). The separated organic layer
was washed with 10% citric acid (10 mL), saturated aqueous
NaHCO3 (10 mL), and brine (10 mL) and then dried (NaSO4) and
concentrated. A mixture of the resulting crude alcohol, activated
4-Å powdered molecular sieves (1.00 g), and anhydrous CH2Cl2
(40 mL) was stirred at room temperature for 15 min, and then
pyridinium chlorocromate (1.64 g, 7.40 mmol) was added in one
portion. The suspension was stirred for 45 min, and then cyclo-
hexane (40 mL) and Et2O (80 mL) were added. The mixture was
stirred for an additional 30 min, filtered through a pad of silica
gel, and concentrated. The residue was eluted from a column of
silica gel with 1.5:1 cyclohexane-Et2O to afford 221b (347 mg,
37%) as a yellow oil: [R]D ) 34.0 (c 2.1, CHCl3) [lit.21b [R]D )
16.4 (c 5, CHCl3)].
Route B. To a cooled (-78 °C), stirred solution benzyl ester
320 (1.23 g, 2.81 mmol) in anhydrous Et2O (30 mL) was added
dropwise DIBAL (3.2 mL, 3.20 mmol of a 1.0 M solution in
hexane). The mixture was stirred at -78 °C for 15 min and then
quenched with H2O (0.5 mL). The suspension was warmed to room
temperature, stirred for an additional 30 min, dried (Na2SO4),
filtered through a pad of Celite, and then concentrated. The residue
was eluted from a column of silica gel with 1.5:1 cyclohexane-
AcOEt to afford 421a (745 mg, 80%) as an oil: [R]D ) -55.4 (c
2.3, CHCl3) [lit.21a [R]D ) -54.9 (c 2, CHCl3)]. A mixture of the
aldehyde 421a (700 mg, 2.11 mmol), lithium bromide (550 mg, 6.34
mmol), and CH3CN (20 mL) was warmed to 65 °C, stirred at that
temperature for 5 h, and then cooled to room temperature and
concentrated. The residue was suspended in AcOEt (50 mL) and
washed with H2O (3  5 mL). The organic phase was dried (Na2-
SO4), concentrated, and eluted from a column of silica gel with
1.5:1 cyclohexane-Et2O to afford 221b (366 mg, 75%) as a yellow
oil: [R]D ) 34.5 (c 3.0, CHCl3).
(2S)-6-tert-Butyl 1-methyl 2-(tert-butoxycarbonylamino)-4-
oxohexanedioate (5). Route A. A mixture of aldehyde 2 (462 mg,
2.00 mmol), tert-butyl diazoacetate (0.33 mL, 2.40 mmol), activated
4-Å powdered molecular sieves (300 mg), and anhydrous CH2Cl2
(20 mL) was stirred at room temperature for 15 min and then cooled
to 0 °C. To the mixture a solution of BF3ÆEt2O (127 íL, 1.00 mmol)
in anhydrous CH2Cl2 (1 mL) was added drop by drop, controlling
the N2 evolution at a low steady rate. The mixture was stirred at
0 °C for an additional 30 min, diluted with 10% NaHCO3 (10 mL),
warmed to room temperature, filtered through a pad of Celite, and
extracted with CH2Cl2 (3  30 mL). The organic layer was dried
(Na2SO4) and concentrated. The residue was eluted from a column
of silica gel with 2:1 cyclohexane-Et2O to give 5 (262 mg, 38%)
as a 10:1 mixture of ketone and enol isomers: [R]D ) 25.3 (c
0.9, CHCl3); 1H NMR (DMSO-d6, ketone isomer) ä ) 7.22 (d, 1
H, J2,NH ) 8.0 Hz, NH), 4.35 (ddd, 1 H, J2,3a ) 5.5 Hz, J2,3b ) 8.5
Hz, H-2), 3.62 (s, 3 H, OCH3), 3.53 and 3.46 (2d, 2 H, J5a,5b )
14.0 Hz, 2 H-5), 3.00 (dd, 1 H, J3a,3b ) 16.5 Hz, H-3a), 2.85 (dd,
1 H, H-3b), 1.38 (s, 9 H, t-Bu); MALDI-TOF MS 368.4 (M+ +
Na), 384.2 (M+ + K). Anal. Calcd for C16H27NO7 (345.39): C,
55.64; H, 7.88; N, 4.06. Found: C, 55.68; H, 7.80; N, 4.10.
Route B. A mixture of Boc-L-Asp-OMe 118 (1.00 g, 4.05 mmol),
Meldrum’s acid (648 mg, 4.50 mmol), DMAP (1.10 g, 8.98 mmol),
and anhydrous CH2Cl2 (10 mL) was cooled to -5 °C, and then a
solution of isopropenyl chloroformate (0.51 mL, 4.66 mmol) in
anhydrous CH2Cl2 (5 mL) was added dropwise under vigorous
magnetic stirring. The mixture was stirred at -5 °C until complete
disappearance of the starting material was detected (TLC analysis,
1 h). Then a 10% aqueous solution of KHSO4 (8 mL) was added
to the solution, the cooling bath was removed, and an additional
portion of 10% aqueous solution of KHSO4 (8 mL) was added.
The mixture was diluted with CH2Cl2 (80 mL), and then the two
phases were separated. The organic phase was washed with brine
(2  5 mL), dried (Na2SO4), and concentrated to give the adduct
6, which was used for the following reaction without any purifica-
tion. A mixture of the above crude adduct 6, anhydrous toluene
(31) Hantzsch, A. Justus Liebigs Ann. Chem. 1882, 215, 1-82.
(32) Wan, Q.; Chen, J.; Chen, G.; Danishefsky, S. J. J. Org. Chem. 2006,
71, 8244-8249.
(33) (a) Sutherlin, D. P.; Stark, T. M.; Hughes, R.; Armstrong, R. W. J.
Org. Chem. 1996, 61, 8350-8354. (b) Orsini, F.; Di Teodoro, E.
Tetrahedron: Asymmetry 2003, 14, 2521-2528.
(34) Eynde, J. V.; Mayence, A.; Maquestiau, A. Tetrahedron Lett. 1992,
48, 463-468.
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(24 mL), and anhydrous t-BuOH (12 mL) was heated under reflux
for 5 h and then concentrated. The residue was eluted from a column
of silica gel with 2:1 cyclohexane-Et2O to give 5 (838 mg, 60%)
as a 10:1 mixture of ketone and enol isomers: [R]D ) 25.4 (c
0.9, CHCl3).
General Procedure for the Synthesis of Sugar Acids 9a,b.
To a stirred solution of sugar aldehyde (1.00 mmol) in CH3CN (10
mL) were added 35% aqueous H2O2 (0.2 mL), 1.2 M aqueous KH2-
PO4 (1.0 mL), and 0.17 M aqueous NaClO2 (7.0 mL). The mixture
was stirred at room temperature for 2 h and then acidified with 1
N aqueous HCl to pH ) 2, diluted with AcOEt (150 mL), and
washed with H2O (2  10 mL). The aqueous phase was extracted
with AcOEt (2  50 mL), and then the combined organic phase
was dried (Na2SO4) and concentrated to give the corresponding
crude acid 9 in almost quantitative yield and at least 95% pure as
judged by 1H NMR analysis.
Crude acid R-9a: 1H NMR ä ) 7.40-7.00 (m, 20 H, Ph), 4.92
and 4.80 (2 d, 2 H, J ) 11.0 Hz, PhCH2), 4.82 and 4.50 (2 d, 2 H,
J ) 11.2 Hz, PhCH2), 4.72 and 4.66 (2 d, 2 H, J ) 11.5 Hz,
PhCH2), 4.67 (ddd, 1 H, J2a,3 ) 5.5 Hz, J2b,3 ) 9.0 Hz, J3,4 ) 3.0
Hz, H-3), 4.64 and 4.48 (2 d, 2 H, J ) 12.0 Hz, PhCH2), 3.84-
3.62 (m, 6 H, H-4, H-5, H-6, H-7, 2 H-8), 2.82 (dd, 1 H, J2a,2b )
15.0 Hz, H-2a), 2.74 (dd, 1 H, H-2b). Anal. Calcd for C36H38O7
(582.68): C, 74.21; H, 6.57. Found: C, 74.35; H, 6.44.
Crude acid R-9b: 1H NMR ä ) 7.40-7.10 (m, 20 H, Ph), 4.72
and 4.60 (2 d, 2 H, J ) 12.0 Hz, PhCH2), 4.69 and 4.57 (2 d, 2 H,
J ) 11.2 Hz, PhCH2), 4.60 and 4.50 (2 d, 2 H, J ) 11.5 Hz,
PhCH2), 4.57 and 4.49 (2 d, 2 H, J ) 11.8 Hz, PhCH2), 4.46 (ddd,
1 H, J2a,3 ) 9.0 Hz, J2b,3) 4.5 Hz, J3,4 ) 3.0 Hz, H-3), 4.16 (ddd,
1 H, J6,7′ ) 3.0 Hz, J7,8a ) 8.0 Hz, J7,8b ) 4.0 Hz, H-7), 4.03 (dd,
1 H, J5,6 ) 4.5 Hz, H-6), 3.95 (dd, 1 H, J8a,8b ) 11.0 Hz, H-8a),
3.78-3.70 (m, 2 H, H-4, H-5), 3.68 (dd, 1 H, H-8b), 2.73 (dd, 1
H, J2a,2b ) 16.0 Hz, H-2a), 2.57 (dd, 1 H, H-2b). Anal. Calcd for
C36H38O7 (582.68): C, 74.21; H, 6.57. Found: C, 74.31; H, 6.48.
General Procedure for the Synthesis of Sugar â-Ketoesters
8a,b. Route B. A mixture of crude sugar acid 9 (1.00 mmol),
Meldrum’s acid (159 mg, 1.10 mmol), DMAP (269 mg, 2.20
mmol), and anhydrous CH2Cl2 (8 mL) was cooled to -5 °C, and
then a solution of isopropenyl chloroformate (131 íL, 1.20 mmol)
in anhydrous CH2Cl2 (4 mL) was added dropwise under vigorous
magnetic stirring. The mixture was stirred at -5 °C until the
complete disappearance of the starting material was detected (TLC
analysis, 1 h). A 10% aqueous solution of KHSO4 (2 mL) was
then added to the solution, the cooling bath was removed, and an
additional portion of 10% aqueous solution of KHSO4 (2 mL) was
added. The mixture was diluted with CH2Cl2 (80 mL), and then
the two phases were separated. The organic phase was washed with
brine (2  5 mL), dried (Na2SO4), and concentrated to give the
corresponding adduct 10, which was used for the following reaction
without any purification.
A 2.0-5.0 mL process vial was filled with the above crude
Meldrum adduct 10 and anhydrous t-BuOH (2.5 mL). The vial was
sealed with the Teflon septum and aluminum crimp by using an
appropriate crimping tool. The vial was then placed in its correct
position in the Biotage Initiator cavity where irradiation for 15 min
at 120 °C was performed. After the full irradiation sequence was
completed, the vial was cooled to room temperature and then
opened. The mixture was diluted with AcOEt (10 mL) and then
concentrated. The residue was eluted from a column of silica gel
with the suitable elution system to give the corresponding sugar
â-keto ester 8.
tert-Butyl 3-Oxo-4-(2′,3′,4′,6′-tetra-O-benzyl-â-D-galactopy-
ranosyl)butanoate (â-8b). Column chromatography with 7:1
cyclohexane-AcOEt afforded â-8b (476 mg, 70%) as a 10:1
mixture of ketone and enol isomers: [R]D ) -8.2 (c 1.0, CHCl3);
1H NMR (ketone isomer) ä ) 7.40-7.20 (m, 20 H, Ph), 4.94 and
4.61 (2 d, 2 H, J ) 11.5 Hz, PhCH2), 4.92 and 4.61 (2 d, 2 H, J )
11.8 Hz, PhCH2), 4.74 and 4.65 (2 d, 2 H, J ) 12.0 Hz, PhCH2),
4.44 and 4.39 (2 d, 2 H, J ) 11.2 Hz, PhCH2), 4.01 (dd, 1 H, J3′,4′
) 3.5 Hz, J4′,5′  0.5 Hz, H-4′), 3.74 (ddd, 1 H, J1′,2′ ) 9.0 Hz,
J1′,4a ) 3.5 Hz, J1′,4b ) 8.5 Hz, H-1′), 3.68 (dd, 1 H, J2′,3′ ) 9.2 Hz,
H-2′), 3.62 (dd, 1 H, H-3′), 3.59-3.48 (m, 3 H, H-5′, 2 H-6′), 3.35
and 3.31 (2 d, 2 H, J2a,2b ) 15.0 Hz, 2 H-2), 2.85 (dd, 1 H, J4a,4b
) 15.5 Hz, H-4a), 2.70 (dd, 1 H, H-4b), 1.40 (s, 9 H, t-Bu);
MALDI-TOF MS 703.9 (M+ + Na). Anal. Calcd for C42H48O8
(680.83): C, 74.09; H, 7.11. Found: C, 74.15; H, 7.12.
tert-Butyl 3-Oxo-4-(2′,3′,4′,6′-tetra-O-benzyl-â-D-glucopyra-
nosyl)butanoate (â-8a). Column chromatography with 6:1 cyclo-
hexane-AcOEt afforded â-8a (422 mg, 62%) as a 8:1 mixture
of ketone and enol isomers: [R]D ) 2.6 (c 1.2, CHCl3); 1H NMR
(ketone isomer) ä ) 7.40-7.20 (m, 20 H, Ph), 4.92 and 4.87 (2 d,
2 H, J ) 10.5 Hz, PhCH2), 4.90 and 4.56 (2 d, 2 H, J ) 11.2 Hz,
PhCH2), 4.81 and 4.62 (2 d, 2 H, J ) 11.0 Hz, PhCH2), 4.58 and
4.49 (2 d, 2 H, J ) 12.0 Hz, PhCH2), 3.76 (ddd, 1 H, J1′,2′ ) 8.5
Hz, J1′,4a ) 3.5 Hz, J1′,4b ) 8.5 Hz, H-1′), 3.68 (dd, 1 H, J2′,3′ )
9.0 Hz, J3′,4′ ) 8.5 Hz, H-3′), 3.71-3.62 (m, 3 H, H-4′, 2 H-6′),
3.43 (ddd, 1 H, J4′,5′ ) 9.0 Hz, J5′,6′a ) 3.0 Hz, J5′,6′b ) 3.5 Hz,
H-5′), 3.38 and 3.33 (2 d, 2 H, J2a,2b ) 14.5 Hz, 2 H-2), 3.32 (dd,
1 H, H-2′), 2.84 (dd, 1 H, J4a,4b ) 15.5 Hz, H-4a), 2.66 (dd, 1 H,
H-4b), 1.42 (s, 9 H, t-Bu); MALDI-TOF MS 703.1 (M+ + Na),
720.0 (M+ + K). Anal. Calcd for C42H48O8 (680.83): C, 74.09; H,
7.11. Found: C, 74.18; H, 7.15.
tert-Butyl 3-Oxo-4-(2′,3′,4′,6′-tetra-O-benzyl-R-D-galactopy-
ranosyl)butanoate (R-8b). Column chromatography with 6:1
cyclohexane-AcOEt afforded R-8b (462 mg, 68%) as a 7:1
mixture of ketone and enol isomers: [R]D ) 23.8 (c 2.2, CHCl3);
1H NMR (ketone isomer) ä ) 7.40-7.20 (m, 20 H, Ph), 4.72 and
4.57 (2 d, 2 H, J ) 11.8 Hz, PhCH2), 4.68 and 4.54 (2 d, 2 H, J )
10.5 Hz, PhCH2), 4.58 (ddd, 1 H, J1′,2′ ) 3.0 Hz, J1′,4a ) 7.5 Hz,
J1′,4b ) 6.0 Hz, H-1′), 4.55 and 4.47 (2 d, 2 H, J ) 11.5 Hz, PhCH2),
4.10-3.98 (m, 2 H, H-4′, H-5′), 3.90-3.82 (m, 2 H, H-2′, H-6′a),
3.71 (dd, 1 H, J2′,3′ ) 9.0 Hz, J3′,4′ ) 3.5 Hz, H-3′), 3.68 (dd, 1 H,
J5′,6′b ) 5.5 Hz, J6′a,6′b ) 11.0 Hz, H-6′b), 3.42 and 3.32 (2 d, 2 H,
J2a,2b ) 15.0 Hz, 2 H-2), 2.86 (dd, 1 H, J4a,4b ) 16.0 Hz, H-4a),
2.78 (dd, 1 H, H-4b), 1.42 (s, 9 H, t-Bu); MALDI-TOF MS: 703.5
(M+ + Na), 719.8 (M+ + K). Anal. Calcd for C42H48O8 (680.83):
C, 74.09; H, 7.11. Found: C, 74.00; H, 7.01.
tert-Butyl 3-Oxo-4-(2′,3′,4′,6′-tetra-O-benzyl-R-D-glucopyra-
nosyl)butanoate (R-8a). Column chromatography with 7:1 cyclo-
hexane-AcOEt afforded R-8a (449 mg, 66%) as a 6:1 mixture
of ketone and enol isomers: [R]D ) 27.7 (c 2.9, CHCl3); 1H NMR
(ketone isomer) ä ) 7.40-7.05 (m, 20 H, Ph), 4.92 and 4.80 (2 d,
2 H, J ) 11.5 Hz, PhCH2), 4.82 and 4.50 (2 d, 2 H, J ) 11.0 Hz,
PhCH2), 4.74 (ddd, 1 H, J1′,2′ ) 4.5 Hz, J1′,4a ) 5.5 Hz, J1′,4b )
8.0 Hz, H-1′), 4.64 and 4.60 (2 d, 2 H, J ) 11.2 Hz, PhCH2), 4.62
and 4.48 (2 d, 2 H, J ) 11.8 Hz, PhCH2), 3.78 (dd, 1 H, J2′,3′ )
9.0 Hz, H-2′), 3.78-3.60 (m, 5 H, H-3′, H-4′, H-5′, 2 H-6′), 3.42
and 3.32 (2 d, 2 H, J2a,2b ) 15.0 Hz, 2 H-2), 3.03 (dd, 1 H, J4a,4b
) 15.8 Hz, H-4a), 2.85 (dd, 1 H, H-4b), 1.42 (s, 9 H, t-Bu);
MALDI-TOF MS 703.5 (M+ + Na), 719.8 (M+ + K). Anal. Calcd
for C42H48O8 (680.83): C, 74.09; H, 7.11. Found: C, 74.05; H,
7.06.
Route A. A mixture of aldehyde R-7a (1.13 g, 2.00 mmol), tert-
butyl diazoacetate (0.33 mL, 2.40 mmol), activated 4-Å powdered
molecular sieves (300 mg), and anhydrous CH2Cl2 (20 mL) was
stirred at room temperature for 15 min and then cooled to 0 °C. To
the mixture was added a solution of BF3ÆEt2O (127 íL, 1.00 mmol)
in anhydrous CH2Cl2 (1 mL) drop by drop, controlling the N2
evolution at a low steady rate. The mixture was stirred at 0 °C for
an additional 30 min, diluted with 10% NaHCO3 (10 mL), warmed
to room temperature, filtered through a pad of Celite, and extracted
with CH2Cl2 (3  50 mL). The organic layer was dried (Na2SO4)
and concentrated. The residue was eluted from a column of silica
gel with 7:1 cyclohexane-AcOEt to afford R-8a (476 mg, 35%)
as a 6:1 mixture of ketone and enol isomers: [R]D ) 27.9 (c 2.0,
CHCl3).
(4R,2′′′S)- and (4S,2′′′S)-4-(2′,3′,4′,6′-Tetra-O-benzyl-â-D-ga-
lactopyranosylmethyl)-2-(2′′′-tert-butoxycarbonylamino-2′′′-meth-
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oxycarbonylethyl)-6-methyl-1,4-dihydropyridine-3,5-dicarbox-
ylic Acid Di-tert-butyl Esters (â-14b). A screw-capped vial,
containing a magnetic bar, was charged with aldehyde â-7b (283
mg, 0.50 mmol), â-ketoester 5 (173 mg, 0.50 mmol), aminocro-
tonate 12 (79 mg, 0.50 mmol), powdered 4 Å molecular sieves
(100 mg), and t-BuOH (3 mL). The mixture was then vigorously
stirred, degassed under vacuum, and saturated with argon (by an
Ar-filled balloon) three times. The mixture was stirred at 70 °C
for 24 h and then cooled to room temperature, diluted with AcOEt
(10 mL), filtered through a pad of Celite, and concentrated. The
residue was eluted from a column of silica gel with 4:1 cyclohex-
ane-AcOEt to give â-14b (232 mg, 45%) as a1:1 mixture of
C-4 epimers: 1H NMR (selected data) ä ) 7.40-7.20 (m, 20 H,
Ph), 6.04 (bs, 0.5 H, NH), 5.89 (d, 0.5 H, J ) 8.0 Hz, NH), 4.04-
4.00 (m, 1 H, H-4′), 4.40-4.20 (m, 1 H, H-2′′′), 3.74 and 3.72 (2
s, 3 H, OCH3), 2.20 and 2.14 (2 s, 3 H, CH3), 1.48-1.38 (6 s, 27
H, 3 t-Bu); MALDI-TOF MS 1056.5 (M+ + Na), 1072.6 (M+ +
K). Anal. Calcd for C60H76N2O13 (1033.25): C, 69.75; H, 7.41; N,
2.71. Found: C, 69.88; H, 7.62; N, 2.65.
General Procedure for the Synthesis of 4-(C-Glycosylmethyl)-
2-alaninylpyridines 15. A 2.0-5.0 mL process vial was filled with
sugar aldehyde 7 (283 mg, 0.50 mmol), â-ketoester 5 (173 mg,
0.50 mmol), aminocrotonate 12 (79 mg, 0.50 mmol), powdered 4
Å molecular sieves (100 mg), and t-BuOH (2.5 mL). The vial was
sealed with the Teflon septum and aluminum crimp by using an
appropriate crimping tool. The mixture was then vigorously stirred,
degassed under vacuum, and saturated with argon (by an Ar-filled
balloon) three times The vial was then placed in its correct position
in the Biotage Initiator cavity where irradiation for 1.5 h at 120 °C
was performed. After the full irradiation sequence was completed,
the vial was cooled to room temperature and then opened. The
mixture was diluted with AcOEt (10 mL), filtered through a pad
of Celite, and concentrated. The residue was dissolved in CH2Cl2
(8 mL), and then Amberlyst 15 (400 mg), Ambersep 900 OH (400
mg), and aminomethylated polystyrene (185 mg, 0.50 mmol
of a 2.7 mmol g-1 resin) were added. The suspension was shaken
for 2 h, and then the polymers were filtered off and washed
thoroughly with CH2Cl2. The combined filtrates were concentrated
to give the corresponding crude dihydropyridine derivative. A
mixture of the above residue, pyridinium chlorochromate im-
mobilized on silica gel34 (1.87 g, 1.50 mmol of a 0.8 mmol
g-1 resin) and anhydrous CH2Cl2 (8 mL) was stirred at room
temperature for 12 h. Then the immobilized reagent was filtered
off and washed thoroughly with CH2Cl2. The combined filtrates
were concentrated, and the resulting residue was eluted from a
column of silica gel with the suitable elution system to give the
corresponding pyridine 15.
(2′′′S)-4-(2′,3′,4′,6′-Tetra-O-benzyl-â-D-galactopyranosyl-meth-
yl)-2-(2′′′-tert-butoxycarbonylamino-2′′′-methoxycarbonylethyl)-
6-methylpyridine-3,5-dicarboxylic Acid Di-tert-butyl Esters (â-
15b). Column chromatography with 4:1 cyclohexane-AcOEt
afforded â-15b (320 mg, 62%) as a white foam: [R]D ) 26.7 (c
0.9, CHCl3); 1H NMR ä ) 7.40-7.10 (m, 20 H, Ph), 5.88 (bd, 1
H, J ) 8.0 Hz, NH), 4.97 and 4.70 (2 d, 2 H, J ) 11.0 Hz, PhCH2),
4.93 and 4.50 (2 d, 2 H, J ) 11.2 Hz, PhCH2), 4.79 and 4.69 (2 d,
2 H, J ) 11.5 Hz, PhCH2), 4.72-4.64 (m, 1 H, H-2′′′), 4.41 and
4.33 (2 d, 2 H, J ) 11.8 Hz, PhCH2), 4.02 (dd, 1 H, J3′,4′ ) 3.5 Hz,
J4′,5′  0.5 Hz, H-4′), 3.69 (s, 3 H, OCH3), 3.68-3.60 (m, 2 H,
H-2′, H-6′a), 3.56 (dd, 1 H, J2′,3′ ) 9.0 Hz, H-3′), 3.48-3.34 (m,
3 H, H-1′, H-5′, H-6′b), 3.28 (d, 2 H, J1′′′,2′′′ ) 7.5 Hz, 2 H-1′′′),
3.20 (dd, 1 H, J1′,1′′a ) 3.0 Hz, J1′’a,1′′b ) 14.0 Hz, H-1′′a), 2.95
(dd, 1 H, J1′,1′′b ) 10.5 Hz, H-1′′b), 2.42 (s, 3 H, CH3), 1.45 and
1.42 (2 s, 27 H, 3 t-Bu); 13C NMR ä ) 173.0, 167.5, 167.1, 155.8,
154.3, 152.9, 142.9 (2 C), 139.2-130.2 (5 C), 128.9-127.6 (20
C), 85.0, 83.5, 83.1, 79.8, 79.2, 79.0, 77.4, 75.5, 75.1, 74.2, 73.6,
72.1, 68.6, 52.3, 36.8, 33.1, 28.6, (3 C), 28.2 (6 C), 23.1; MALDI-
TOF MS 1032.5 (M+ + H), 1054.2 (M+ + Na). Anal. Calcd for
C60H74N2O13 (1031.24): C, 69.88; H, 7.23; N, 2.72. Found: C,
69.88; H, 7.28; N, 2.66.
(2′′′S)-4-(2′,3′,4′,6′-Tetra-O-benzyl-â-D-glucopyranosylmethyl)-
2-(2′′′-tert-butoxycarbonylamino-2′′′-methoxycarbonylethyl)-6-
methylpyridine-3,5-dicarboxylic Acid Di-tert-butyl Esters (â-
15a). Column chromatography with 3:1 cyclohexane-AcOEt
afforded â-15a (314 mg, 61%) as a white foam: [R]D ) 36.7 (c
0.9, CHCl3); 1H NMR ä ) 7.40-7.10 (m, 20 H, Ph), 5.88 (bd, 1
H, J ) 8.5 Hz, NH), 4.92 and 4.88 (2 d, 2 H, J ) 11.0 Hz, PhCH2),
4.91 and 4.68 (2 d, 2 H, J ) 12.0 Hz, PhCH2), 4.82 and 4.64 (2 d,
2 H, J ) 10.5 Hz, PhCH2), 4.68-4.64 (m, 1 H, H-2′′′), 4.52 and
4.36 (2 d, 2 H, J ) 11.5 Hz, PhCH2), 3.72-3.62 (m, 3 H, H-3′,
H-4′, H-6′a), 3.68 (s, 3 H, OCH3), 3.62 (dd, 1 H, J5′,6′b ) 3.5 Hz,
J6′a,6′b ) 10.5 Hz, H-6′b), 3.44 (ddd, 1 H, J1′,2′ ) 9.0 Hz, J1′,1′′a )
2.5 Hz, J1′,1′′b ) 11.0 Hz, H-1′), 3.30-3.18 (m, 4 H, H-2′, H-5′, 2
H-1′′′), 3.17 (dd, 1 H, J1′′a,1′′b ) 14.5 Hz, H-1′′a), 2.88 (dd, 1 H,
H-1′′b), 2.42 (s, 3 H, CH3), 1.52 and 1.44 (2 s, 27 H, 3 t-Bu); 13C
NMR ä ) 172.7, 167.1, 166.6, 155.6, 154.2, 152.9, 142.4 (2 C),
138.6-137.9 (5 C), 129.7-127.2 (20 C), 87.4, 83.2, 82.8, 82.5,
79.5, 79.4, 78.8, 78.4, 75.7, 75.1, 74.9, 73.0, 69.3, 52.1, 36.6, 32.8,
29.7 (3C), 28.3 (6 C), 22.3; MALDI-TOF MS 1032.8 (M+ + H),
1054.6 (M+ + Na). Anal. Calcd for C60H74N2O13 (1031.24): C,
69.88; H, 7.23; N, 2.72. Found: C, 69.75; H, 7.20; N, 2.75.
(2′′′S)-4-(2′,3′,4′,6′-Tetra-O-benzyl-R-D-galactopyranosylmethyl)-
2-(2′′′-tert-butoxycarbonylamino-2′′′-methoxycarbonylethyl)-6-
methylpyridine-3,5-dicarboxylic Acid Di-tert-butyl Esters (R-
15b). Column chromatography with 5:1 cyclohexane-AcOEt
afforded R-15b (299 mg, 58%) as a white foam: [R]D ) 6.8 (c
0.8, CHCl3); 1H NMR ä ) 7.40-6.90 (m, 20 H, Ph), 5.75 (bd, 1
H, J ) 8.5 Hz, NH), 4.70 and 4.52 (2 d, 2 H, J ) 12.0 Hz, PhCH2),
4.63 (ddd, 1 H, J1′′′a,2′′′ ) 6.0 Hz, J1′′′b,2′′′ ) 4.5 Hz, H-2′′′), 4.56
and 4.52 (2 d, 2 H, J ) 11.2 Hz, PhCH2), 4.54 and 4.41 (2 d, 2 H,
J ) 11.5 Hz, PhCH2), 4.51 and 4.40 (2 d, 2 H, J ) 11.8 Hz,
PhCH2), 4.23-4.14 (m, 2 H, H-1′, H-6′a), 3.96-3.80 (m, 4 H, H-2′,
H-3′, H-4′, H-6′b), 3.59 (s, 3 H, OCH3), 3.50 (dd, 1 H, J1′,1′′a )
10.5 Hz, J1′′a,1′′b ) 14.0 Hz, H-1′′a), 3.45-3.41 (m, 1 H, H-5′),
3.29 (dd, 1 H, J1′′′a,1′′′b ) 16.0 Hz, H-1′′′a), 3.16 (dd, 1 H, H-1′′′b),
2.57 (dd, 1 H, J1′,1′′b ) 1.0 Hz, H-1′′b), 2.36 (s, 3 H, CH3), 1.44
and 1.38 (2 s, 27 H, 3 t-Bu); 13C NMR ä ) 172.7, 167.3, 166.9,
155.6, 154.1, 152.6, 143.5 (2 C), 139.0-137.9 (5 C), 129.8-127.0
(20 C), 83.1, 82.7, 79.6, 77.9, 75.7, 74.2, 73.7, 73.4, 72.8, 72.4,
71.8, 68.4, 65.7, 52.1, 36.6, 30.9, 28.3 (3 C), 27.9 (6 C), 22.9;
MALDI-TOF MS 1032.8 (M+ + H). Anal. Calcd for C60H74N2O13
(1031.24): C, 69.88; H, 7.23; N, 2.72. Found: C, 69.77; H, 7.29;
N, 2.69.
(2′′′S)-4-(2′,3′,4′,6′-tetra-O-Benzyl-R-D-glucopyranosylmethyl)-
2-(2′′′-tert-butoxycarbonylamino-2′′′-methoxycarbonylethyl)-6-
methylpyridine-3,5-dicarboxylic Acid Di-tert-butyl Esters (R-
15a). Column chromatography with 5:1 cyclohexane-AcOEt
afforded R-15a (284 mg, 55%) as a white foam: [R]D ) 30.5 (c
0.7, CHCl3); 1H NMR (DMSO-d6, 120 °C) ä ) 7.40-7.05 (m, 20
H, Ph), 6.42 (bs, 1 H, NH), 4.70 and 4.65 (2 d, 2 H, J ) 10.5 Hz,
PhCH2), 4.68 and 4.55 (2 d, 2 H, J ) 11.2 Hz, PhCH2), 4.66 and
4.53 (2 d, 2 H, J ) 11.8 Hz, PhCH2), 4.56 (dd, 1 H, J1′′′a,2′′′ ) 6.0
Hz, J1′′′b,2′′′ ) 7.0 Hz, H-2′′′), 4.32-4.26 (m, 1 H, H-1′), 4.26 (s, 2
H, PhCH2), 3.92 (dd, 1 H, J ) 4.5 Hz, J ) 5.5 Hz, H-3′), 3.81
(ddd, 1 H, J ) 3.5 Hz, J ) 4.0 Hz, J ) 8.0 Hz, H-5′), 3.67-3.52
(m, 4 H, H-2′, H-4′, 2 H-6′), 3.58 (s, 3 H, OCH3), 3.36 (dd, 1 H,
J1′,1′′a ) 9.5 Hz, J1′′a,1′′b ) 14.0 Hz, H-1′′a), 3.22 (dd, 1 H, J1′′′a,1′′b
) 15.5 Hz, H-1′′′a), 3.07 (dd, 1 H, H-1′′′b), 2.86 (dd, 1 H, J1′,1′′b
) 4.0 Hz, H-1′′b), 2.20 (s, 3 H, CH3), 1.53, 1.51, and 1.37 (3 s, 27
H, 3 t-Bu); 13C NMR ä ) 172.7, 167.5, 167.1, 155.6, 154.5, 153.0,
143.6 (2 C), 138.6-137.9 (5 C), 129.4-127.4 (20 C), 83.6, 83.1,
81.4, 79.6, 79.5, 74.2, 74.0, 73.3, 72.9, 72.8, 72.7, 68.8, 52.2, 36.7,
30.0, 28.3 (3 C), 28.0 (6 C), 23.1; MALDI-TOF MS 1054.9 (M+
+ Na). Anal. Calcd for C60H74N2O13 (1031.24): C, 69.88; H, 7.23;
N, 2.72. Found: C, 69.90; H, 7.30; N, 2.78.
General Procedure for the Synthesis of 2-(C-Glycosylmethyl)-
4-alaninylpyridines 16. A 2.0-5.0 mL process vial was filled with
aldehyde 2 (116 mg, 0.50 mmol), sugar â-ketoester 8 (340 mg,
0.50 mmol), aminocrotonate 12 (79 mg, 0.50 mmol), powdered 4
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Å molecular sieves (100 mg), and t-BuOH (2.5 mL). The vial was
sealed with the Teflon septum and aluminum crimp by using an
appropriate crimping tool. The mixture was then vigorously stirred,
degassed under vacuum, and saturated with argon (by an Ar-filled
balloon) three times The vial was then placed in its correct position
in the Biotage Initiator cavity where irradiation for 2.5 h at 120 °C
was performed. After the full irradiation sequence was completed,
and the vial was cooled to room temperature and then opened. The
mixture was diluted with AcOEt (10 mL), filtered through a pad
of Celite, and concentrated. The residue was dissolved in CH2Cl2
(8 mL), and then Amberlyst 15 (400 mg), Ambersep 900 OH (400
mg), and aminomethylated polystyrene (185 mg, 0.50 mmol of a
2.7 mmol g-1 resin) were added. The suspension was shaken for 2
h, and then the polymers were filtered off and washed thoroughly
with CH2Cl2. The combined filtrates were concentrated to give the
corresponding crude dihydropyridine derivative. A mixture of the
above residue, pyridinium chlorochromate immobilized on silica
gel34 (1.87 g, 1.50 mmol of a 0.8 mmol g-1 resin) and anhydrous
CH2Cl2 (8 mL), was stirred at room temperature for 12 h. Then
the immobilized reagent was filtered off and washed thoroughly
with CH2Cl2. The combined filtrates were concentrated, and the
resulting residue was eluted from a column of silica gel with the
suitable elution system to give the corresponding pyridine 16.
(2′′′S)-2-(2′,3′,4′,6′-tetra-O-Benzyl-â-D-galactopyranosyl-meth-
yl)-4-(2′′′-tert-butoxycarbonylamino-2′′′-methoxycarbonylethyl)-
6-methylpyridine-3,5-dicarboxylic Acid Di-tert-butyl Esters (â-
16b). Column chromatography with 4:1 cyclohexane-AcOEt
afforded â-16b (351 mg, 68%) as a white foam: [R]D ) -17.8 (c
0.7, CHCl3); 1H NMR (DMSO-d6, 140 °C) ä ) 7.40-7.10 (m, 20
H, Ph), 6.08 (bs, 1 H, NH), 4.88 and 4.55 (2 d, 2 H, J ) 11.5 Hz,
PhCH2), 4.86 and 4.69 (2 d, 2 H, J ) 11.8 Hz, PhCH2), 4.81 and
4.69 (2 d, 2 H, J ) 12.0 Hz, PhCH2), 4.42-4.36 (m, 1 H, H-2′′′),
4.38 and 4.32 (2 d, 2 H, J ) 11.8 Hz, PhCH2), 4.05 (dd, 1 H, J3′,4′
) 2.5 Hz, J4′,5′  0.5 Hz, H-4′), 3.92-3.84 (m, 1 H, H-1′), 3.78-
3.72 (m, 2 H), 3.62-3.52 (m, 2 H), 3.60 (s 3 H, OCH3), 3.46-
3.40 (m, 1 H), 3.24 (dd, 1 H, J1′,1′′a ) 3.5 Hz, J1′′a,1′′b ) 14.0 Hz,
H-1′′a), 3.17 (dd, 1 H, J1′′′a,2′′′ ) 6.5 Hz, J1′′′a,1′′′b ) 14.5 Hz, H-1′′′a),
2.95 (dd, 1 H, J1′,1′′b ) 9.0 Hz, H-1′′b), 2.89 (dd, 1 H, J1′′′b,2′′′ ) 9.5
Hz, H-1′′′b), 2.42 (s, 3 H, CH3), 1.61, 1.52, and 1.30 (3 s, 27 H, 3
t-Bu); 13C NMR ä ) 172.8, 167.7, 167.3, 157.6-154.7 (5 C),
139.1-135.0 (5 C), 129.4-127.3 (20 C), 84.8, 83.9, 79.5, 79.3,
78.9, 78.4, 75.1, 74.5, 74.0, 73.3, 72.0, 68.6, 53.7, 52.2, 38.9, 31.9,
28.0 (3 C), 27.9 (6 C), 23.1; MALDI-TOF MS 1070.9 (M+ + K).
Anal. Calcd for C60H74N2O13 (1031.24): C, 69.88; H, 7.23; N, 2.72.
Found: C, 69.82; H, 7.23; N, 2.71.
(2′′′S)-2-(2′,3′,4′,6′-Tetra-O-benzyl-â-D-glucopyranosylmethyl)-
4-(2′′′-tert-butoxycarbonylamino-2′′′-methoxycarbonylethyl)-6-
methylpyridine-3,5-dicarboxylic Acid Di-tert-butyl Esters (â-
16a). Column chromatography with 4:1 cyclohexane-AcOEt
afforded â-16a (320 mg, 62%) as a white foam: [R]D ) -23 (c
0.5, CHCl3); 1H NMR (DMSO-d6, 120 °C): ä ) 7.40-7.10 (m,
20 H, Ph), 6.25 (bs, 1 H, NH), 4.84 and 4.72 (2 d, 2 H, J ) 12.0
Hz, PhCH2), 4.83 (s, 2 H, PhCH2), 4.73 and 4.60 (2 d, 2 H, J )
11.2 Hz, PhCH2), 4.41-4.30 (m, 1 H, H-2′′′), 4.40 and 4.33 (2 d,
2 H, J ) 11.8 Hz, PhCH2), 3.97 (ddd, 1 H, J1′,1′′a ) 3.5 Hz, J1′,1′′b
) 8.5 Hz, J1′,2′ ) 9.0 Hz, H-1′), 3.74 (dd, 1 H, J ) 8.8 Hz, J ) 9.0
Hz), 3.64-3.51 (m, 2 H, 2 H-6′), 3.59 (s, 3 H, OCH3), 3.51 (dd, 1
H, J ) 8.0 Hz, J ) 8.5 Hz), 3.44 (dd, 1 H, J ) 8.8 Hz, J ) 9.0
Hz), 3.39 (m, 1 H, H-5′), 3.27 (dd, 1 H, J1′′a,1′′b ) 14.5 Hz, H-1′′a),
3.19 (dd, 1 H, J1′′′a,2′′′ ) 8.0 Hz, J1′′′a,1′′′b ) 14.0 Hz, H-1′′′a), 3.26
(dd, 1 H, H-1′′b), 2.88 (dd, 1 H, H-1′′′b), 2.40 (s, 3 H, CH3), 1.59,
1.56, and 1.28 (3 s, 27 H, 3 t-Bu); 13C NMR (selected data) ä )
172.7, 87.4, 84.0, 82.1, 79.4, 78.7, 75.6, 74.9, 73.2, 68.9, 52.7, 52.4,
38.5, 31.7, 28.2, 28.0, 23.0; MALDI-TOF MS 1032.4 (M+ + H),
1054.2 (M+ + Na). Anal. Calcd for C60H74N2O13 (1031.24): C,
69.88; H, 7.23; N, 2.72. Found: C, 69.82; H, 7.28; N, 2.71.
(2′′′S)-4-(2′,3′,4′,6′-Tetra-O-benzyl-R-D-galactopyranosylmethyl)-
2-(2′′′-tert-butoxycarbonylamino-2′′′-methoxycarbonylethyl)-6-
methylpyridine-3,5-dicarboxylic Acid Di-tert-butyl Esters (R-
16b). Column chromatography with 6:1 cyclohexane-AcOEt
afforded R-16b (320 mg, 62%) as a white foam: [R]D ) -3.6 (c
1.2, CHCl3); 1H NMR (DMSO-d6, 140 °C): ä ) 7.40-7.10 (m,
20 H, Ph), 6.18 (bs, 1 H, NH), 4.70 and 4.65 (2 d, 2 H, J ) 11.5
Hz, PhCH2), 4.69-4.62 (m, 1 H, H-2′′′), 4.68 and 4.55 (2 d, 2 H,
J ) 12.0 Hz, PhCH2), 4.62 and 4.56 (2 d, 2 H, J ) 11.0 Hz,
PhCH2), 4.42-4.34 (m, 1 H, H-1′), 4.38 and 4.31 (2 d, 2 H, J )
11.5 Hz, PhCH2), 4.11 (ddd, 1 H, J4′,5′ ) 1.5 Hz, J5′,6′a ) 4.5 Hz,
J5′,6′b ) 9.0 Hz, H-5′), 4.05 (dd, 1 H, J3′,4′ ) 2.0 Hz, H-4′), 3.94
(dd, 1 H, J2′,3′ ) 6.0 Hz, H-3′), 3.88 (dd, 1 H, J1′,2′ ) 3.5 Hz, H-2′),
3.76-3.68 (m, 2 H, 2 H-6′), 3.60 (s, 3 H, OCH3), 3.24 (dd, 1 H,
J1′,1′′a ) 6.0 Hz, J1′′a,1′′b ) 14.0 Hz, H-1′′a), 3.12 (dd, 1 H, J1′′′a,2′′′
) 8.0 Hz, J1′′′a,1′′′b ) 15.0 Hz, H-1′′′a), 3.06 (dd, 1 H, J1′′′b,2′′′ ) 6.0
Hz, H-1′′′b), 2.42 (s, 3 H, CH3), 1.61, 1.55, and 1.30 (3 s, 27 H, 3
t-Bu); 13C NMR (selected data): ä ) 172.8, 167.5, 167.2, 155.5,
155.3, 154.6, 139.0, 138.2, 138.1, 129.0-127.4 (20 C), 84.2, 84.0,
79.6, 75.6, 74.0, 73.1, 72.9, 72.5, 66.8, 53.6, 52.3, 34.0, 31.6, 28.2
(3 C), 28.0 (6 C), 23.0; MALDI-TOF MS 1032.7 (M+ + H). Anal.
Calcd for C60H74N2O13 (1031.24): C, 69.88; H, 7.23; N, 2.72.
Found: C, 69.93; H, 7.15; N, 2.70.
(2′′′S)-4-(2′,3′,4′,6′-Tetra-O-benzyl-R-D-glucopyranosylmethyl)-
2-(2′′′-tert-butoxycarbonylamino-2′′′-methoxycarbonylethyl)-6-
methylpyridine-3,5-dicarboxylic Acid Di-tert-butyl Esters (R-
16a). Column chromatography with 4:1 cyclohexane-AcOEt
afforded R-16a (299 mg, 58%) as a white foam: [R]D ) 16.8 (c
0.8, CHCl3); 1H NMR (DMSO-d6, 120 °C) ä ) 7.40-7.10 (m, 20
H, Ph), 6.24 (bs, 1 H, NH), 4.81 and 4.73 (2 d, 2 H, J ) 11.0 Hz,
PhCH2), 4.80-4.70 (m, 1 H, H-1′), 4.72 and 4.57 (2 d, 2 H, J )
11.5 Hz, PhCH2), 4.68 and 4.64 (2 d, 2 H, J ) 10.8 Hz, PhCH2),
4.42 and 4.35 (2 d, 2 H, J ) 11.8 Hz, PhCH2), 4.40-4.30 (m, 1 H,
H-2′′′), 3.92-3.82 (m, 2 H), 3.76 (dd, 1 H, J ) 4.5 Hz, J ) 7.5
Hz), 3.64-3.50 (m, 3 H), 3.60 (s, 3 H, OCH3), 3.23 (dd, 1 H, J1′′′a,2′′′
) 6.5 Hz, J1′′′a,1′′′b ) 14.0 Hz, H-1′′′a), 3.18 (dd, 1 H, J1′,1′′a ) 6.5
Hz, J1′′a,1′′b ) 14.5 Hz, H-1′′a), 3.12 (dd, 1 H, J1′,1′′b ) 5.0 Hz,
H-1′′b), 2.87 (dd, 1 H, J1′′′b,2′′′ ) 8.0 Hz, H-1′′′b), 2.44 (s, 3 H,
CH3), 1.62, 1.56, and 1.31 (3 s, 27 H, 3 t-Bu); 13C NMR ä ) 172.7,
167.5, 167.2, 155.5-154.9 (5 C), 139.0-138.2 (5 C), 128.8-127.5
(20 C), 84.5, 84.1, 82.4, 79.7, 78.0, 75.2, 74.7, 73.7, 73.3, 72.8,
71.8, 68.5, 53.7, 52.3, 32.0, 31.7, 28.2 (3 C), 28.0 (6 C), 23.1;
MALDI-TOF MS 1054.3 (M+ + Na). Anal. Calcd for C60H74N2O13
(1031.24): C, 69.88; H, 7.23; N, 2.72. Found: C, 69.81; H, 7.18;
N, 2.86.
(2′′′S)-4-(2′,3′,4′,6′-Tetra-O-benzyl-â-D-galactopyranosylmethyl)-
2-(2′′′-tert-butoxycarbonylamino-2′′′-carboxyethyl)-6-methylpy-
ridine-3,5-dicarboxylic Acid Di-tert-butyl Esters (17). To a cooled
(0 °C) stirred solution of methyl ester â-15b (103 mg, 0.10 mmol)
in THF (2 mL) was added dropwise a pre-cooled 0.2 M aqueous
solution of LiOH (0.60 mL, 0.12 mmol). The mixture was stirred
at 0 °C until the complete disappearance of the starting material
was detected (TLC analysis, 1 h). The mixture was then acidified
with 5% aqueous HCl to pH ) 2, warmed to room temperature,
diluted with CH2Cl2 (80 mL), and washed with H2O (2  10 mL).
The organic phase was dried (Na2SO4) and concentrated to give
the crude acid 17 in almost quantitative yield: 1H NMR ä ) 7.40-
7.10 (m, 20 H, Ph), 5.93 (bd, 1 H, J ) 6.0 Hz, NH), 4.98 and 4.52
(2 d, 2 H, J ) 10.5 Hz, PhCH2), 4.93 and 4.71 (2 d, 2 H, J ) 11.0
Hz, PhCH2), 4.80 and 4.68 (2 d, 2 H, J ) 11.5 Hz, PhCH2), 4.47
and 4.38 (2 d, 2 H, J ) 12.0 Hz, PhCH2), 4.38 (ddd, 1 H, J1′′′a,2′′′
) 8.5 Hz, J1′′′b,2′′′ ) 8.5 Hz, H-2′′′), 4.03 (dd, 1 H, J3′,4′ ) 3.5 Hz,
J4′,5′  0.5 Hz, H-4′), 3.72-3.60 (m, 2 H, H-2′, H-6′a), 3.57 (dd,
1 H, J2′,3′ ) 9.0 Hz, H-3′), 3.50-3.30 (m, 4 H, H-1′′a, H-1′, H-5′,
H-6′b), 3.22 (dd, 1 H, J1′,1′b ) 9.5 Hz, J1′′a,1′′b ) 16.5 Hz, H-1′’b),
3.10 (d, 2 H, 2 H-1′′′), 2.52 (s, 3 H, CH3), 1.44, 1.42, and 1.28 (3
s, 27 H, 3 t-Bu). Anal. Calcd for C59H72N2O13 (1017.21): C, 69.66;
H, 7.13; N, 2.75. Found: C, 69.75; H, 7.10; N, 2.70.
(2′S,2′′S,1′′′S)-4-(2,3,4,6-Tetra-O-benzyl-â-D-galactopyrano-
sylmethyl)-2-[2′-(2′′-tert-butoxycarbonylamino-3′′-methylpropio-
nylamino)-2′-(1′′′-ethoxycarbonyl-2′′′-phenylethylcarbamoyl)-
ethyl]-6-methylpyridine-3,5-dicarboxylic Acid Di-tert-butyl Ester
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(Boc-Ala-Pal-Phe-OEt) (19). To a cooled (0 °C), stirred solution
of crude acid 17 (101 mg, 0.10 mmol), L-phenylalanine ethyl ester
hydrochloride (34 mg, 0.15 mmol), and (benzotriazol-1-yloxy)-
tripyrrolidinophosphonium hexafluorophosphate (62 mg, 0.12 mmol)
in anhydrous CH2Cl2 (2.0 mL) was added N,N-diisopropylethy-
lamine (52 íL, 0.30 mmol). The solution was warmed to room
temperature, stirred for an additional 2 h, and then concentrated.
The residue was suspended with AcOEt (80 mL) and washed with
H2O (2  10 mL). The organic phase was dried (Na2SO4),
concentrated, and eluted from a column of silica gel with 1:1
cyclohexane-AcOEt to give dipeptide 18 (94 mg, 80%) slightly
contaminated by uncharacterized byproducts: 1H NMR (selected
data) ä ) 8.08 (bd, 1 H, J ) 7.5 Hz, NH), 7.40-7.10 (m, 25 H,
Ph), 6.12 (bd, 1 H, J ) 8.05 Hz, NH), 4.96 and 4.68 (2 d, 2 H, J
) 11.5 Hz, PhCH2), 4.93 and 4.50 (2 d, 2 H, J ) 11.0 Hz, PhCH2),
4.78 and 4.69 (2 d, 2 H, J ) 11.2 Hz, PhCH2), 4.43 and 4.38 (2 d,
2 H, J ) 12.0 Hz, PhCH2), 4.08 (bq, 2 H, J ) 7.0 Hz, OCH2CH3),
4.02 (dd, 1 H, J3,4 ) 3.5 Hz, J4,5  0.5 Hz, H-4s), 3.57 (dd, 1 H,
J2,3 ) 9.0 Hz, H-3s), 2.33 (bs, 3 H, CH3), 1.44, 1.42, and 1.28 (3
s, 27 H, 3 t-Bu), 1.22 (t, 3 H, OCH2CH3).
To a cooled (0 °C), stirred solution of dipeptide 18 (94 mg, 0.08
mmol) in CH2Cl2 (2.0 mL) was slowly added a solution of TFA-
CH2Cl2 (0.50 mL-1.50 mL). Stirring was continued at 0 °C for an
additional 30 min and then warmed to room temperature. After 30
min at room temperature, the solution was neutralized at 0 °C with
saturated aqueous Na2CO3 and extracted with CH2Cl2 (2  50 mL).
The combined organic phases were dried (Na2SO4) and concentrated
to give the corresponding crude free amine (85 mg), which was
used for the following reaction without any purification.
To a cooled (0 °C), stirred solution of the above crude amine
(85 mg, 0.08 mmol), tert-butoxycarbonyl-L-alanine (22 mg, 0.12
mmol), and (benzotriazol-1-yloxy)tripyrrolidinophosphonium hexaflu-
orophosphate (73 mg, 0.14 mmol) in anhydrous CH2Cl2 (2.0 mL)
was added N,N-diisopropylethylamine (60 íL, 0.35 mmol). The
solution was warmed to room temperature, stirred for an additional
2 h, and then concentrated. The residue was suspended with AcOEt
(80 mL) and washed with saturated aqueous NaHCO3 (10 mL) and
brine (10 mL). The organic phase was dried (Na2SO4), concentrated,
and eluted from a column of silica gel with 1.5:1 cyclohexane-
AcOEt to give tripeptide 19 (65 mg, 65% from 35): [R]D ) 23.5
(c 0.8, CHCl3); 1H NMR ä ) 7.78 (bd, 2 H, J  7.5 Hz, 2 NH),
7.40-7.00 (m, 25 H, Ph), 5.08 (bd, 1 H, J ) 8.0 Hz, NH), 4.98
and 4.68 (2 d, 2 H, J ) 11.0 Hz, PhCH2), 4.92 and 4.48 (2 d, 2 H,
J ) 11.2 Hz, PhCH2), 4.86-4.78 (m, 2 H, H-2′, H-1′′′), 4.78 and
4.70 (2 d, 2 H, J ) 11.5 Hz, PhCH2), 4.38 and 4.32 (2 d, 2 H, J )
12.0 Hz, PhCH2), 4.20-4.12 (m, 1 H, H-2′′), 4.08 (q, 2 H, J ) 7.0
Hz, OCH2CH3), 4.01 (dd, 1 H, J3,4 ) 3.5 Hz, J4,5  0.5 Hz, H-4s),
3.64 (dd, 1 H, J1,2 ) 8.8 Hz, J2,3 ) 9.0 Hz, H-2s), 3.68-3.60 (m,
1 H, H-5s), 3.57 (dd, 1 H, H-3s), 3.44 (ddd, 1 H, J1,CH2a ) 3.0 Hz,
J1,CH2b ) 10.5 Hz, H-1s), 3.42-3.32 (m, 2 H, 2 H-6s), 3.20-3.06
(m, 5 H, CH2a, 2 H-1′, 2 H-2′′′), 2.95 (dd, 1 H, JCH2a,CH2b ) 14.0
Hz, CH2b), 2.36 (s, 3 H, CH3), 1.62, 1.42, and 1.40 (3 s, 27 H, 3
t-Bu), 1.28 (d, 3 H, J ) 7.0 Hz, CH3), 1.15 (t, 3 H, OCH2CH3);
MALDI-TOF MS 1286.7 (M+ + Na). Anal. Calcd for C73H90N4O15
(1263.5): C, 69.39; H, 7.18; N, 4.43. Found: C, 69.45; H, 7.20;
N, 4.39.
Acknowledgment. We greatly acknowledge the University
of Ferrara for financial support.
Supporting Information Available: General experimental
methods and NMR spectra for new compounds. This material is
available free of charge via the Internet at http://pubs.acs.org.
JO071221R
Synthesis of C-Glycosylmethyl Pyridylalanines
J. Org. Chem, Vol. 72, No. 20, 2007 7687
Subscriber access provided by UNIV DI FERRARA
The Journal of Organic Chemistry is published by the American Chemical Society.
1155 Sixteenth Street N.W., Washington, DC 20036
Article
Click Azide#Nitrile Cycloaddition as a New Ligation Tool for
the Synthesis of Tetrazole-Tethered C-Glycosyl #-Amino Acids†
Mohammad Aldhoun, Alessandro Massi, and Alessandro Dondoni
J. Org. Chem., 2008, 73 (24), 9565-9575 • DOI: 10.1021/jo801670k • Publication Date (Web): 11 October 2008
Downloaded from http://pubs.acs.org on January 8, 2009
More About This Article
Additional resources and features associated with this article are available within the HTML version:
• Supporting Information
• Links to the 1 articles that cite this article, as of the time of this article download
• Access to high resolution figures
• Links to articles and content related to this article
• Copyright permission to reproduce figures and/or text from this article
Click Azide-Nitrile Cycloaddition as a New Ligation Tool for the
Synthesis of Tetrazole-Tethered C-Glycosyl r-Amino Acids†
Mohammad Aldhoun, Alessandro Massi,* and Alessandro Dondoni*
Dipartimento di Chimica, Laboratorio di Chimica Organica, UniVersita` di Ferrara,
Via L. Borsari 46, I-44100 Ferrara, Italy
adn@unife.it; msslsn@unife.it
ReceiVed July 28, 2008
Glycoproteins play a key role in a multitude of biological events in living organisms. Hence,
neoglycopeptides obtained from unnatural C-glycosyl R-amino acids can be used as synthetic probes in
studies aiming at clarifying the role of the carbohydrate domain in glycoprotein biological activity. A
new class of C-glycosyl R-amino acids featuring a nitrogenated heterocycle ring holding the carbohydrate
and glycinyl moiety was designed in our laboratory. Having previously prepared isoxazole-, 1,2,3-triazole-,
and pyridine-tethered compounds, the family has now been enlarged by a group of newcomers represented
by tetrazole derivatives. Two sets of compounds have been prepared, one being constituted of C-galactosyl
and C-ribosyl O-tetrazolyl serines while the other contains S-tetrazolyl cysteine derivatives. In both cases,
the synthetic scheme involved a two-step route, the first one being the thermal cycloaddition of a sugar
azide with p-toluensulfonyl cyanide (TsCN) to give a 1-substituted 5-sulfonyl tetrazole and the second
the replacement of the tosyl group with a serine or cysteine residue. For the high efficiency and operational
simplicity, the azide-TsCN cycloaddition appears to be a true click process. Finally, one of the amino
acids prepared was incorporated into a tripeptide.
Introduction
A great deal, about 50%, of proteins in humans are glyco-
sylated.1 A variety of oligosaccharides that are mostly branched
are introduced in the protein backbone mainly through O- and
N-glycosyl amino acids, being serine, threonine, hydroxyproline,
and asparagine, the most common derivatives. The carbohydrate
domain in glycoproteins is key to vital biological processes
including cell-cell recognition and interaction and it affects
protein folding, conformation, stability, and biological activity.2
In this context, defects in the attachment of carbohydrate to
protein in humans may be the main cause of undesired
biochemical events that result in serious diseases.3 A striking
example is represented by the disease known as congenital
disorder of glycosylation (CDG) syndrome. Specifically, fol-
lowing the original observations of a pediatrician in Belgium
in the beginning of the 1980s, further studies have revealed that
congenital underglycosylation of proteins causes severe health
problems in children and typically results in multisystemic
presentation involving interference with normal development
of the brain and functions of the liver, stomach, and nervous
and intestinal systems.4 On the other hand, the beneficial effects
of glycosylation in neuropeptides (e.g., enkephalins) in terms
of improved blood-brain barrier penetration and analgesic
potency have been recently discussed.5 The role of antifreeze
glycoproteins6 in Teleost fish is crucial to prevent in vivo ice
growth in organisms inhabiting subzero environments. Conse-
† Dedicated to the fond memory of Albert I. Meyers.
(1) Wong, C.-H. J. Org. Chem. 2005, 70, 4219–4225.
(2) (a) Essentials of Glycobiology; Varki, A., Cummings, R. D., Esko, J. D.,
Freeze, H. H., Hart, G. W., Marth, J., Eds.; Cold Spring Harbor Laboratory
Press: New York, 1999. (b) Seitz, O. ChemBioChem 2000, 1, 214–246. (c) Hang,
H. C.; Bertozzi, C. R. Acc. Chem. Res. 2001, 34, 727–736.
(3) (a) Kornfeld, S. J. Clin. InVest. 1998, 101, 1293–1295. (b) Spiro, R. G.
Glycobiology 2002, 12, 43R–56R. (c) Glycoproteins and Disease; Montreuil,
J., Vliegenthart, J. F. G., Schachter, H., Eds.; Elsevier: New York, 1996.
(4) For a review with leading references, see: Lehle, L.; Strahl, S.; Tanner,
W. Angew. Chem., Int. Ed. 2006, 45, 6802–6818.
(5) Polt, R.; Dhanasekaran, M.; Keyari, C. M. Med. Res. ReV. 2005, 25, 557–
585.
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quently, efficient protection of these organisms against cryoin-
jury and death is achieved. In general, however, numerous
mechanisms of carbohydrate action in glycoproteins are at
present poorly understood.1 Natural and unnatural glycopeptides
with a well-defined structure and composition can serve as
probes in biochemical studies, while the latter are also potential
leads for the developments of new drugs against carbohydrate-
based metabolic disorders. Hence, a great deal of efforts are
made toward the search of efficient synthetic methods of natural
O- and N-linked glycosyl amino and glycopeptides2b,7 as well
as of unnatural C-linked analogues8 to be incorporated into
peptidic chains. Attention is also drawn to the synthesis of
S-linked glycosyl amino acids and thioglycopeptides.9 While
in early studies we have carried out the synthesis of methylene
isosteres of glycosyl serines10 and ethylene isosteres of glycosyl
asparagines,10c,11 more recently we have started a program
focused on the synthesis of a newly designed family of
C-glycosyl amino acids that feature a nitrogenated heterocycle
as a tether of the carbohydrate and glycinyl moiety (Figure 1).
In our view, the heterocycle should serve not only as a passive
yet robust linker but can also act as an additional site of
interaction with target substrates through dipolar interactions
and hydrogen bonding. Therefore, glycopeptides in which such
amino acids are embedded may give rise to highly selective
molecular recognition processes. Synthetic approaches to these
glycosyl amino acids having isoxazole,12 1,2,3-triazole,12 and
pyridine rings13 as linkers have been reported and reviewed.14
In this paper, we report on the first synthesis of tetrazole-tethered
C-glycosyl amino acids that relies on an very efficient
azide-nitrile cycloaddition as a key step for the heterocyclic
ring formation. This ligation strategy is quite attractive because
tetrazole is a lipophilic and highly stable unit under a variety
of reaction conditions and being densely nitrogenated may
induce strong intermolecular interactions via an extensive set
of hydrogen bondings. The biological relevance of the tetrazole
ring is well-recognized as a metabolically stable surrogate for
a carboxylic or amide group.15
Results and Discussion
Formation of tetrazole rings by the Huisgen 1,3-dipolar
cycloaddition between nitriles and organic azides16 is in principle
the most direct method. However, this reaction is limited in
scope because only nitriles activated by strong electron-
withdrawing groups can be effectively engaged as dipolarophilic
partners by organic azides. A few years ago, Demko and
Sharpless have shown for the first time the existence of a
reaction window by coupling under solvent-free conditions
p-toluenesulfonyl cyanide (TolSO2-CN, TsCN)17 and acyl
cyanides18 with various aromatic and aliphatic azides to give
exclusively the corresponding 1,5-disubstituted tetrazoles. As
the reactions were carried out using 1 equiv of each reagent
and gave nearly quantitative conversion into almost pure
products, the process was considered as a case of click chemistry
transformation as defined by Sharpless and co-workers.19
Moreover, earlier work of Gol’tsberg and Koldobskii had
previously demonstrated that the 5-sulfonyl substituent in
tetrazoles can be readily replaced by a wide range of nucleo-
(6) (a) Czechura, P.; Tam, R. Y.; Dimitrijevic, E.; Murphy, A. V.; Ben, R. N.
J. Am. Chem. Soc. 2008, 130, 2928–2929. (b) Bouvet, V. R.; Lorello, G. R.;
Ben, R. N. Biomacromolecules 2006, 7, 565–571.
(7) (a) Arsequell, G.; Valencia, G. Tetrahedron: Asymmetry 1997, 8, 2839–
2876. (b) Taylor, C. M. Tetrahedron 1998, 54, 11317–11362. (c) Herzner, H.;
Reipen, T.; Schultz, M.; Kunz, H. Chem. ReV. 2000, 100, 4495–4537. (d) Davis,
B. G. Chem. ReV. 2002, 102, 579–601.
(8) (a) Dondoni, A.; Marra, A. Chem. ReV. 2000, 100, 4395–4421. (b)
Selected articles published from 2001: Nishikawa, T.; Ishikawa, M.; Wada, K.;
Isobe, M. Synlett 2001, 945–947. Westermann, B.; Walter, A.; Flo¨rke, U.;
Altenbach, H.-J. Org. Lett. 2001, 3, 1375–1378. Schweizer, F.; Inazu, T. Org.
Lett. 2001, 3, 4115–4118. Turner, J. J.; Leeuwenburgh, M. A.; van der Marel,
G. A.; van Boom, J. H. Tetrahedron Lett. 2001, 42, 8713–8716. McGarvey,
E. J.; Benedum, T. E.; Schmidtmann, F. W. Org. Lett. 2002, 4, 3591–3594.
Nolen, E. G.; Watts, M. M.; Fowler, D. J. Org. Lett. 2002, 4, 3963–3965. Brenna,
E.; Fuganti, C.; Grasselli, P.; Serra, S.; Zambotti, S. Chem. Eur. J. 2002, 8,
1872–1875. Xu, X.; Fakha, G.; Sinou, D. Tetrahedron 2002, 58, 7539–7544.
Nishikawa, T.; Wada, K.; Isobe, M. Biosci. Biotechnol. Biochem. 2002, 66, 2273–
2278. Ohnishi, Y.; Ichikawa, Y. Bioorg. Med. Chem. Lett. 2002, 12, 997–999.
Colombo, L.; di Giacomo, M.; Ciceri, P. Tetrahedron 2002, 58, 9381–9386.
Paterson, D. E.; Griffin, F. K.; Alcaraz, M.-L.; Taylor, R. J. K. Eur. J. Org.
Chem. 2002, 132, 3–1336. Manabe, S.; Marui, Y.; Ito, Y. Chem. Eur. J. 2003,
9, 1435–1447. Boucard, V.; Larrieu, K.; Lubin-Germain, N.; Uziel, J.; Auge`, J.
Synlett 2003, 1834–1837. Wang, Q.; Linhardt, R. J. J. Org. Chem. 2003, 68,
2668–2672. Gustafsson, T.; Saxin, M.; Kihlberg, J. J. Org. Chem. 2003, 68,
2506–2509. Nolen, E. G.; Kurish, A. J.; Wong, K. A.; Orlando, M. D.
Tetrahedron Lett. 2003, 44, 2449–2453. McNabb, S. B.; Ueda, M.; Naito, T.
Org. Lett. 2004, 6, 1911–1914. Kuijpers, B. H. M.; Groothuys, S.; Keereweer,
A. R.; Quaedflierg, P. J. L. M.; Blaaauw, R. H.; van Delft, F. L.; Rutjes, F. P. J. T.
Org. Lett. 2004, 6, 3123–3126. Czifra´k, K.; Szila´gyi, P.; Somsa´k, L. Tetrahedron:
Asymmetry 2005, 16, 127–141. Chambers, D. J.; Evans, J. R.; Fairbanks, A. J.
Tetrahedron: Asymmetry 2005, 16, 45–55. Ousmer, M.; Boucard, V.; Lubin-
Germain, N.; Uziel, J.; Auge`, J. Eur. J. Org. Chem. 2006, 121, 6–1221.
Nishikawa, T.; Koide, Y.; Kanakubo, A.; Yoshimura, H.; Isobe, M. Org. Biomol.
Chem. 2006, 4, 1268–1277. Gustafsson, T.; Hedenstro¨m, M.; Kihlberg, J. J.
Org. Chem. 2006, 71, 1911–1919. Groothuys, S.; Kuijpers, B. H. M.; Quaedflierg,
P. J. L. M.; Roelen, H. C. P. F.; Wiertz, R. W.; Blaaauw, R. H.; van Delft,
F. L.; Rutjes, F. P. J. T. Synthesis 2006, 3146–3152. Dondoni, A.; Massi, A.;
Nuzzi, A. Synlett 2007, 303–307.
(9) (a) Marcaurelle, L. A.; Bertozzi, C. R. Chem.sEur. J. 1999, 5, 1384–
1390. (b) Pachamuthu, K.; Schmidt, R. R. Chem. ReV. 2006, 106, 160–187.
(10) (a) Dondoni, A.; Giovannini, P.; Marra, A. J. Chem. Soc., Perkin Trans.
1 2001, 2380–2388. (b) Dondoni, A.; Mariotti, G.; Marra, A.; Massi, A. Synthesis
2001, 2129–2137. (c) Dondoni, A.; Marra, A.; Massi, A. J. Org. Chem. 1999,
64, 933–944. (d) Dondoni, A.; Marra, A.; Massi, A. Chem. Commun. 1998, 1741–
1742. (e) Dondoni, A.; Marra, A.; Massi, A. Tetrahedron 1998, 54, 2827–2832.
(11) (a) Dondoni, A.; Mariotti, G.; Marra, A. J. Org. Chem. 2002, 67, 4475–
4486. (b) Dondoni, A.; Massi, A.; Marra, A. Tetrahedron Lett. 1998, 39, 6601–
6604.
(12) Dondoni, A.; Giovannini, P. P.; Massi, A. Org. Lett. 2004, 6, 2929–
2932.
(13) Dondoni, A.; Massi, A.; Aldhoun, M. J. Org. Chem. 2007, 72, 7677–
7687.
(14) Dondoni, A.; Massi, A. Synthesis of Heterocycle-Linked C-Glycosyl
R-Amino Acids and C-Glycopeptides. In Current Frontiers in Asymmetric
Synthesis and Application of R-Amino Acids; Soloshonok; V. A.; Izawa, K. Eds.;
ACS Symposium Series; Oxford University Press: Oxford, 2008;to be published.
(15) (a) Singh, H.; Chawla, A. S.; Kapoor, V. K.; Paul, D.; Malhotra, R. K.
Prog. Med. Chem. 1980, 17, 151–183. (b) Yu, K.-L.; Johnson, R. L. J. Org.
Chem. 1987, 52, 2051–2059. (c) Zabrocki, J.; Smith, G. D.; Dunbar, J. B.; Iijima,
H.; Marshall, G. R. J. Am. Chem. Soc. 1988, 110, 5875–5880.
(16) (a) Huisgen, R. Angew. Chem., Int. Ed. 1963, 2, 565–598. (b) Huisgen,
R. Angew. Chem., Int. Ed. 1963, 2, 633–645.
(17) Demko, Z. P.; Sharpless, K. B. Angew. Chem., Int. Ed. 2002, 41, 2110–
2113.
(18) Demko, Z. P.; Sharpless, K. B. Angew. Chem., Int. Ed. 2002, 41, 2113–
2116.
(19) For the click chemistry concept, see: (a) Kolb, H. C.; Finn, M. G.;
Sharpless, K. B. Angew. Chem., Int. Ed. 2001, 40, 2004–2021. (b) Kolb, H. C.;
Sharpless, K. B. Drug DiscoVery Today 2003, 8, 1128–1137.
FIGURE 1. Heterocycle-tethered C-glycosyl amino acids.
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philes.20 The click azide-TsSCN cycloaddition together with
the tosyl substitution in the formed 1-substituted 5-sulfonyl
tetrazole established a two-step route toward the synthesis of a
variety of 1,5-disubstituted tetrazoles that were hardly accessible
by the direct Huisgen azide-nitrile cycloaddition. Recently, we
have validated the effectiveness of this click ligation route for
the synthesis of complex molecules such as glycoclusters
installed on a calix[4]arene platform through tetrazole tethers.21
With this in mind, we planned the synthesis of target
C-glycosylmethyl tetrazole serines 5 and cysteines 6 as shown
in Scheme 1. This consisted of the click cycloaddition of
benzylated and acetylated glycosylmethyl azides (azidomethyl
glycosides) 1 and 2 with TsCN to give 1-glycosylmethyl-5-
tosyl tetrazoles 3 and 4 followed by the replacement of the tosyl
group by serine and cysteine derivatives acting as O- and
S-nucleophile, respectively. Azides 1 and 2 as starting materials
were selected in order to introduce a methylene bridge between
the carbohydrate and tetrazole ring, thus creating a robust
C-glycosidic linkage that would preserve the final product from
chemical and enzymatic degradation. Another point of great
importance was the careful choice of orthogonal protective
groups PG1 and PG2 in the carbohydrate and glycinyl moiety
in order to make the formed amino acids suitable building blocks
in peptide synthesis.
A. Synthesis of Glycosylmethyl Azides 1 and 2. Although
the preparation of -azidomethyl glycosides was reported in
previous papers from our laboratory starting from formyl -C-
glycosides,22 we have developed a new and more efficient,
general method starting from glycosyl cyanides. These C-
glycosides are available as either R- or -anomers by cyanation
of glycosyl acetates with trimethylsilyl cyanide (TMSCN).23
Benzylated galactosyl and ribosyl cyanides 7 were reduced in
nearly quantitative yields by lithium aluminum hydride to
amines 8, and these were transformed in very good yields
(62-87%) into azides 1 by diazotransfer reaction using imida-
zole-1-sulfonyl azide (ISA) hydrochloride24 (Scheme 2). Key
in our method was this new, efficient, and shelf-stable diaz-
otransfer reagent. The ISA reagent provided a safer, more
effective azide transfer than the commonly used diazo transfer
reagent trifluoromethanesulfonyl azide, whose preparation and
manipulation require special caution.25 Following Scheme 2,
we have prepared a set of four benzylated glycosylmethyl azides
1a-d with R- and -galacto and R- and -ribo configurations.
In order to modulate the orthogonal protecting group setting
in the final amino acid, acetylated glycosylmethyl azides 2a-d
were conveniently prepared employing aminomethyl glycosides
8 (Scheme 3). Debenzylation of these compounds by hydroge-
nation over Pd(OH)2 afforded the amines 9 that, as crude
material, were subjected to the diazotransfer reaction with ISA
hydrochloride to give the azides 10. These compounds were
acetylated to give good overall yields (62-74%) of azides
2a-d.
B. Synthesis of C-Glycosylmethyl O-Tetrazolyl Serines
5. The method and conditions for the synthesis of these
compounds are illustrated by the synthesis of the -D-galacto-
sylmethyl derivative 5b (Scheme 4). Neat tetrabenzyl -D-
galactosylmethyl azide 1b and TsCN (2.0 equiv) were heated
at 100 °C (oil bath). At this temperature, a homogeneous liquid
resulted so that the mixture was efficiently stirred by a magnetic
bar. As the reaction proceeded, the mixture solidified. The excess
of TsCN was simply removed by sublimation under vacuum
so that nearly pure 1-galactosylmethyl-5-tosyl tetrazole 3b was
(20) (a) Gol’tsberg, M. A.; Koldobskii, G. I. Russ. J. Org. Chem. 1995, 31,
1552–1553. (b) Gol’tsberg, M. A.; Koldobskii, G. I. Russ. J. Org. Chem. 1996,
32, 1194–1201. (c) Gol’tsberg, M. A.; Koldobskii, G. I. Chem. Heterocycl.
Compd. 1996, 32, 1300–1304.
(21) Dondoni, A.; Marra, A. Tetrahedron 2007, 63, 6339–6345.
(22) (a) Dondoni, A.; Massi, A.; Sabbatini, S.; Bertolasi, V. J. Org. Chem.
2002, 67, 6979–6994. (b) Dondoni, A.; Marra, A. J. Org. Chem. 2006, 71, 7546–
7557.
(23) (a) Togo, H.; Ishigami, S.; Fujii, M.; Ikuma, T.; Yokoyama, M. J. Chem.
Soc., Perkin Trans. 1 1994, 2931–2942. (b) Igarashi, Y.; Shiozawa, T.; Ichikawa,
Y. Bioorg. Med. Chem. Lett. 1997, 7, 613–616, and references therein.
(24) Goddard-Borger, E. D.; Stick, R. V. Org. Lett. 2007, 9, 3797–3800.
(25) (a) Nyffeler, P. T.; Liang, C.-H.; Koeller, K. M.; Wong, C.-H. J. Am.
Chem. Soc. 2002, 124, 10773–10778. (b) Lundquist, J. T., IV.; Pelletier, J. C.
Org. Lett. 2001, 3, 781–783.
SCHEME 1. Azide-Nitrile Cycloaddition-Based Approach
toward the Synthesis of C-Glycosylmethyl Tetrazole Serines
and Cysteines
SCHEME 2. Synthesis of Perbenzylated Glycosylmethyl
Azides
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isolated (93% yield) as the sole regioisomer. The 1,5-substitution
pattern in the tetrazole ring was assumed on the basis of previous
observations.17,18,26 A highly performing click azide-nitrile
cycloaddition appeared to take place as well with a complex
alkyl azide such as 1b.27 As the substitution of the tosyl group
by an O-nucleophile required strong basic conditions, this
prevented the use of a protected serine derivative such as N-Boc-
L-serine methyl ester. The tosyl group of 3b was replaced by
reaction with N-Boc-N,O-isopropylidene-D-serinol 1128 and
NaH. This reaction provided the masked serine derivative 12b.
It has been demonstrated that compound 11 functions as a
configurationally stable equivalent of serine by virtue of
the easy transformation of the N-Boc oxazolidine ring into the
glycinyl group.10,11 Unexpectedly, treatment of 12b with the
Jones reagent (H2SO4-H2O, CrO3) at room temperature to
achieve one-pot cleavage of the oxazolidine ring and oxidation
of the amino alcohol afforded the target amino acid in very
poor yield (15%). In addition, the use of aqueous 60-80%
AcOH10 to remove the acetonide protecting group gave poor
results (25% yield of the corresponding alcohol). Fortunately,
a recent method for cleaving protected cyclic N,O-aminals by
using catalytic BiBr3 was available.29 To our satisfaction,
treatment of 12b with BiBr3 in acetonitrile at room temperature,
then oxidation of the alcohol with the Jones reagent, and finally
esterification with diazomethane afforded the orthogonally
protected N-Boc methyl serinate 5b in 60% isolated overall
yield. This final product displayed all prerequisites for being a
suitable building block in N-Boc-based peptide synthesis.
Debenzylation of the carbohydrate moiety of 5b by palladium-
catalyzed hydrogenolysis proved to be compatible with the
presence of basic nitrogen atoms of the tetrazole ring, thus
leading to the amino ester 5b′.
The cycloaddition-substitution sequence was successfully
applied to the other three benzylated glycosylmethyl azides
prepared, i.e., the R-D-galactosyl derivative 1a and the R-D- and
-D-ribosyl derivatives 1c and 1d. As quoted in Table 1,
uniformly high yields of intermediates 3 and 12 and amino esters
5 were observed in all cases, thus confirming the efficiency of
the method.
C. Synthesis of C-Glycosylmethyl S-Tetrazolyl Cystei-
nes 6. Having in mind the final role of the amino acids under
preparation, i.e., their use in cotranslational modification of
glycopeptides, we decided to use peracetylated glycosylmethyl
azides 2 as starting material. We envisaged the acetyl group
removal by saponification of either the final amino acid or the
peptide in which it was introduced.30 In this way, we avoided
the risk that the removal of the carbohydrate benzyl groups by
Pd-catalyzed hydrogenation could fail due to the presence of
the cysteine sulfur atom. Hence, a typical synthesis of a model
(26) Butler, R. N. In ComprehensiVe Heterocyclic Compounds; Katritzky,
A. R., Rees, C. W., Scriven, E. F. V., Eds.; Pergamon: Oxford, U.K., 1966;
Vol. 4.
(27) The proficuous choice of thermal conditions to perform the cycloaddition
of 1b with TsCN became apparent when the reaction was carried out under
Cu(I) catalysis as described by Bosch and Vilarrasa: Bosch, L.; Vilarrasa, J.
Angew. Chem., Int. Ed. 2007, 46, 3926–3930. In our hands, treatment of 1b
with TsCN (2.0 equiv) in CH2Cl2 (room temperature) in the presence of Cu2(OTf)
2 ·C6H6 (0.1 equiv) as the catalyst produced a complex reaction mixture from
which the cycloadduct 12b was isolated in very low yield (18%).
(28) Dondoni, A.; Perrone, D. Org. Synth. 1999, 77, 64–70.
(29) Cong, X.; Hu, F.; Liu, K.-G.; Liao, Q.-J.; Yao, Z.-J. J. Org. Chem.
2005, 70, 4514–4516. It is worth noting that errors in some references cited in
this paper as author given names instead of family names have been reported.
SCHEME 3. Synthesis of Peracetylated Glycosylmethyl
Azides
SCHEME 4. Synthesis of Model Tetrabenzylated
-C-Glycosylmethyl Tetrazole Serine 5b
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compound is succinctly illustrated here (Scheme 5). The reaction
of the tetraacetyl azidomethyl -D-galactoside 2b with excess
TsCN (2.0 equiv) was run neat at 100 °C, and the isolated
5-tosyl tetrazole 4b (93% yield) was treated with N-fluorenyl-
methoxycarbonyl (N-Fmoc) cysteine 1331 (1.1 equiv) under mild
basic conditions (K2CO3) at room temperature. The cysteine
13 was added in two portions to 4b in order to reduce its
transformation into N-Fmoc cystine. The final C-galactosylm-
ethyl S-tetrazolyl N-Fmoc cysteine 6b was isolated in high yield
(90%) without any apparent loss of configurational integrity of
the glycinyl group. This approach appeared to be more
straightforward than that followed in the synthesis of the serine
derivatives 5 (see previous section) in which a masked amino
acid nucleophile had to be employed because of the strong basic
conditions required for the substitution of the tosyl group.
The same reaction sequence was applied to the other
peracetylated glycosylmethyl azides shown in Scheme 3, i.e.,
compounds 2a, 2c, and 2d. Both the cycloadducts 4a, 4c, and
4d and the tetrazole-tethered C-glycosyl cysteines 6a, 6c, and
6d were isolated in good to excellent yields (Table 2). It is worth
noting that the set of orthogonal protective groups in amino
acids 6a-d makes these compounds all suitable for the N-Fmoc-
based automated peptide synthesis.30
D. Synthesis of Tetrazole-Tethered Glycopeptides. In order
to demonstrate the potential of the prepared C-glycosyl amino
acids as orthogonally protected building blocks for the cotrans-
lational modification of glycopeptides, the O-serine derivative
(30) As a selected example of this protection strategy in glycopeptide
synthesis, see: Liu, S.; Ben, R. N. Org. Lett. 2005, 7, 2385–2388.
(31) Lumbierres, M.; Palomo, J.; Kragol, G. S. R.; Mu¨ller, O.; Waldmann,
H. Chem.sEur. J. 2005, 11, 7405–7415.
TABLE 1. Glycosylmethyl Tetrazole Serines Prepareda
a See the Experimental Section for details. b Isolated yield by chromatography.
SCHEME 5. Synthesis of Model Tetracetylated
-C-Glycosylmethyl Tetrazole Cysteine 6b
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14 was selected as a prototype in this crucial validating test
(Scheme 6). A crude sample of this amino acid as obtained from
the cleavage of the oxazolidine precursor 12b was employed
in the coupling with phenylalanine ethyl ester hydrochloride
(H-Phe-OEt ·HCl). The reaction was carried out at ambient
temperature under activation of the condensation agent (ben-
zotriazol-1-yloxy)tripyrrolidinophosphonium hexafluorophos-
phate (PyBOP) in the presence of the Hu¨nig’s base (diisopro-
pylethyl amine, DIPEA). From this reaction, the dipeptide 15
was isolated by chromatography in very good yield (80%). The
removal of the N-Boc protective group from 15 was readily
carried out upon treatment with diluted trifluoroacetic acid
(TFA). The amine that formed was used in the condensation
with N-Boc alanine (Boc-Ala-OH) under the same coupling
conditions described above. The tetrazole-tethered glycopeptide
16 was isolated after chromatography in 72% yield. This
tripeptide can be inserted in a more complex peptide via N-Boc-
based peptide synthesis.
Conclusions
In summary, we have demonstrated the efficiency of the
Sharpless-Demko azide-sulfonyl cyanide cycloaddition/sul-
fonyl substitution route for the synthesis of tetrazole-tethered
C-glycosyl R-amino acids. A new ligation tool has been
established for unnatural C-glycosyl R-amino acid synthesis,
the building blocks required for the cotranslational modification
of glycopeptides. The key step in this strategy was the thermal
azide-cyanide cycloaddition, a reaction that is highlighted as
a click process when the organic cyanide is activated by a strong
TABLE 2. Glycosylmethyl Tetrazole Cysteines Prepareda
a See the Experimental Section for details. b Isolated yield by chromatography.
SCHEME 6. Synthesis of Tripetide 16
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electron-withdrawing substituent such as the sulfonyl group. This
and previous work reported from our laboratory21 demonstrated
the fidelity of this thermally induced metal-free process even
when applied to complex systems. This reaction combined with
the sulfonyl group substitution step appears to have its own value
as a new ligation tool. The tetrazole ring that is formed plays
the role of a robust molecular keystone holding the biologically
active residues. So far the glycosyl amino acids prepared were
serine and cysteine derivatives. It can be envisaged that
substitution of the sulfonyl group with N-, Se-, and C-
nucleophile amino acids or their synthetic equivalents will
expand the scope of this new synthetic method.
Experimental Section
Cyanides 7a-d,23 amines 8b,22a 8d,22a and 9a,32a 9b,32 azides
1b,22a 1d,22a and 2b,22b tetrazoles 3b21and 3d,21 serinol 11,28 and
cysteine 1331 are known compounds, and their spectroscopic data
were identical to those reported.
General Procedure for the Synthesis of Benzylated Amines
8. To a stirred suspension of LiAlH4 (304 mg, 8.00 mmol) in
anhydrous THF (10 mL) was slowly added a solution of cyanide 7
(1.10 g, 2.00 mmol) in anhydrous THF (4 mL). The resulting
mixture was stirred under reflux until disappearance of starting
cyanide (TLC analysis, typically 1 h), cooled to room temperature,
and then diluted with 28% aqueous NH4OH (2 mL). The resulting
mixture was stirred at room temperature until the formation of a
white precipitate was observed (typically 30 min). The mixture was
then filtered over a pad of Celite and washed thoroughly with
AcOEt. The combined filtrates were concentrated to give the
corresponding crude amine 8 in almost quantitative yield. Each
amine 8 was used in the next step without any purification.
(2,3,4,6-Tetra-O-benzyl-r-D-galactopyranosyl)methylamine (8a).
1H NMR: δ ) 7.50-7.20 (m, 20 H, Ph), 4.75 and 4.61 (2 d, 2 H,
J ) 11.8 Hz, PhCH2), 4.73 and 4.51 (2 d, 2 H, J ) 12.0 Hz,
PhCH2), 4.66 and 4.64 (2 d, 2 H, J ) 11.5 Hz, PhCH2), 4.56 and
4.52 (2 d, 2 H, J ) 12.2 Hz, PhCH2), 4.10-4.04 (m, 1 H, H-5),
4.02 (dd, 1 H, J4,5 ) 2.8 Hz, J3,4 ) 3.8 Hz, H-4), 3.95-3.81 (m,
2 H, H-2, H-3), 3.81-3.71 (m, 2 H, H-1, H-6a), 3.66 (dd, 1 H,
J5,6b ) 4.2 Hz, J6a,6b ) 10.5 Hz, H-6b), 2.97 (dd, 1 H, J1,1′a ) 8.9
Hz, J1′a,1′b ) 13.5 Hz, H-1′a), 2.78 (dd, 1 H, J1,1′b ) 4.2 Hz, H-1′b).
(2,3,5-Tri-O-benzyl-r-D-ribofuranosyl)methylamine (8c). 1H
NMR: δ ) 7.40-7.25 (m, 15 H, Ph), 4.78 and 4.59 (2 d, 2 H, J )
11.8 Hz, PhCH2), 4.62 and 4.52 (2 d, 2 H, J ) 12.0 Hz, PhCH2),
4.57 and 4.54 (2 d, 2 H, J ) 12.2 Hz, PhCH2), 4.20 (ddd, 1 H, J3,4
) 7.0 Hz, J4,5a ) 3.3 Hz, J4,5b ) 4.10 Hz, H-4), 4.08 (dd, 1 H, J1,2
) 4.8 Hz, J2,3 ) 4.8 Hz, H-2), 4.06-3.98 (m, 2 H, H-1, H-3), 3.60
(dd, 1 H, J5a,5b ) 10.6 Hz, H-5a), 3.49 (dd, 1 H, H-5b), 3.01 (dd,
1 H, J1,1′a ) 6.7 Hz, J1′a,1′b ) 13.2 Hz, H-1′a), 2.92 (dd, 1 H, J1,1′b
) 5.1 Hz, H-1′b).
General Procedure for the Synthesis of Benzylated Azides
1. A mixture of crude amine 8 (553 mg, ∼1.00 mmol), imidazole-
1-sulfonyl azide hydrochloride (251 mg, 1.20 mmol), K2CO3 (235
mg, 1.70 mmol), CuSO4 ·5H2O (2.5 mg, 0.01 mmol), and MeOH
(5 mL) was stirred at room temperature for 4 h. The mixture was
then concentrated, diluted with H2O (15 mL), acidified with concd
HCl, and extracted with AcOEt (3 × 25 mL). The combined organic
layers were dried (Na2SO4), concentrated, and eluted from a column
of silica gel with the suitable elution system to give the corre-
sponding azide 1.
(2,3,4,6-Tetra-O-benzyl-r-D-galactopyranosyl)methyl azide
(1a). Column chromatography with 9:1 cyclohexane-AcOEt af-
forded 1a (452 mg, 79%) as white foam. [R]D ) 16.2 (c 1.3,
CHCl3). 1H NMR: δ ) 7.42-7.20 (m, 20 H, Ph), 4.72 and 4.59 (2
d, 2 H, J ) 12.0 Hz, PhCH2), 4.70 and 4.51 (2 d, 2 H, J ) 11.8
Hz, PhCH2), 4.62 and 4.60 (2 d, 2 H, J ) 11.5 Hz, PhCH2), 4.60
and 4.53 (2 d, 2 H, J ) 12.2 Hz, PhCH2), 4.22-4.08 (m, 2 H, H-1,
H-5), 4.05 (dd, 1 H, J4.5 ) 2.7 Hz, J3,4 ) 4.2 Hz, H-4), 3.92(dd, 1
H, J5,6a ) 7.3 Hz, J6a,6b) 10.7 Hz, H-6a), 3.82-3.70 (m, 3 H, H-2,
H-3, H-6b), 3.60 (dd, 1 H, J1,1′a ) 8.5 Hz, J1′a,1′b ) 12.9 Hz, H-1′a),
3.27 (dd, 1 H, J1,1′b ) 4.8 Hz, H-1′b). 13C NMR: δ ) 138.3 (2C),
137.8 (2C), 128.5-127.4 (20C), 75.9, 75.5, 73.7, 73.3, 73.1, 73.2,
73.0, 72.9, 70.2, 66.6, 49.2. MALDI-TOF MS: 602.9 (M+ + Na).
Anal. Calcd for C35H37N3O5 (579.27): C, 75.52; N, 7.25; H, 6.43.
Found: C, 75.50; N, 7.27; H, 6.41.
(2,3,5-Tri-O-benzyl-r-D-ribofuranosyl)methyl Azide (1c). Col-
umn chromatography with 9:1 cyclohexane-AcOEt afforded 1c
(285 mg, 62%) as a white foam. [R]D ) 40.3 (c 2.8, CHCl3). 1H
NMR (400 MHz): δ ) 7.40-7.20 (m, 15 H, Ph), 4.77 and 4.55 (2
d, 2 H, J ) 11.5 Hz, PhCH2), 4.62 and 4.54 (2 d, 2 H, J ) 11.8
Hz, PhCH2), 4.57 and 4.49 (2 d, 2 H, J ) 12.0 Hz, PhCH2), 4.25
(ddd, 1 H, J3,4 ) 5.5 Hz, J4,5a ) 3.6 Hz, J4,5b ) 3.4 Hz, H-4), 4.21
(ddd, 1 H, J1,2 ) 4.8 Hz, J1,1′a ) 8.0 Hz, J1,1′b ) 5.0 Hz, H-1), 4.12
(dd, 1H, J2,3 ) 4.8 Hz, H-2), 4.07 (dd, 1 H, H-3), 3.65 (dd, 1 H,
J1′a,1′b ) 12.8 Hz, H-1′a), 3.59 (dd, 1 H, J5a,5b ) 10.7 Hz, H-5a),
3.51 (dd, 1 H, H-5b), 3.46 (dd, 1 H, H-1′b). 13C NMR: δ ) 138.0,
137.8, 137.7, 128.4-127.6 (15C), 80.4, 79.0, 78.7, 77.5, 73.4, 73.1,
72.6, 69.9, 50.9. MALDI-TOF MS: 460.4 (M+ + H). Anal. Calcd
for C27H29N3O4 (459.22): C, 70.57; N, 9.14; H, 6.36. Found: C,
70.53; N, 9.11; H, 6.38.
General Procedure for the Synthesis of Unprotected Ami-
nes 9. A vigorously stirred mixture of amine 8 (553 mg, ∼1.00
mmol), 20% palladium hydroxide on carbon (227 mg), and AcOH
(8 mL) was degassed under vacuum and saturated with hydrogen
(by a H2-filled balloon) three times. The suspension was stirred at
room temperature for 12 h under a positive pressure of hydrogen
(8 bar), filtered through a plug of cotton, and concentrated to give
crude amine 9 in almost quantitative yield. Each amine 9 was used
in the next step without any purification.
(r-D-Ribofuranosyl)methylamine (9c). 1H NMR (D2O): δ )
4.19 (dd, 1 H, J1,2 ) 4.0 Hz, J2,3 ) 4.5 Hz, H-2), 4.15 (ddd, 1 H,
J1,1′a ) 6.0 Hz, J1,1′b ) 4.5 Hz, H-1), 4.03 (dd, 1 H, J3,4 ) 7.8 Hz,
H-3), 3.81 (ddd, 1 H, J4,5a ) 2.8 Hz, J4,5b ) 5.4 Hz, H-4), 3.66
(dd, 1 H, J5a,5b ) 12.5 Hz, H-5a), 3.49 (dd, 1 H, H-5b), 3.15 (dd,
1 H, J1′a,1′b ) 13.0 Hz, H-1′a), 3.11 (dd, 1 H, H-1′b). 13C NMR
(D2O): δ ) 81.9, 75.9, 72.5, 71.8, 61.5, 39.6.
(-D-Ribofuranosyl)methylamine (9d). 1H NMR: δ ) 3.93 (dd,
1 H, J1,2 ) 5.1 Hz, J2,3 ) 5.0 Hz, H-2), 3.90 (ddd, 1 H, J1,1′a ) 3.2
Hz, J1,1′b ) 13.3 Hz, H-1), 3.84 (dd, 1 H, J3,4 ) 5.2 Hz, H-3), 3.82
(ddd, 1 H, J4.5a ) 3.2 Hz, J4,5b ) 4.9 Hz, H-4), 3.17 (dd, 1 H,
J1′a,1′b ) 13.3 Hz, H-1′a), 2.91 (dd, 1 H, H-1′b). 13C NMR (D2O):
δ ) 84.4, 78.5, 72.7, 71.2, 61.5, 41.7.
General Procedure for the Synthesis of Acetylated Azides 2. A
mixture of crude amine 9 (193 mg, ∼1.00 mmol), imidazole-1-
sulfonyl azide hydrochloride (251 mg, 1.20 mmol), K2CO3 (235
mg, 1.70 mmol), CuSO4 ·5H2O (2.5 mg, 0.01 mmol), and MeOH
(5 mL) was stirred at room temperature for 4 h. The mixture was
then concentrated and coevaporated with toluene (2 × 10 mL).
Acetic anhydride (3 mL) and pyridine (3 mL) were added to the
residue, and the resulting mixture was stirred for an additional 5 h,
diluted with H2O (10 mL), and extracted with AcOEt (3 × 25 mL).
The combined organic layers were dried (Na2SO4), concentrated,
and eluted from a column of silica gel with the suitable elution
system to give the corresponding azide 2.
(2,3,4,6-Tetra-O-acetyl-r-D-galactopyranosyl)methyl azide (2a).
Column chromatography with 2:1 cyclohexane-AcOEt afforded
2a (248 mg, 64%) as a yellow syrup. [R]D ) 53.0 (c 1.3, CHCl3).
1H NMR (400 MHz): δ ) 5.44 (dd, 1 H, J3.4 ) 3.3 Hz, J4,5 ) 3.5
Hz, H-4), 5.27 (dd, 1 H, J1,2 ) 4.6 Hz, J2,3 ) 8.5 Hz, H-2), 5.21
(dd, 1 H, H-3), 4.39 (dd, 1 H, J5.6a ) 8.0 Hz, J6a,6b ) 11.7 Hz,
H-6a), 4.37 (ddd, 1 H, J1,1′a ) 8.8 Hz, J1,1′b ) 3.7 Hz, H-1), 4.24
(ddd, 1 H, J5,6b ) 4.7 Hz, H-5), 4.10 (dd, 1 H, H-6b), 3.61 (dd, 1
H, J1′a,1′b ) 13.5 Hz, H-1′a), 3.28 (dd, 1 H, H-1′b), 2.12, 2.10, 2.07,
and 2.05 (4s, 12 H, CH3). 13C NMR: δ ) 170.7, 169.8, 169.6, 169.5,
70.8, 69.9, 67.7, 67.6, 66.9, 60.7, 48.3, 20.7 (3C), 20.6. MALDI-
TOF MS: 426.4 (M+ + K). Anal. Calcd for C15H21N3O9 (387.13):
C, 46.51; N, 10.85; H, 5.46. Found: C, 46.50; N, 10.88; H, 5.45.
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(2,3,5-Tri-O-acetyl-r-D-ribofuranosyl)methyl Azide (2c). Column
chromatography with 2.5:1 cyclohexane-AcOEt afforded 2c (208
mg, 66%) as a white foam. [R]D ) 55.8 (c 1.4, CHCl3). 1H NMR
(400 MHz): δ ) 5.54 (dd, 1 H, J1,2 ) 4.7 Hz, J2,3 ) 5.0 Hz, H-2),
5.32-5.26 (m, 1 H, H-3), 4.38 (ddd, 1 H, J1,1′a ) 7.2 Hz, J1,1′b )
5.5 Hz, H-1), 4.33-4.24 (m, 2 H, H-4, H-5a), 4.16-4.08 (m, 1 H,
H-5b), 3.51 (dd, 1 H, J1′a,1′b ) 13.0 Hz, H-1′a), 3.40 (dd, 1 H,
H-1′b), 2.16, 2.12, and 2.08 (3s, 9 H, CH3). 13C NMR: δ ) 170.6,
169.6, 169.5, 77.8, 77.6, 71.8, 71.5, 63.4, 50.2, 20.8, 20.6, 20.5.
MALDI-TOF MS: 338.1 (M+ + Na). Anal. Calcd for C12H17N3O7
(315.11): C, 45.71; N, 13.33; H, 5.43. Found: C, 45.74; N, 13.35;
H, 5.40.
(2,3,5-Tri-O-acetyl--D-ribofuranosyl)methyl azide (2d). Column
chromatography with 2.5:1 cyclohexane-AcOEt afforded 2d (214
mg, 68%) as a white foam. [R]D ) -76.3 (c 1.7, CHCl3). 1H NMR
(400 MHz): δ ) 5.18-5.13 (m, 2 H, H-2, H-3), 4.34 (dd, 1 H,
J4.5a ) 2.9 Hz, J5b,5a ) 11.9 Hz, H-5a), 4.21 (ddd, 1 H, J3,4 ) 5.5
Hz, J4,5b ) 5.0 Hz, H-4), 4.15 (dd, 1 H, H-5b), 4.13 (ddd, 1 H, J1,2
) 5.5 Hz, J1,1′a ) 3.1 Hz, J1,1′b ) 4.2 Hz, H-1), 3.60 (dd, 1 H,
J1′a,1′b ) 13.3 Hz, H-1′a), 3.36 (dd, 1 H, H-1′b), 2.11, 2.09, and
2.07 (3s, 9 H, CH3). 13C NMR: δ ) 170.6, 169.7, 169.6, 80.6,
79.4, 71.6, 71.4, 63.2, 51.6, 20.7, 20.5 (2C). MALDI-TOF MS:
338.4 (M+ + Na). Anal. Calcd for C12H17N3O7 (315.11): C, 45.71;
N, 5.43; H, 35.5. Found: C, 45.73; N, 13.34; H, 5.44.
General Procedure for the Synthesis of 1-Glycosylmethyl-5-
tosyl tetrazoles 3 and 4. A mixture of either azide 1 or 2 (0.50
mmol) and commercially available p-toluensulfonyl cyanide (181
mg, 1.00 mmol) was stirred at 100 °C in the absence of solvent
under a nitrogen atmosphere and then cooled to room temperature.
The excess of p-toluensulfonyl cyanide was then removed by
sublimation under vacuum to give nearly pure tetrazole 3 or 4.
Analytical quality samples of 3 and 4 were obtained by eluting the
corresponding crude derivative from a column of silica gel with
the suitable elution system.
1-(2,3,4,6-Tetra-O-benzyl-r-D-galactopyranosylmethyl)-5-(p-tolu-
ensulfonyl)-1H-tetrazole (3a). Column chromatography with 4.5:1
cyclohexane-AcOEt afforded 3a (319 mg, 84%) as a white
amorphous solid. [R]D ) 47.1 (c 1.1, CHCl3). 1H NMR (400 MHz):
δ ) 8.00-7.90 (m, 2 H, Ar), 7.50-7.20 (m, 20 H, Ar), 7.18-7.10
(m, 2 H, Ar), 5.10 (dd, 1 H, J1,1′a ) 10.3 Hz, J1′a,1′b ) 14.2 Hz,
H-1′a), 4.89 (dd, 1 H, J1,1′b ) 3.6 Hz, H-1′b), 4.75 and 4.57 (2 d,
2 H, J ) 11.8 Hz, PhCH2), 4.74 and 4.67 (2 d, 2 H, J ) 11.5 Hz,
PhCH2), 4.71 and 4.66 (2 d, 2 H, J ) 11.8 Hz, PhCH2), 4.65 (ddd,
1 H, J1,2 ) 4.5 Hz, H-1), 4.30 and 4.23 (2 d, 2 H, J ) 12.0 Hz,
PhCH2), 4.18-4.08 (m, 2 H, H-4, H-5), 4.03 (dd, 1 H, J2,3 ) 7.5
Hz, H-2), 3.79 (dd, 1 H, J3.4 ) 2.6 Hz, H-3), 3.63 (dd, 1 H, J5,6a )
6.0 Hz, J6a,6b ) 10.4 Hz, H-6a), 3.60 (dd, 1 H, J5,6b ) 7.0 Hz,
H-6b), 2.43 (s, 3 H, CH3). 13C NMR: δ ) 155.1, 147.2, 138.3,
138.1, 137.6, 137.5, 134.4, 130.3 (2C), 129.2 (2C), 127.9-127.0
(20C), 75.2, 75.1, 73.7, 73.6, 73.4, 73.2, 72.9, 72.8, 70.9, 66.9,
47.7, 21.9. MALDI-TOF MS: 783.4 (M+ + Na). Anal. Calcd for
C43H44N4O7S (760.29): C, 67.88; N, 7.36; H, 5.83; S, 4.21. Found:
C, 67.89; N, 7.32; H, 5.81; S, 4.23.
1-(2,3,5-Tri-O-benzyl-r-D-ribofuranosylmethyl)-5-(p-toluensul-
fonyl)-1H-tetrazole (3c). Column chromatography with 4:1 cyclo-
hexane-AcOEt afforded 3c (256 mg, 80%) as a white amorphous
solid. [R]D ) 43.6 (c 2.0, CHCl3). 1H NMR (400 MHz): δ )
8.00-7.90 (m, 2 H, Ar), 7.50-7.30 (m, 15 H, Ar), 7.30-7.10 (m,
2 H, Ar), 5.37 (dd, 1 H, J1,1′a ) 9.9 Hz, J1′a,1′b ) 14.2 Hz, H-1′a),
4.82 (dd, 1 H, J1,1′b ) 2.8 Hz, H-1′b), 4.74 and 4.59 (2 d, 2 H, J
) 11.8 Hz, PhCH2), 4.70 and 4.63 (2 d, 2 H, J ) 12.0 Hz, PhCH2),
4.64 (ddd, 1 H, J1,2 ) 6.5 Hz, H-1), 4.53 (ddd, 1 H, J3,4 ) 2.8 Hz,
J4,5a ) 3.6 Hz, J4,5b ) 4.0 Hz, H-4), 4.51 and 4.43 (2 d, 2 H, J )
12.2 Hz, PhCH2), 4.29 (dd, 1 H, J2,3 ) 5.5 Hz, H-2), 4.06 (dd, 1
H, H-3), 3.47 (dd, 1 H, J5a,5b ) 10.5 Hz, H-5a), 3.44 (dd, 1 H,
H-5b), 2.45 (s, 3 H, CH3). 13C NMR: δ ) 155.4, 147.1, 137.9,
137.7, 137.4, 134.2, 130.2 (2C), 129.1 (2C), 128.5-127.6 (15C),
81.6, 78.2, 77.9, 77.8, 73.5, 72.9, 72.4, 70.2, 50.7, 21.8. MALDI-
TOF MS: 641.3 (M+ + H). Anal. Calcd for C35H36N4O6S (640.24):
C, 65.61; N, 8.74; H, 5.66; S, 5.00. Found: C, 65.63; N, 8.71; H,
5.67; S, 5.02.
1-(2,3,4,6-Tetra-O-acetyl-r-D-galactopyranosylmethyl)-5-(p-tolu-
ensulfonyl)-1H-tetrazole (4a). Column chromatography with 2:1
cyclohexane-AcOEt afforded 4a (267 mg, 94%) as a white
amorphous solid. [R]D ) 59.7 (c 1.0, CHCl3). 1H NMR (400 MHz):
δ ) 8.01-7.97 (m, 2 H, Ar), 7.49-7.42 (m, 2 H, Ar), 5.49 (dd, 1
H, J3,4 ) 3.3 Hz, J4,5 ) 3.2 Hz, H-4), 5.43 (dd, 1 H, J1,2 ) 4.8 Hz,
J2,3 ) 8.5 Hz, H-2), 5.28 (dd, 1 H, H-3), 5.06 (dd, 1 H, J1,1′a )
10.8 Hz, J1′a,1′b ) 14.5 Hz, H-1′a), 4.95 (dd, 1 H, J1,1′b ) 3.0 Hz,
H-1′b), 4.75 (ddd, 1 H, H-1), 4.35 (ddd, 1 H, J5,6a ) 8.5 Hz, J5,6b
) 4.5 Hz, H-5), 4.21 (dd, 1 H, J6a,6b ) 11.8 Hz, H-6a), 4.04 (dd,
1 H, H-6b), 2.49 (s, 3 H, CH3), 2.21, 2.11, 2.08 and 1.93 (4s, 12
H, CH3). 13C NMR: δ )170.6, 169.8, 169.7, 169.6, 154.9, 147.6,
134.1, 130.4 (2C), 129.3 (2C), 70.4, 69.7, 67.3, 67.0, 66.8, 60.4,
46.4, 21.9, 20.7 (2C), 20.6 (2C). MALDI-TOF MS: 607.5 (M+ +
K). Anal. Calcd for C23H28N4O11S (568.15): C, 48.59; N, 9.85; H,
4.96; S, 5.64. Found: C, 48.57; N, 9.83; H, 4.92; S, 5.66.
1-(2,3,4,6-Tetra-O-acetyl--D-galactopyranosylmethyl)-5-(p-tolu-
ensulfonyl)-1H-tetrazole (4b). Column chromatography with 2:1
cyclohexane-AcOEt afforded 4b (264 mg, 93%) as a white
amorphous solid. [R]D ) -7.8 (c 1.4, CHCl3). 1H NMR: δ )
8.01-7.95 (m, 2 H, Ar), 7.47-7.42 (m, 2 H, Ar), 5.42 (dd, 1 H,
J3,4 ) 3.3 Hz, J4,5 ) 0.5 Hz, H-4), 5.28 (dd, 1 H, J1,2 ) 9.8 Hz, J2,3
) 9.9 Hz, H-2), 5.13 (dd, 1 H, H-3), 5.08 (dd, 1 H, J1,1′a ) 9.2 Hz,
J1′a,1′b ) 14.5 Hz, H-1′a), 4.87 (dd, 1 H, J1,1′b ) 2.5 Hz, H-1′b),
4.05-3.90 (m, 3 H, H-1, 2H-6), 3.79 (ddd, 1 H, J5,6a ) 6.7 Hz,
J5,6b ) 6.8 Hz, H-5), 2.49 (s, 3 H, CH3), 2.18, 2.15, 2.01, and 1.94
(4s, 12 H, CH3). 13C NMR: δ ) 170.6, 170.5, 170.4, 170.2, 155.4,
147.6, 134.3, 130.4 (2C), 129.3 (2C), 76.4, 74.2, 71.5, 67.4, 67.3,
61.1, 50.6, 21.9, 20.7, 20.6, 20.5, 20.4. MALDI-TOF MS: 591.4
(M+ + Na). Anal. Calcd for C23H28N4O11S (568.15): C, 48.59; N,
9.85; H, 4.96; S, 5.64. Found: C, 48.57; N, 9.83; H, 4.92; S, 5.66.
1-(2,3,5-Tri-O-acetyl-r-D-ribofuranosylmethyl)-5-(p-toluensulfo-
nyl)-1H-tetrazole (4c). Column chromatography with 1.5:1 cyclo-
hexane-AcOEt afforded 4c (243 mg, 98%) as a white amorphous
solid. [R]D ) 48.8 (c 1.2, CHCl3). 1H NMR (400 MHz): δ )
8.01-7.97 (m, 2 H, Ar), 7.47-7.42 (m, 2 H, Ar), 5.56 (dd, 1 H,
J1,2 ) 5.5 Hz, J2,3 ) 5.2 Hz, H-2), 5.34 (dd, 1 H, J3,4 ) 5.0 Hz,
H-3), 5.23 (dd, 1 H, J1,1′a ) 9.8 Hz, J1′a,1′b ) 14.5 Hz, H-1′a),
4.88-4.80 (m, 2 H, H-1, H-1′b), 4.46 (ddd, 1 H, J4,5a ) 3.2 Hz,
J4,5b ) 4.8 Hz, H-4), 4.22 (dd, 1 H, J5a,5b ) 12.2 Hz, H-5a), 4.14
(dd, 1 H, H-5b), 2.50 (s, 3 H, CH3), 2.19, 2.14, and 2.09 (3s, 9 H,
CH3). 13C NMR: δ ) 170.4, 169.7, 169.3, 155.5, 147.5, 134.3,
130.3 (2C), 129.2 (2C), 79.1, 77.4, 71.9, 71.0, 63.2, 49.3, 21.9,
20.7, 20.6, 20.4. MALDI-TOF MS: 497.4 (M+ + H). Anal. Calcd
for C20H24N4O9S (496.13): C, 48.38; N, 11.28; H, 4.87; S, 6.46.
Found: C, 48.35; N, 11.26; H, 4.85; S, 6.47.
1-(2,3,5-Tri-O-acetyl--D-ribofuranosylmethyl)-5-(p-toluensulfo-
nyl)-1H-tetrazole (4d). Column chromatography with 1.5:1 cyclo-
hexane-AcOEt afforded 4d (223 mg, 90%) as a white amorphous
solid. [R]D ) -23.6 (c 1.3, CHCl3). 1H NMR (400 MHz): δ )
8.02-7.97 (m, 2 H, Ar), 7.45-7.40 (m, 2 H, Ar), 5.19-5.12 (m,
3 H, H-2, H-3, H-1′a), 5.03 (dd, 1 H, J1,1′b ) 5.8 Hz, J1′a,1′b ) 14.1
Hz, H-1′b), 4.54-4.48 (m, 1 H, H-1), 4.20 (ddd, 1 H, J3,4 ) 4.0
Hz, J4,5a ) 3.2 Hz, J4,5b ) 3.0 Hz, H-4), 4.11 (dd, 1 H, J5a,5b )
12.3 Hz, H-5a), 4.06 (dd, 1 H, H-5b), 2.48 (s, 3 H, CH3), 2.10,
2.08, and 2.03 (3s, 9 H, CH3). 13C NMR: δ ) 170.5, 169.7 (2C),
155.7, 147.5, 134.5, 130.3 (2C), 129.3 (2C), 80.7, 78.1, 71.9, 71.7,
63.0, 50.2, 21.8, 20.7, 20.5, 20.3. MALDI-TOF MS: 519.7 (M+ +
Na). Anal. Calcd for C20H24N4O9S (496.13): C, 48.38; N, 11.28;
H, 4.87; S, 6.46. Found: C, 48.35; N, 11.26; H, 4.85; S, 6.47.
General Procedure for the Synthesis of Masked Glycosyl
Amino Acids 12 (Table 1). To a stirred solution of D-serinol 11
(92 mg, 0.40 mmol) in anhydrous DMF (4 mL) was added NaH
(32 mg, 0.80 mmol of a 60% dispersion in oil). The mixture was
stirred at room temperature for 30 min and then diluted with a
solution of sugar tetrazole 3 (304 mg, 0.40 mmol) in anhydrous
DMF (2 mL). The resulting solution was stirred at room temperature
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for 16 h, diluted with saturated aqueous NH4Cl (10 mL), and
extracted with AcOEt (3 × 50 mL). The combined organic phases
were dried (Na2SO4), concentrated, and eluted from a column of
silica gel with the suitable elution system to give the corresponding
adduct 12.
(4R)-2,2-Dimethyl-4-[1-(2′,3′,4′,6′-tetra-O-benzyl-r-D-galactopy-
ranosylmethyl)-1H-tetrazol-5-yloxymethyl)]oxazolidine-3-carboxy-
lic Acid tert-Butyl Ester (12a). Column chromatography with 3:1
cyclohexane-AcOEt afforded 12a (268 mg, 80%) as a white foam.
[R]D ) 37.4 (c 1.3, CHCl3). 1H NMR (DMSO-d6, 120 °C) selected
data: δ ) 7.40-7.20 (m, 20 H, Ph), 4.72 and 4.62 (2 d, 2 H, J )
11.5 Hz, PhCH2), 4.70 and 4.54 (2 d, 2 H, J ) 11.8 Hz, PhCH2),
4.25-4.18 (m, 1 H), 4.16-4.08 (m, 1 H), 3.64 (d, 2 H, J ) 6.0
Hz), 1.45 and 1.43 (2s, 6 H), 1.42 (s, 9 H). MALDI-TOF MS:
858.8 (M+ + Na). Anal. Calcd for C47H57N5O9 (835.42): C, 67.53;
N, 8.38; H, 6.87. Found: C, 67.55; N, 8.34; H, 6.81.
(4R)-2,2-Dimethyl-4-[1-(2′,3′,4′,6′-tetra-O-benzyl--D-galactopy-
ranosylmethyl)-1H-tetrazol-5-yloxymethyl)]oxazolidine-3-carboxy-
lic Acid tert-Butyl Ester (12b). Column chromatography with 3:1
cyclohexane-AcOEt afforded 12b (284 mg, 85%) as a yellow
syrup. [R]D ) 1.5 (c 2.3, CHCl3). 1H NMR (DMSO-d6, 120 °C): δ
) 7.40-7.10 (m, 20 H, Ph), 4.92 and 4.56 (2 d, 2 H, J ) 11.5 Hz,
PhCH2), 4.83 and 4.67 (2 d, 2 H, J ) 11.2 Hz, PhCH2), 4.81 and
4.72 (2 d, 2 H, J ) 12.0 Hz, PhCH2), 4.54 and 4.42 (2 d, 2 H, J )
10.5 Hz, PhCH2), 4.46-4.34 (m, 3 H), 4.28-4.14 (m, 2 H), 4.06
(dd, 1 H, J ) 1.0 Hz, J ) 2.5 Hz), 3.92 (d, 2 H, J ) 4.5 Hz),
3.82-3.72 (m, 3 H), 3.67 (ddd, 1 H, J ) 1.0 Hz, J ) 6.0 Hz, J )
7.5 Hz), 3.56 (dd, 1 H, J ) 6.0 Hz, J ) 10.5 Hz), 3.46 (dd, 1 H,
J ) 6.5 Hz, J ) 10.5 Hz), 1.49 and 1.43 (2s, 6 H), 1.42 (s, 9 H).
MALDI-TOF MS: 836.7 (M+ + H). Anal. Calcd for C47H57N5O9
(835.42): C, 67.53; N, 8.38; H, 6.87. Found: C, 67.54; N, 8.33; H,
6.82.
(4R)-2,2-Dimethyl-4-[1-(2′,3′,5′-tri-O-benzyl-r-D-ribofuranosyl-
methyl)-1H-tetrazol-5-yloxymethyl)]oxazolidine-3-carboxylic Acid
tert-Butyl Ester (12c). Column chromatography with 3:1 cyclo-
hexane-AcOEt afforded 12c (237 mg, 83%) as a white foam. [R]D
) 49.2 (c 1.4, CHCl3). 1H NMR (DMSO-d6, 120 °C): δ )
7.40-7.20 (m, 15 H, Ph), 4.75 and 4.62 (2 d, 2 H, J ) 11.5 Hz,
PhCH2), 4.68 and 4.62 (2 d, 2 H, J ) 11.8 Hz, PhCH2), 4.57 (dd,
1 H, J ) 4.5 Hz, J ) 10.5 Hz), 4.52-4.30 (m, 5 H), 4.48 (s, 2 H,
PhCH2), 4.22-4.15 (m, 2 H), 4.12 (t, 1 H, J ) 4.5 Hz), 4.00-3.88
(m, 2 H), 3.51 (d, 2 H, J ) 5.5 Hz), 1.45 and 1.43 (2s, 6 H), 1.42
(s, 9 H). MALDI-TOF MS: 836.7 (M+ + K). Anal. Calcd for
C39H49N5O8 (715.36): C, 65.44; N, 9.78; H, 6.90. Found: C, 65.44;
N, 9.72; H, 6.93.
(4R)-2,2-Dimethyl-4-[1-(2′,3′,5′-tri-O-benzyl--D-ribofuranosyl-
methyl)-1H-tetrazol-5-yloxymethyl)]oxazolidine-3-carboxylic Acid
tert-Butyl Ester (12d). Column chromatography with 3:1 cyclo-
hexane-AcOEt afforded 12d (223 mg, 78%) as a white foam. [R]D
) -3.4 (c 1.3, CHCl3). 1H NMR (DMSO-d6, 120 °C): δ )
7.40-7.20 (m, 15 H, Ph), 4.62 and 4.53 (2 d, 2 H, J ) 11.5 Hz,
PhCH2), 4.58 (dd, 1 H, J ) 3.2 Hz, J ) 10.0 Hz), 4.56 (s, 2 H,
PhCH2), 4.48 (s, 2 H, PhCH2), 4.44 (dd, 1 H, J ) 7.0 Hz, J ) 10.0
Hz), 4.34-4.18 (m, 4 H), 4.14-4.08 (m, 1 H), 4.02-3.94 (m, 4
H), 3.47 (dd, 1 H, J ) 4.5 Hz, J ) 10.5 Hz), 3.43 (dd, 1 H, J )
5.0 Hz, J ) 10.5 Hz), 1.48 and 1.44 (2s, 6 H), 1.42 (s, 9 H).
MALDI-TOF MS: 738.4 (M+ + Na). Anal. Calcd for C39H49N5O8
(715.36): C, 65.44; N, 9.78; H, 6.90. Found: C, 65.41; N, 9.73; H,
6.92.
General Procedure for the Synthesis of Glycosylmethyl Tetra-
zole Serines 5 (Table 1). To a stirred solution of adduct 12 (167
mg, 0.20 mmol) in MeCN (2 mL) was added BiBr3 (9 mg, 0.02
mmol) in one portion. The resulting mixture was stirred at room
temperature for 6 h, diluted with saturated aqueous NaHCO3
solution (5 mL), and extracted with AcOEt (3 × 25 mL). The
combined organic phases were dried (Na2SO4), and concentrated
to give the corresponding crude N-Boc amino alcohol.
To a cooled (0 °C), stirred solution of the above crude N-Boc
amino alcohol (159 mg, ∼0.20 mmol) in acetone (6 mL) freshly
prepared 1 M Jones reagent (0.60 mL, 0.60 mmol) was added in
one portion. The mixture was allowed to warm to room temperature
in 30 min, stirred at room temperature for an additional 1.5 h, and
then diluted with i-PrOH (0.5 mL). The suspension was neutralized
with saturated aqueous NaHCO3, diluted with AcOEt (80 mL), and
then washed with brine (2 × 5 mL). The organic phase was dried
(Na2SO4) and concentrated to afford the corresponding crude
carboxylic acid derivative.
To a stirred, cooled (0 °C) solution of the above crude carboxylic
acid in CH2Cl2 (2.0 mL) was added an ethereal solution of CH2N2
until a pale yellow color persisted. The solution was stirred for an
additional 15 min at 0 °C and then dried under vacuum. The residue
was eluted from a column of silica gel with the suitable elution
system to give the corresponding glycosylmethyl tetrazole serine
5.
(2S)-2-tert-Butoxycarbonylamino-3-[1-(2′,3′,4′,6′-tetra-O-benzyl-
r-D-galactopyranosylmethyl)-1H-tetrazol-5-yloxy]propionic Acid
Methyl Ester (5a). Column chromatography with 2.5:1 cyclo-
hexane-AcOEt afforded 5a (102 mg, 62%) as a white foam. [R]D
) 16.1 (c 1.1, CHCl3). 1H NMR (400 MHz): δ ) 7.44-7.14 (m,
20 H, Ph), 6.07 (d, 1 H, J2,NH ) 7.5 Hz, NH), 4.80-4.62 (m, 5 H,
2H-3, 3 CHPh), 4.62-4.46 (m, 4 H, H-2, 3 CHPh), 4.45-4.36 (m,
1 H, H-1′), 4.35 (s, 2 H, CH2Ph), 4.25 (d, 2 H, J ) 8.0 Hz, 2H-
1′′), 4.16-4.09 (m, 1 H, H-5′), 4.02-3.94 (m, 2 H, H-2′, H-4′),
3.76 (dd, 1 H, J2′,3′ ) 7.6 Hz, J3′,4′ ) 2.7 Hz, H-3′), 3.70-3.60 (m,
1 H, H-6′a), 3.68 (s, 3 H, CH3), 3.54 (dd, 1 H, J5′,6′b ) 4.5 Hz,
J6′a,6′b ) 11.5 Hz, H-6′b), 1.43 (s, 9 H, t-Bu). 13C NMR: δ ) 169.5,
161.1, 155.3, 138.0 (2C), 137.7, 137.6, 128.6-127.4 (20C), 80.2,
75.3, 73.8, 73.5, 73.4, 73.3, 73.0, 72.9, 72.3, 70.5, 68.1, 53.1, 52.7,
43.6, 29.7, 28.3 (3C). MALDI-TOF MS: 846.7 (M+ + Na). Anal.
Calcd for C45H53N5O10 (823.38): C, 65.60; N, 8.50; H, 6.48. Found:
C, 65.62; N, 8.53; H, 6.41.
(2S)-2-tert-Butoxycarbonylamino-3-[1-(2′,3′,4′,6′-tetra-O-benzyl-
-D-galactopyranosylmethyl)-1H-tetrazol-5-yloxy]propionic Acid
Methyl Ester (5b). Column chromatography with 3:1 cyclo-
hexane-AcOEt afforded 5b (99 mg, 60%) as a white foam. [R]D
) 4.5 (c 1.0, CHCl3). 1H NMR (400 MHz): δ ) 7.45-7.10 (m, 20
H, Ph), 5.85 (d, 1 H, J2,NH ) 8.5 Hz, NH), 5.02 and 4.74 (2 d, 2 H,
J ) 11.2 Hz, PhCH2), 4.90 and 4.52 (2 d, 2 H, J ) 11.5 Hz,
PhCH2), 4.80-4.69 (m, 2 H, 2H-3), 4.76 and 4.66 (2 d, 2 H, J )
11.8 Hz, PhCH2), 4.66-4.59 (m, 1 H, H-2), 4.42 and 4.36 (2 d, 2
H, J ) 11.8 Hz, PhCH2), 4.32 (dd, 1 H, J1′,1′′a ) 2.8 Hz, J1′′a,1′′b )
14.1 Hz, H-1”a), 4.09 (dd, 1 H, J1′,1′′b ) 8.0 Hz, H-1′′b), 3.96 (dd,
1 H, J3′,4′ ) 2.6 Hz, J4′,5′ ) 0.5 Hz, H-4′), 3.80 (dd, 1 H, J1′,2′ ) 9.0
Hz, J2′,3′ ) 9.5 Hz, H-2′), 3.67 (dd, 1 H, H-3′), 3.65 (ddd, 1 H,
H-1′), 3.60 (s, 3 H, CH3), 3.52-3.45 (m, 3 H, H-5′, 2H-6′), 1.45
(s, 9 H, t-Bu). 13C NMR: δ ) 169.4, 161.5, 155.1, 138.5, 138.0,
137.9, 137.8, 129.0-127.0 (20C), 84.6, 80.5, 77.4, 76.6, 75.7, 75.1,
74.6, 73.4, 72.1, 68.5, 53.2, 52.8, 47.0, 26.7, 28.3 (3C). MALDI-
TOF MS: 824.2 (M+ + H). Anal. Calcd for C45H53N5O10 (823.38):
C, 65.60; N, 8.50; H, 6.48. Found: C, 65.62; N, 8.53; H, 6.41.
(2S)-2-tert-Butoxycarbonylamino-3-[1-(2′,3′,5′-tri-O-benzyl-r-D-
ribofuranosylmethyl)-1H-tetrazol-5-yloxy]propionic Acid Methyl
Ester (5c). Column chromatography with 2:1 cyclohexane-AcOEt
afforded 5c (94 mg, 67%) as a white foam. [R]D ) 44.9 (c 1.2,
CHCl3). 1H NMR (400 MHz): δ ) 7.40-7.20 (m, 15 H, Ph), 5.63
(d, 1 H, J2,NH ) 8.5 Hz, NH), 4.83 (d, 2 H, J ) 3.0 Hz, 2H-3),
4.71 and 4.52 (2 d, 2 H, J ) 11.5 Hz, PhCH2), 4.74-4.67 (m, 1 H,
H-2), 4.67 and 4.61 (2 d, 2 H, J ) 12.0 Hz, PhCH2), 4.50-4.34
(m, 6 H, 2H-1”, H-1′, H-4′, PhCH2), 4.22 (dd, 1 H, J1′,2′ ) 5.5 Hz,
J2′,3′ ) 5.3 Hz, H-2′), 4.02 (dd, 1 H, J3′,4′ ) 3.5 Hz, H-3′), 3.66 (s,
3 H, CH3), 3.52 (dd, 1 H, J4′,5′a ) 4.5 Hz, J5′a,5′b ) 10.5 Hz, H-5′a),
3.47 (dd, 1 H, J4′,5′b ) 4.0 Hz, H-5′b), 1.41 (s, 9 H, t-Bu). 13C
NMR: δ ) 169.5, 161.5, 155.1, 137.8, 137.6, 137.5, 128.5-127.5
(15C), 81.4, 80.5, 77.9, 77.6, 73.5, 72.9, 72.8, 72.3, 70.3, 53.2,
52.8, 46.4, 28.2 (4C). MALDI-TOF MS: 742.8 (M+ + K). Anal.
Calcd for C37H45N5O9 (703.32): C, 63.14; N, 9.95; H, 6.44. Found:
C, 63.17; N, 9.91; H, 6.45.
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(2S)-2-tert-Butoxycarbonylamino-3-[1-(2′,3′,5′-tri-O-benzyl--D-
ribofuranosylmethyl)-1H-tetrazol-5-yloxy]propionic Acid Methyl
Ester (5d). Column chromatography with 2:1 cyclohexane-AcOEt
afforded 5d (86 mg, 61%) as a white foam. [R]D ) -38.5 (c 1.2,
CHCl3). 1H NMR (400 MHz): δ ) 7.50-7.10 (m, 15 H, Ph), 5.83
(d, 1 H, J2,NH ) 8.5 Hz, NH), 4.89 (dd, 1 H, J2,3a ) 2.8 Hz, J3a,3b
) 10.3 Hz, H-3a), 4.62 (ddd, 1 H, J2,3b ) 3.4 Hz, H-2), 4.95 and
4.55 (2 d, 2 H, J ) 11.5 Hz, PhCH2), 4.54 (dd, 1 H, H-3b), 4.45
(s, 2 H, PhCH2), 4.38 and 4.20 (2 d, 2 H, J ) 12.0 Hz, PhCH2),
4.33-4.27 (m, 3 H, H-1′, 2H-1”), 4.16 (ddd, 1 H, J3′,4′ ) 2.2 Hz,
J4′,5′a ) 3.8 Hz, J4′,5′b ) 3.3 Hz, H-4′), 3.84 (dd, 1 H, J1′,2′ ) 8.0
Hz, J2′,3′ ) 5.0 Hz, H-2′), 3.75 (s, 3 H, CH3), 3.63 (dd, 1 H, H-3′),
3.17 (dd, 1 H, J5′a,5′b ) 10.2 Hz, H-5′a), 3.13 (dd, 1 H, H-5′b),
1.48 (s, 9 H, t-Bu). 13C NMR: δ ) 169.6, 161.6, 155.3, 137.5 (3C),
128.5-127.6 (15C), 82.3, 80.4, 78.1, 78.0, 77.2, 73.3, 72.8, 71.8,
69.3, 53.0, 52.9, 45.6, 28.3 (4C). MALDI-TOF MS: 726.4 (M+ +
Na). Anal. Calcd for C37H45N5O9 (703.32): C, 63.14; N, 9.95; H,
6.44. Found: C, 63.13; N, 9.94; H, 6.43.
(2S)-2-tert-Butoxycarbonylamino-3-[1-(-D-galactopyranosylm-
ethyl)-1H-tetrazol-5-yloxy]propionic Acid Methyl Ester (5b′). A
vigorously stirred mixture of 5b (165 mg, 0.20 mmol), 20%
palladium hydroxide on carbon (80 mg), and MeOH (4 mL) was
degassed under vacuum and saturated with hydrogen (by an H2-
filled balloon) three times. The suspension was stirred at room
temperature for 4 h under a slightly positive pressure of hydrogen
(balloon) and then filtered off through a plug of cotton and washed
thoroughly with MeOH (5 mL) and water (2 mL). The combined
filtrates were concentrated to afford crude 5b′ (88 mg, 95%) at
least 90% pure as established by 1H NMR analysis. 1H NMR
(CD3OD): δ ) 4.83-4.75 (m, 2 H, 2H-3), 4.72-4.65 (m, 1 H,
H-2), 4.51 (dd, 1 H, J1′,1′′a ) 3.5 Hz, J1′′a,1′′b ) 14.0 Hz, H-1′′a),
4.31 (dd, 1 H, J1′,1′′b ) 7.5 Hz, H-1”b), 3.85 (dd, 1 H, J3′,4′ ) 3.5
Hz, J4′,5′ ) 0.5 Hz, H-4′), 3.70-3.40 (m, 6 H, H-1′, H-2′, H-3′,
H-5′, 2H-6′), 3.77 (s, 3 H, CH3), 1.45 (s, 9 H, t-Bu). 13C NMR
(CD3OD): δ ) 169.6, 161.1, 155.8, 78.8, 77.5, 74.7, 71.9, 69.2,
68.9, 61.1, 53.1, 51.9, 47.1, 27.4 (4C). MALDI-TOF MS: 464.8
(M+ + H), 486.1 (M+ + Na).
General Procedure for the Synthesis of Glycosylmethyl Tetra-
zole Cysteines 6 (Table 2). To a stirred mixture of glycosylmethyl
tetrazole 4 (142 mg, 0.25 mmol), K2CO3 (103 mg, 0.75 mmol),
and anhydrous MeCN (2.5 mL) was added cysteine 13 (45 mg,
0.13 mmol) in one portion. The resulting mixture was stirred at
room temperature for 2 h, and then a second portion of cysteine
13 (45 mg, 0.13 mmol) was added. The mixture was stirred for an
additional 3 h and then concentrated. The resulting residue was
eluted from a column of silica gel with the suitable elution system
to give the corresponding glycosylmethyl tetrazole cysteine 6.
(2R)-2-(9H-Fluoren-9-ylmethoxycarbonylamino)-3-[1-(2′,3′,4′,6′-
tetra-O-acetyl-r-D-galactopyranosylmethyl)-1H-tetrazol-5-ylsulfa-
nyl)propionic Acid (6a). Column chromatography with 32.3:1
AcOEt-AcOH afforded 6a (174 mg, 92%) as a white amorphous
solid. [R]D ) 47.7 (c 0.6, CHCl3). 1H NMR (400 MHz): δ )
7.79-7.73 (m, 2 H, Ar), 7.64-7.55 (m, 2 H, Ar), 7.44-7.36 (m,
2 H, Ar), 7.35-7.28 (m, 2 H, Ar), 6.44 (d, 1 H, J2,NH ) 6.4 Hz,
NH), 5.45 (dd, 1 H, J ) 3.0 Hz, J ) 3.5 Hz, H-4′), 5.34-5.21 (m,
2 H, H-2′, H-3′), 4.82-4.68 (m, 1 H, H-2), 4.66-4.57 (m, 1 H,
H-1′), 4.57-4.43 (m, 2 H, 2H-1′′), 4.43-4.27 (m, 4 H, FmocCH2,
2H-6′), 4.27-4.19 (m, 1 H, FmocCH), 3.97-3.77 (m, 3 H, 2H-3,
H-5′), 2.15, 2.09, and 1.97 (3s, 12 H, CH3). 13C NMR: δ ) 171.3,
169.7 (2C), 169.6 (2C), 156.3, 154.1, 143.6 (2C), 141.3 (2C), 127.8
(2C), 127.1 (2C), 125.2 (2C), 120.0 (2C), 70.5, 68.6, 67.8, 67.5,
67.3, 66.3, 59.9, 47.0, 45.8, 36.0, 20.7 (2C), 20.6 (2C). MALDI-
TOF MS: 778.4 (M+ + Na). Anal. Calcd for C34H37N5O13S
(755.21): C, 54.03; N, 9.27; H, 4.93; S, 4.24. Found: C, 54.01; N,
9.26; H, 4.94; S, 4.23.
(2R)-2-(9H-Fluoren-9-ylmethoxycarbonylamino)-3-[1-(2′,3′,4′,6′-
tetra-O-acetyl--D-galactopyranosylmethyl)-1H-tetrazol-5-ylsulfa-
nyl)propionic Acid (6b). Column chromatography with 24:1
AcOEt-AcOH afforded 6b (170 mg, 90%) as a white amorphous
solid. [R]D ) 15.8 (c 1.2, CHCl3). 1H NMR: δ ) 7.80-7.73 (m, 2
H, Ar), 7.63-7.55 (m, 2 H, Ar), 7.45-7.35 (m, 2 H, Ar), 7.35-7.27
(m, 2 H, ar), 6.39 (d, 1 H, J2,NH ) 6.5 Hz, NH), 5.40 (dd, 1 H, J3′,4′
) 3.0 Hz, J4′,5′ ) 0.5 Hz, H-4′), 5.15 (dd, 1 H, J1′,2′ ) 9.5 Hz, J2′,3′
) 9.8 Hz, H-2′), 5.05 (dd, 1 H, H-3′), 4.81-4.70 (m, 1 H, H-2),
4.50-4.26 (m, 4 H, 2H-1′′, FmocCH2), 4.22 (t, 1 H, J ) 7.0 Hz,
FmocCH), 4.04 (dd, 1 H, J5′,6′a ) 6.5 Hz, J6′a,6′b ) 11.0 Hz, H-6′a),
3.98-3.80 (m, 3 H, H-3a, H-1′, H-6′b), 3.79-3.61 (m, 2 H, H-3b,
H-5′), 2.10, 2.00, and 1.90 (3s, 12 H, CH3). 13C NMR: δ ) 171.4,
171.0, 170.1, 170.0, 169.9, 156.2, 155.4, 143.6 (2c), 141.3 (2C),
127.8 (2C), 127.1 (2C), 125.1 (2C), 120.0 (2C), 76.2, 74.2, 71.4,
67.4, 67.2, 67.1, 61.3, 53.8, 48.7, 47.0, 35.7, 20.7, 20.6, 20.5 (2C).
MALDI-TOF MS: 801.6 (M+ + K). Anal. Calcd for C34H37N5O13S
(755.21): C, 54.03; N, 9.27; H, 4.93; S, 4.24. Found: C, 54.03; N,
9.25; H, 4.91; S, 4.24.
(2R)-2-(9H-Fluoren-9-ylmethoxycarbonylamino)-3-[1-(2′,3′,5′-tri-
O-acetyl-r-D-ribofuranosylmethyl)-1H-tetrazol-5-ylsulfanyl)propi-
onic Acid (6c). Column chromatography with 19:1 AcOEt-AcOH
afforded 6c (155 mg, 91%) as a white amorphous solid. [R]D ) 36.8
(c 1.1, CHCl3). 1H NMR: δ ) 7.74-7.60 (m, 2 H, Ar), 7.56-7.40
(m, 2 H, Ar), 7.37-7.20 (m, 2 H, Ar), 7.29-7.10 (m, 2 H, Ar), 6.42
(d, 1 H, J2,NH ) 7.5 Hz, NH), 5.49 (dd, 1 H, J1′,2′ ) 5.0 Hz, J2′,3′ )
5.5 Hz, H-2′), 5.27 (dd, 1 H, J3′,4′ ) 5.5 Hz, H-3′), 4.74 (ddd, 1 H,
J2,3a ) 3.5 Hz, J2,3b ) 6.5 Hz, H-2), 4.59 (ddd, 1 H, J1′,1”a ) 6.0 Hz,
J1′,1”b ) 6.0 Hz, H-1′), 4.46 (d, 2 H, 2H-1′′), 4.42-4.28 (3 H, H-4′,
FmocCH2), 4.22-4.12 (m, 2 H, H-5′a, FmocCH), 4.07 (dd, 1 H, J4′,5′a
) 4.5 Hz, J5′a,5′b ) 8.5 Hz, H-5′b), 3.93 (dd, 1 H, J3a,3b ) 14.5 Hz,
H-3a), 3.76 (dd, 1 H, H-3b), 2.11, 2.05, and 2.01 (3s, 9 H, CH3). 13C
NMR: δ ) 171.8, 170.8, 169.6, 169.5, 156.2, 154.6, 143.6, 143.5,
141.2, 141.1, 127.7 (2C), 127.1 (2C), 125.1 (2C), 120.0 (2C), 78.5,
77.2, 71.9, 71.1, 67.3, 63.2, 54.0, 47.3, 46.9, 35.8, 20.7, 20.5 (2C).
MALDI-TOF MS: 684.6 (M+ + H). Anal. Calcd for C31H33N5O11S
(683.19): C, 54.46; N, 10.24; H, 4.87; S, 4.69. Found: C, 54.48; N,
10.23; H, 4.81; S, 4.64.
(2R)-2-(9H-Fluoren-9-ylmethoxycarbonylamino)-3-[1-(2′,3′,5′-
tri-O-acetyl--D-ribofuranosylmethyl)-1H-tetrazol-5-ylsulfanyl)pro-
pionic Acid (6d). Column chromatography with 24:1 AcOEt-AcOH
afforded 6d (154 mg, 90%) as a white foam. [R]D ) -17.4 (c 1.2,
CHCl3). 1H NMR (400 MHz): δ ) 7.77-7.68 (m, 2 H, Ar),
7.65-7.55 (m, 2 H, Ar), 7.41-7.35 (m, 2 H, Ar), 7.30-7.25 (m,
2 H, Ar), 6.55 (d, 1 H, J2,NH ) 7.5 Hz, NH), 5.05 (dd, 1 H, J2′,3′ )
5.5 Hz, J3′,4′ ) 4.0 Hz, H-3′), 4.96 (dd, 1 H, J1′,2′ ) 7.5 Hz, H-2′),
4.73 (ddd, 1 H, J2,3a ) 3.5 Hz, J2,3b ) 7.0 Hz, H-2), 4.55 (dd, 1 H,
J1′,1′′a ) 4.0 Hz, J1′′a,1′′b ) 14.5 Hz, H-1”a), 4.50 (dd, 1 H, J1′,1”b )
4.5 Hz, H-1′′b), 4.40-4.30 (m, 3 H, H-1′, FmocCH2), 4.25-4.10
(m, 3 H, H-4′, H-5′a, FmocCH), 4.05 (dd, 1 H, J4′,5′b ) 3.5 Hz,
J5′a,5′b ) 12.0 Hz, H-5′b), 3.83 (dd, 1 H, J3a,3b ) 14.5 Hz, H-3),
3.73 (dd, 1 H, H-3b), 1.99, 2.06, and 2.07 (3s, 9 H, CH3). 13C NMR:
δ ) 171.9, 170.9, 169.8 (2C), 156.3, 155.4, 143.6 (2C), 141.2 (2C),
127.7 (2C), 127.1 (2C), 125.2 (2C), 119.9 (2C), 80.6, 78.2, 71.4,
67.5, 63.2, 53.9, 48.1, 47.0, 35.6, 20.7, 20.5, 20.4. MALDI-TOF
MS: 706.4 (M+ + Na). Anal. Calcd for C31H33N5O11S (683.19):
C, 54.46; N, 10.24; H, 4.87; S, 4.69. Found: C, 54.44; N, 10.21;
H, 4.87; S, 4.63.
Dipetide (15). To a cooled (0 °C), stirred solution of crude acid
14 (81 mg, ∼0.10 mmol), L-phenylalanine ethyl ester hydrochloride
(34 mg, 0.15 mmol), and (benzotriazol-1-yloxy)tripyrrolidinophos-
phonium hexafluorophosphate (62 mg, 0.12 mmol) in anhydrous
CH2Cl2 (2.0 mL) was added N,N-diisopropylethylamine (52 µL,
0.30 mmol). The solution was warmed to room temperature, stirred
for an additional 2 h, and then concentrated. The residue was
suspended with AcOEt (80 mL) and washed with H2O (2 × 10
mL). The organic phase was dried (Na2SO4), concentrated, and
eluted from a column of silica gel with 1:1 cyclohexane-AcOEt
to give dipeptide 15 (79 mg, 80%) as a white foam. [R]D ) 5.5 (c
1.0, CHCl3). 1H NMR (400 MHz) selected data: δ ) 7.40-7.00
(m, 25 H, Ar), 6.90 (bs, 1 H, NH), 5.60 (bs, 1 H, NH), 5.01 and
4.70 (2 d, 2 H, J ) 11.5 Hz, PhCH2), 4.88 and 4.72 (2 d, 2 H, J )
12.0 Hz, PhCH2), 4.42 and 4.34 (2 d, 2 H, J ) 11.8 Hz, PhCH2),
Aldhoun et al.
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4.08 (q, 2 H, J ) 7.0 Hz, CH2CH3), 3.86 (dd, 1 H, J3,4 ) 3.5 Hz,
J4,5 ) 0.5 Hz, H-4sug), 3.81 (dd, 1 H, J1,2 ) 9.0 Hz, J2,3 ) 9.5 Hz,
H-2sug), 3.68 (ddd, 1 H, J1,1′a ) 1.5 Hz, J1,1′b ) 2.0 Hz, H-1sug),
3.62 (dd, 1 H, H-3sug), 3.52-3.46 (m, 3 H, H-5sug, 2H-6sug), 3.06
(dd, 1 H, J ) 6.0 Hz, J ) 14.5 Hz), 2.98 (dd, 1 H, J ) 7.0 Hz, J
) 14.5 Hz), 1.40 (s, 9 H, t-Bu), 1.18 (t, 3 H, J ) 7.0 Hz, CH2CH3).
MALDI-TOF MS: 985.8 (M+ + H). Anal. Calcd for C55H64N6O11
(984.46): C, 67.06; N, 8.53; H, 6.55. Found: C, 67.03; N, 8.52; H,
6.58.
Tripeptide (16). To a cooled (0 °C), stirred solution of dipeptide
15 (79 mg, 0.08 mmol) in CH2Cl2 (2.0 mL) was slowly added a
solution of TFA-CH2Cl2 (0.50 mL-1.50 mL). Stirring was
continued at 0 °C for an additional 30 min, and then the solution
was warmed to room temperature. After 30 min at room temper-
ature, the solution was neutralized at 0 °C with saturated aqueous
Na2CO3 and extracted with CH2Cl2 (2 × 50 mL). The combined
organic phases were dried (Na2SO4) and concentrated to give the
corresponding crude free amine (70 mg), which was used for the
following reaction without any purification.
To a cooled (0 °C), stirred solution of the above crude amine
(70 mg, ∼0.08 mmol), tert-butoxycarbonyl-L-alanine (22 mg, 0.12
mmol), and (benzotriazol-1-yloxy)tripyrrolidinophosphonium hexaflu-
orophosphate (73 mg, 0.14 mmol) in anhydrous CH2Cl2 (2.0 mL)
was added N,N-diisopropylethylamine (60 µL, 0.35 mmol). The
solution was warmed to room temperature, stirred for an additional
2 h, and then concentrated. The residue was suspended with AcOEt
(80 mL) and washed with saturated aqueous NaHCO3 (10 mL) and
brine (10 mL). The organic phase was dried (Na2SO4), concentrated,
and eluted from a column of silica gel with 1.5:1 cyclohexane-AcOEt
to give tripeptide 16 (60 mg, 72% from 15). [R]D ) -14.8 (c 0.7,
CHCl3). 1H NMR (400 MHz) selected data: δ ) 7.40-7.00 (m,
27 H, Ar, 2 NH), 5.08 (bs, 1 H, NH), 5.00 and 4.70 (2 d, 2 H, J )
11.5 Hz, PhCH2), 4.80 and 4.56 (2 d, 2 H, J ) 11.0 Hz, PhCH2),
4.09 (q, 2 H, J ) 7.0 Hz, CH2CH3), 3.98 (dd, 1 H, J3,4 ) 3.5 Hz,
J4,5 ) 0.5 Hz, H-4sug), 3.80 (dd, 1 H, J1,2 ) 9.0 Hz, J2,3 ) 9.5 Hz,
H-2sug), 3.73-3.64 (m, 2 H, H-1sug, H-3sug), 3.52-3.40 (m, 3 H,
H-5s, 2H-6s), 3.10 (dd, 1 H, J ) 6.0 Hz, J ) 14.5 Hz), 3.00 (dd,
1 H, J ) 7.0 Hz, J ) 14.5 Hz), 1.40 (s, 9 H, t-Bu), 1.28 (d, 3 H,
J ) 7.0 Hz, CH3), 1.17 (t, 3 H, J ) 7.0 Hz, CH2CH3). MALDI-
TOF MS: 1056.9 (M+ + H). Anal. Calcd for C58H69N7O12
(1055.50): C, 65.95; N, 9.28; H, 6.58. Found: C, 65.93; N, 9.23;
H, 6.56.
Acknowledgment. We greatly acknowledge the University
of Ferrara for financial support.
Supporting Information Available: General experimental
methods and NMR spectra for new compounds. This material
is available free of charge via the Internet at http://pubs.acs.org.
JO801670K
(32) (a) BeMiller, J. N.; Yadav, M. P.; Kalabokis, V. N.; Myers, R. W.
Carbohydr. Res. 1990, 200, 111–126. (b) Bhat, A. S.; Gervay-Hague, J. Org.
Lett. 2001, 3, 2081–2084.
Synthesis of Tetrazole-Tethered C-Glycosyl R-Amino Acids
J. Org. Chem. Vol. 73, No. 24, 2008 9575
